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ABSTRACT

ANDREA KELSEY ANDERSON. Regulation of Murine Physiology and
Metabolism by the Adipocyte Circadian Clock through Sphingosine
Kinase 1. (Under the direction of LAUREN ASHLEY COWART).

The adipocyte, widely known for its large lipid droplets, is a crucial signaling
cell at the crux of metabolism. Programs within the adipocyte itself may have
massive impacts upon the body. For example, the internal cell-autonomous
circadian clock within the adipocyte regulates such lipid droplet-associated
processes as lipolysis (triacylglycerol breakdown) and lipogenesis (lipid uptake,
triacylglycerol synthesis), which influence circulating lipids, thus impacting other
organs. Circadian rhythms (molecular, metabolic, and behavioral patterning over a
day) and lipid droplets are both highly evolutionarily conserved biological
phenomena that also happen to be intertwined in the system about which we care
today, the global human obesity pandemic. Excessive adiposity is a hallmark of
obesity, and humans live in an extraordinarily artificially-lit world, which serves to
disrupt circadian clocks, thereby disrupting metabolism.
Characterized by their unique sphingosine backbone, sphingolipids, which
may derive, in part, from the excess of adiposity and lipid free fatty acids, are well
known to affect metabolic disease phenotypes. As the Cowart lab has shown in the
past, and as shown in this work, sphingosine kinase 1 (SPHK1) and its enzymatic
product sphingosine-1-phosphate (S1P) affect cellular signaling pathways that
directly influence metabolism. SPHK1 is a lipid kinase which phosphorylates
sphingosine (an N-acylated amino alcohol) to S1P, a bioactive autocrine and

paracrine signaling lipid, to influence various processes including cellular survival,
angiogenesis, endothelial permeability, immune cell trafficking, and oncogenesis.
Since SPHK1 is highly involved in metabolism, such as glucose metabolism, and
since metabolism is a circadian-governed process, we hypothesized that SPHK1 is
involved in the regulation of the adipocyte circadian clock, which may impact
circulating metabolites, such as glucose, fatty acids, and adipokines, thereby
affecting weight gain and glucose tolerance. Using a wide variety of techniques and
methodologies including RNA sequencing, mass spectrometry coupled with
lipidomics and proteomics, chromatin immunoprecipitation (ChIP), protein coimmunoprecipitation, microscopy, gene and protein expression analysis, we
conclude that novel properties of SPHK1 and S1P elicit changes in nuclear
chromatin remodeling events, leading to circadian clock disruption and subsequent
impairment of key metabolic physiological parameters in the mouse. To our
knowledge, his is the first report of a lipid metabolite directly affecting the circadian
clock.
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ABSTRACT
The adipocyte, widely known for its large lipid droplets, is a crucial signaling
cell at the crux of metabolism. Programs within the adipocyte itself may have
massive impacts upon the body. For example, the internal cell-autonomous
circadian clock within the adipocyte regulates such lipid droplet-associated
processes as lipolysis (triacylglycerol breakdown) and lipogenesis (lipid uptake,
triacylglycerol synthesis), which influence circulating lipids, thus impacting other
organs. Circadian rhythms (molecular, metabolic, and behavioral patterning over a
day) and lipid droplets are both highly evolutionarily conserved biological
phenomena that also happen to be intertwined in the system about which we care
today, the global human obesity pandemic. Excessive adiposity is a hallmark of
obesity, and humans live in an extraordinarily artificially-lit world, which serves to
disrupt circadian clocks, thereby disrupting metabolism.
Characterized by their unique sphingosine backbone, sphingolipids, which
may derive, in part, from the excess of adiposity and lipid free fatty acids, are well
known to affect metabolic disease phenotypes. As the Cowart lab has shown in the
past, and as shown in this work, sphingosine kinase 1 (SPHK1) and its enzymatic
product sphingosine-1-phosphate (S1P) affect cellular signaling pathways that
directly influence metabolism. SPHK1 is a lipid kinase which phosphorylates
sphingosine (an N-acylated amino alcohol) to S1P, a bioactive autocrine and
paracrine signaling lipid, to influence various processes including cellular survival,
angiogenesis, endothelial permeability, immune cell trafficking, and oncogenesis.
Since SPHK1 is highly involved in metabolism, such as glucose metabolism, and
since metabolism is a circadian-governed process, we hypothesized that SPHK1 is
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involved in the regulation of the adipocyte circadian clock, which may impact
circulating metabolites, such as glucose, fatty acids, and adipokines, thereby
affecting weight gain and glucose tolerance. Using a wide variety of techniques and
methodologies including RNA sequencing, mass spectrometry coupled with
lipidomics and proteomics, chromatin immunoprecipitation (ChIP), protein coimmunoprecipitation, microscopy, gene and protein expression analysis, we
conclude that novel properties of SPHK1 and S1P elicit changes in nuclear
chromatin remodeling events, leading to circadian clock disruption and subsequent
impairment of key metabolic physiological parameters in the mouse. To our
knowledge, this is the first report of a lipid metabolite directly affecting the circadian
clock.
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PREFACE
This project began with the generation of the adipocyte-specific sphingosine
kinase 1-null mice due to interest from previous work in the Cowart lab showing protection
from systemic inflammation yet drastically increased weight gain on high fat diet in mice
lacking sphingosine kinase 1 (SPHK1) constitutively. During the course of the adipocytespecific SPHK1 knockout (SK1fatKO) diet-induced obesity study, we discovered through
unbiased messenger RNA sequencing of gonadal white adipose tissue that these mice
had disrupted circadian clocks, as measured by fold change of key clock regulatory genes.
The text herein describes the intertwined nature of adipocyte metabolism and the clock
and how sphingolipids are poised to perturb homeostasis in both of those systems. The
overall hypothesis of the project is that SPHK1, a sphingolipid biosynthesis enzyme,
participates in the regulation of the adipocyte circadian clock molecular machinery, which
manifests in metabolic disturbances, such as aberrant circulating lipids and adipokines,
and this impacts the overall metabolic phenotype, such as glucose tolerance and weight
gain.
The first specific aim of the project was to determine if Sphk1 is a clock-controlled
gene in adipocytes, and if it is directly controlled by the clock transcriptional machinery, or
by indirect mechanism(s). To further answer whether SPHK1 may be involved in a novel
feedback regulatory loop with the clock, we developed the next aim. The second specific
aim was to determine the extent to which SPHK1 may participate in the regulation of the
core molecular components of the circadian clock. Finally, we sought to determine a
potential role for adipocyte SPHK1 in the maintenance of whole-body metabolic
homeostasis of carbohydrates and lipids using an in vivo mammalian model system.

xxiv

It should be noted that the work described in Chapter 3 reflects in vivo and ex vivo
work utilizing only the SK1fatKO mouse that we generated for the first time. The work in
Chapter 4, however, is mostly in vitro work derived from primary adipocytes from wildtype
or SPHK1-/- constitutive knockout mice, for a culture free of SPHK1. The emphasis here is
to show that Chapter 3 is the overall metabolic characterization of the conditional knockout
mouse along with a role for adipocyte SPHK1 in the metabolic perturbations observed
when challenged with a high fat diet. For Chapter 4, the SK1fatKO mouse is described
further, specifically in the context of circadian rhythm with minimal panels of in vivo data,
which is not a part of Chapter 3. In addition, Chapter 4 is largely based on tissue culture
data, in which we assessed the role of SPHK1 in circadian rhythm in adipocytes in a dish.
At the Cowart lab’s disposal, which is not always typical, was the constitutive SPHK1
knockout (SPHK1-/-) mouse, so we therefore assessed roles for SPHK1 largely utilizing a
model of constitutive genetic deletion of SPHK1 compared to wildtype controls.
The reason to also make the distinction between the usage of a constitutive
knockout for tissue culture versus conditional knockout for physiological characterization
clear is because conducting the primary tissue culture protocol for matured adipocytes
derived from the adipose stromal vascular fraction from the Cowart lab’s novel SK1fatKO
mice was not suitable for drawing conclusions on SPHK1 loss, as the tissue culture system
would be contaminated with SPHK1-expressing cells. As the reader will find later, the
adipose tissue is described as a highly heterogenous milieu of cell types, and the SK1fatKO
is generated only in cells expressing adiponectin, which are presumably the mature
adipocytes, but not the remainder of the adipose tissue (preadipocytes, immune cells,
stem cells, etc.). Therefore, it was noted that any experiments performed in a dish in which
we compared SPHK1 genetic ablation with a control, we solely utilized cells from SPHK1xxv

/-

mice, which lack SPHK1 in all cells, rather than just those cells that express adiponectin

(the Cre driver in the SK1fatKO). To conclude, the tissue culture experiments were always
performed in conditions in which the growth-arrested mature adipocytes comprised ≥85%
of the visible culture under a light microscope. That is to say, the tissue culture is not
entirely pure, although it is highly enriched for adipogenic stem cells that had successfully
undergone an adipocyte differentiation protocol. Despite all of these nuances, be assured
that the protocol for obtaining these fresh cells (for single-passage use) was highly
successful, performed on a weekly basis or more frequently, and adhered to the most
accepted protocols in use today for the study of primary matured adipocytes in culture.
The writer is compelled to qualify these details to preemptively declare that cellular roles
for SPHK1 were delineated in this project by the use of the SPHK1-/- mouse primary cells
rather than the use of 1) the novel SK1fatKO mouse primary cells, 2) transfection, or 3) viral
infection silencing strategies.
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CHAPTER 1

BACKGROUND AND INTRODUCTION

1

1.1. Sphingolipid Biochemistry
Sphingolipids were discovered by Johann Thudichum in the late 19th century
(Kleuser, 2018; Thudichum, 1962.) He was a neurochemist; and he was extracting brain
tissue in organic solvent (ethanol) to discover what he thought to be enigmaticallybehaving lipids, which he named in honor of the riddle of the Greek sphinx (Breathnach,
2001). Sphingolipids are formed through three prominent pathways within the sphingolipid
biosynthetic pathway (Merrill, et al., 1988; Castillo, et al., 2016). The de novo sphingolipid
pathway begins at the top with the condensation of a fatty acyl CoA and an amino acid
(Merrill Jr., et al., 2002, Hannun and Obeid, 2002). In most cases in mammalian
sphingolipid biosynthesis, the pathway is initiated with palmitic acid and serine, however,
the enzyme responsible for this condensation may preferentially utilize other species, such
as myristic acid, and alanine or glycine (Merrill Jr., et al., 2002). This is mediated by the
specific subunits comprising this enzyme, serine palmitoyltransferase, which has a long
chain base subunit (SPTLC1, 2, 3) as well as a short chain subunit (Sptss1a, 1b) and
other regulatory components, such as the ORMDL proteins and other non-protein
constituents, and the manner by which they heteromultimerize determines the substrate
preference and the unique backbone chemistry of the subsequently formed sphingolipid
(Gable, et al., 2010; Han, et al., 2009; Hornemann, et al., 2009).
Further down the sphingolipid biosynthetic pathway is described in Chapter 2. In
short, through a series of condensation, reduction, and dehydrogenation reactions,
ceramide is generated de novo (the first of three pathways) and can be interconverted to
more complex glycosylceramide species, sphingomyelin, or sphingosine. A careful
balance emerges among several metabolites at this juncture (traditionally, chiefly
ceramide); and the second pathway, the sphingomyelinase pathway, serves to
2

reconstitute the ceramide pool by the action of the eponymous enzyme, and thirdly, the
salvage pathway within the lysosome contributes to sphingosine conversion by ceramide
synthases to ceramide (Kitatani, et al., 2008; Zelnik, et al., 2020). On the other hand,
cytotoxic sphingosine can be phosphorylated by either of two known kinase isoenzymes,
sphingosine kinase (SPHK) 1 and 2, which are further discussed later. The emphasis of
this dissertation is SPHK1, a cytosolic enzyme, and its bioactive product sphingosine-1phosphate, S1P for shorthand (Figure 1). SPHK2 is mainly thought to be a nuclear protein
(Igarashi, et al., 2003; Qin, et al., 2018). S1P may be dephosphorylated by either of two
sphingosine phosphatase enzymes or irreversibly cleaved by the sphingosine-1phosphate lyase enzyme to generate myristaldehyde and phosphoethanolamine.
Moreover, other lipid phosphatases (such as lipid phosphate phosphatase 3) and
ectophosphatases are thought to act on S1P in tissue and certainly in the circulation in
vivo (Bréart, et al., 2011; Kharel, et al., 2020; López-Juárez, et al., 2011; Tang, et al.,
2015).
S1P is known to signal through extracellular G-protein coupled receptors (S1Pr15) (Figure 1). Moreover, S1P may be transported between extracellular and cytosolic
compartments by Spinster 2 (Spns2) or ATP-binding cassette (ABC) transporters, such
as ABCC1 (Ihlefeld, et al., 2015; Nagahashi, et al., 2013; Nieuwenhuis, et al., 2009;
Spiegel, et al., 2019). More roles and insights continue to be uncovered about S1P
metabolism and dynamics with each passing year.

3

Figure 1. S1P synthesis, degradation, and utilization. A. The most typically
studied mammalian S1P chemical species is 2S-amino-4E-octadecene-1,3R-diol 1(dihydrogen phosphate). This is also referred to as d18:1 sphingosine-1-phosphate. This
molecule is a phosphorylated N-acylated amino alcohol, typically with the 18-carbon acyl
chain generating the sphingoid backbone. The acyl moiety to the left is hydrophobic while
the alcohol and phosphate groups lend to hydrophilicity and a negative charge at
physiological pH. B. There are two distinct breakdown pathways for S1P, and only one
synthetic pathway for S1P. Ceramides can be broken down by ceramidases in different
cellular locations to generate sphingosine, which can then be phosphorylated by SPHK1
4

(Figure 1 legend, continued.)
or SPHK2 to generate S1P. S1P can be broken down reversibly by either of the two S1P
phosphatases to regenerate sphingosine. If S1P is broken down by S1P lyase, this is
irreversible, and it marks the exit from the sphingolipid biosynthetic pathway.
Myristaldehyde may be utilized post-processing as a fatty acid in a variety of synthetic
pathways, including sphingolipid synthesis. Phosphoethanolamine is primarily associated
with the plasma membrane. C. S1P may signal through one of 5 G-protein coupled
receptors to generate a variety of cellular responses. S1PR1-3 are the best-characterized
S1P receptors, signaling through Ras, phosphoinositide 3-kinase (PI3K), Rho, or
phospholipase C. acCDase, acid ceramidase; alkCDase, alkaline ceramidase; nCDase,
neutral ceramidase; CerS 1-6, ceramide synthase 1, 2, 3, 4, 5, 6; PLC, phospholipase C;
PI3K, phosphoinositide-3-kinase; K1, sphingosine kinase 1; K2, sphingosine kinase 2;
SgpP1-2, sphingosine-1-phosphate phosphatase 1, 2; SgpL, sphingosine 1 phosphate
lyase; S1Pr1-3, sphingosine-1-phosphate receptor 1-3.
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Of important mention, sphingosine kinases and their product S1P are enigmatic
(Spiegel and Milstien, 2003). It was found in human skin fibroblasts that SPHK1-/- cells
had increased sphingosine levels, compared to baseline (as expected), however, S1P
levels were also increased in SPHK1-/- fibroblasts compared to wildtype fibroblasts (Qin,
et al., 2018). On the other hand, SPHK2-/- fibroblasts showed somewhat of a decrease in
cellular S1P (Qin, et al., 2018). In contrast, Samad and colleagues showed that SPHK1-/mice had decreased S1P (as would be expected) but sphingosine was unchanged in null
animals compared to controls (Wang, et al., 2014). Strangely, SPHK2-/- mice also have
much higher circulating levels of S1P compared to wildtype counterparts (Kharel, et al.,
2012 and 2020; Sensken, et al., 2010). Moreover, SPHK2, but not SPHK1, is generally
considered the kinase responsible for phosphorylation of the FDA-approved multiple
sclerosis drug FTY-720 in vivo (Billich, et al., 2003; Saba and Hla, 2004; Sanchez, et al.,
2003).
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1.2. Importance and Significance of Sphingolipids
Although not related to the project described here, a major FDA-approved
treatment on the market for multiple sclerosis is fingolimod, which is an S1P receptor 1
(S1PR1) modulator (Pelletier and Hafler, 2012). S1PR1 is critically important for immune
cell function and trafficking (Adada, et al., 2013; Liu, et al., 2000). In fact, the circadian
(24-hour cycle) oscillation of S1PR1 within immune cells is crucial for their variation in
circulatory egress versus lymph node and organ homing (Druzd, et al., 2017). Knockout
of S1PR1 in mice is embryonically lethal, with impaired vasculogenesis and severe
hemorrhaging (Liu, et al., 2000). Moreover, knockout of both sphingosine kinases results
in an embryonically lethal phenotype (Mizugishi, et al., 2005). Much of this is attributable
to early angiogenic and endothelial developmental perturbations, and hemorrhaging within
the embryo is visible to the naked eye (Mizugishi, et al., 2005).
Sphingolipids are also present throughout cellular membranes, meaning not just
the plasma membrane but organellar membranes. Sphingolipids are generally thought to
reside in special domains of the plasma membrane lipid bilayer called “lipid rafts,” and it
is within these specialized domains that protein complexes may anchor to create signaling
platforms (Brugger, et al., 2004; Gulbins and Kolesnick, 2003). Thus, sphingolipids
contribute to the membrane heterogeneity that is necessary for curvature as well as
specialized membrane locations with varying docking affinity for protein signaling
complexes (Sonnino, et al., 2006).
Sphingolipids are also appreciated as bioactive signaling molecules, with ceramide
and S1P at the forefront. Typically, ceramide is thought to be pro-apoptotic while S1P is
thought to be pro-survival, and the balance of these two species is highly dependent on
sphingosine kinases (Mathias and Kolesnick, 1993; Ruvolo, et al., 2002; Van Brocklyn, et
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al., 2012). These pathways have been exploited for treatment strategies in cancer (Lewis,
et al., 2018; Ponnusamy, et al., 2010). However, for this project the study of SPHK1 and
its significance in metabolism were studied since the Cowart lab focuses on metabolic
disease. Indeed, roles for sphingolipids and sphingolipid enzymes in metabolic disease
have been established in the literature over the last few decades. In short, many changes
in sphingolipids are context- and tissue-specific, lending to the varying degrees of
metabolic perturbations observed in response to sphingolipid alterations. In general,
ceramides tend to increase with obesity (Holland, et al., 2007). Even more fascinating, the
ratio of particular acyl-chain length ceramide species found in the circulation may provide
better prognostic information than circulating cholesterol-laden lipoproteins for
cardiovascular disease, one of the major hallmarks of the metabolic syndrome
(Laaksonen, et al., 2016; Peterson, et al., 2018; Turpin, et al., 2014).
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1.3. Adipose Tissue
Adipose tissue was underappreciated for a long time as an inert energy storage
depot. The discovery of leptin, which is nicknamed the obesity gene, is what set ablaze
the field of adipose endocrinology, physiology, and metabolism. In the 1950’s, a subset of
mice at the Jackson Laboratories had a recessive mutation leading to an overweight
phenotype, and in the early 90’s, the gene responsible for this phenotype was cloned and
named leptin (Zhang, et al., 1994; Halaas, et al., 1995). Today, the adipose tissue is
understood to be a master secretory organ, as it releases adipokines that signal receptors
in distant tissues (Scherer, 2006). Moreover, the adipose tissue-intrinsic processes of
lipolysis and lipogenesis plant this tissue at the center of metabolic regulation within the
organism. Its extreme plasticity in comparison to other organs also contributes to its
function and effects upon the rest of the body; and this plasticity arises from the processes
of adipocyte hyperplasia and hypertrophy, which are defined as expansion in cell number
and cell size, respectively (Jo, et al., 2009; Muir, et al., 2016).
Adipose tissue that is hyperplastic tends to be healthier adipose compared to the
fat pad that selectively undergoes hypertrophy of the residing adipocytes (SamochaBonet, et al., 2014; Vishvanath and Gupta, 2019). Hyperplastic adipose is thought to be
more adipogenic, thus allowing the tissue to expand healthily in the face of excess energy
(Muir, et al., 2016). On the other hand, hypertrophic adipocytes suggest various
mechanistic issues including overactive lipogenesis, underactive lipolysis, and
underachieving adipogenesis. As the adipose tissue expands via hypertrophy, resident
immune cells begin to infiltrate, thus propagating a state of chronic low-grade inflammation
(Berg and Scherer, 2005; Crewe, et al., 2017). Moreover, rapid expansion of the adipocyte
squelches nearby capillaries, and the immediate surrounding tissue becomes hypoxic due
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to loss of oxygen and nutrients as angiogenesis programs must inc to support the tissue
(Hosogai, et al., 2007). All of the processes mentioned are subjects of intense study.
At basal regulation of both lipolysis and lipogenesis in the adipocyte, key enzymes
are responsible for the ebb and flow of these processes, including ATGL, HSL, stearoylCoA desaturase-1 (SCD1), and lipoprotein lipase (LPL) (Paschos, et al., 2012; Shostak,
et al., 2013). ATGL is rate-limiting for hydrolysis of the lipid droplet, as it is the first enzyme
to cleave a fatty acyl group from the triacylglycerol (TAG) glycerol backbone (Duncan, et
al., 2010). LPL is important at the cell surface for breaking down circulating TAG so that
individual fatty acyl and glycerol components can be utilized within the cell to re-esterify
the glycerol backbone for storage inside the lipid droplet (Maggio and Greenwood, 1982).
SCD-1 is the rate-limiting enzyme for synthesizing monounsaturated fatty acids from
saturated fatty acids, and it is important for the lipogenic capacity of the adipocyte (Ntambi,
et al., 2002; Thiede and Strittmatter, 1985).
Moreover, the basal lipolysis state also shows itself to be redundant in the face of
lipase deficiency. For example, HSL-deficient mice still have detectable circulating levels
of fatty acids and glycerol at baseline, and they also have significant increases of both of
these plasma species in the presence of an isoproterenol (a pharmacological lipolysis
inducer) injection, although it is severely blunted, of course (Osuga, et al., 2000). In
agreement with these, ATGL-deficient mice also maintain a comparable level of secreted
fatty acids and glycerol without lipolytic stimulation. However, adipose explants from Atgl/-

mice fail to mount a lipolytic burst of free fatty acids and glycerol with isoproterenol

stimulation (Langin, et al, 2005).
In contrast to basal homeostatic lipid control, catecholamines (epinephrine,
isoproterenol) initiate β-3 adrenergic receptor (β-3AR) agonism through GαS to stimulate
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cyclic AMP and ultimately PKA, to stimulate HSL (hormone sensitive lipase) and PLIN1
(perilipin 1) in a sequential cascade (Bezaire, et al., 2009). Treatment with these
compounds is typical for stimulating lipolysis, although it must always be qualified as β3AR-mediated when reported. Lipolytic bursts flood the circulation with fatty acids and
glycerol to be used as energy substrates during a fight-or-flight response (Geerling, et al.,
2014). Insulin opposes lipolysis by signaling through the insulin receptor to activate the
PI3K pathway; then PIP3 activates AKT to lead to the activation of phosphodiesterase 3B
(PDE3B); PDE3B works against cAMP accumulation by converting cAMP into 5’-AMP.
Hence, insulin decreases cAMP. Thus, insulin can stop the action of catecholaminemediated lipolysis (Morigny, et al., 2016).
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1.4. Sphingolipids in Adipose Tissue
Roles for sphingolipids other than S1P and its kinases (isomers SPHK1 and
SPHK2) have been described in adipose tissue. A complete review of sphingolipids and
their function in adipose tissue was written in 2018 and the contents of which are laid out
in Chapter 2.
Since the contents of Chapter 2 went to press, it was published that the other
isoform of SPHK1, SPHK2, was involved in metabolic homeostasis governed by glucose
absorption (Ravichandran, et al., 2018). SPHK2-null mice were found to be protected from
aging-related obesity, as well as more glucose tolerant with lower levels of circulating
leptin and insulin when compared to control animals (Ravichandran, et al., 2018).
Importantly, this study did not subject the SPHK2-/- mice to a high fat diet regimen, so it is
unknown how the genetic depletion of Sphk2 orchestrates metabolic parameters, such as
liver and adipose lipids (triglycerides, sphingolipids, fatty acids), and circulating glucose,
insulin, and adipokines (Ravichandran, et al., 2018). On the other hand, no notable
differences were observed between SPHK1-/- and WT mice on control diet, but high fat fed
SPHK1-/- mice gained more weight than their WT counterparts; notwithstanding mutants
were protected from obesity-induced IL-6 expression in the plasma and skeletal muscle
(Ross, et al., 2013). In another report, Samad and colleagues showed that SPHK1-/- mice
weighed the same as WT mice when fed a high fat diet, but had better metabolic profiles
compared to WT matches, such as lower plasma insulin and better glucose tolerance
(Wang, et al., 2014).
Due to the nuanced findings of SPHKs and weight gain by the Cowart lab and
others, it seemed reasonable to further assess the role for SPHK1 in obesity by ablating
it specifically in the adipocyte, a crucial cell type involved in the onset, progression, and
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maintenance of obesity. Thus, the project for adipocyte-specific Cre-recombinasemediated deletion of Sphk1 with dietary intervention and the subsequent findings are laid
out in Chapter 3. This is the first report utilizing a mouse model with an adipocyte-specific
ablation of Sphk1. Importantly, the mechanisms underlying the metabolic abnormalities
described in Chapter 3 are still open for debate. Thus, forthcoming publications further
describing roles for adipocyte SPHK1 are set to be released that would underlie and
provide explanation for the Chapter 3 findings. Hence, Chapter 4 uncovers a novel role
for adipocyte SPHK1 and the maintenance of the circadian clock and its epigenetics. Other
efforts have been aimed at clarifying mechanisms for SPHK1 in adipogenesis and in
brown adipose mitochondrial biogenesis, which both (adipogenesis and mitochondrial
biogenesis) contribute to obesity-associated pathological outcomes (Lambert, data not
shown; Valentine, data not shown).
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1.5. Circadian Rhythm
To begin this section, it is important to acknowledge that the Nobel Prize in
Medicine or Physiology during the course of this Ph.D. dissertation was awarded to three
circadian researchers in 2017. I had the privilege of attending two circadian rhythm
conferences where I interacted with the likes of Drs. Michael Rosbash, Mike Young, Joe
Takahashi, Carrie Partch, Katja Lamia, Gad Asher, Satchin Panda, Charna Dibner,
Luciano DiTacchio, Chuck Weitz, and other impressive scientists. This added
immeasurable value to my degree work, and I am so grateful.
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1.5.i. The Molecular Circadian Clock
The molecular circadian clock is composed of the primary positive and negative
feedback loops, in which BMAL1 and CLOCK (or their paralogs BMAL2 and NPAS2,
respectively) are the positive limb transcription factors that regulate the expression of the
negative limb composed of PERs and CRYs (Figure 2).

15

Figure 2. The molecular circadian clock. The transcriptional translational
feedback loop undergoes a 24-hour round of positive and negative regulation upon itself.
BMAL1 and CLOCK transcription factors heterodimerize to form a transcriptional
activation complex which elicits transcription of its targets through E-box elements in the
target promoters. Targets of BMAL1:CLOCK include Pers and Crys as well as the nuclear
hormone receptors Rors and Reverbs. Comprising the core negative loop, PERs and
CRYs are translated in the cytosol following transcription, and they translocate back to the
nucleus as a large complex to inhibit BMAL:CLOCK activity. In so doing, PERs and CRYs
repress their own expression while at the same time undergo temporally controlled
degradation.
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(Figure 2 legend, continued.)
Eventually, this PER:CRY brake is released on BMAL:CLOCK so that BMAL:CLOCK may
resume once again another round of transcription. Accessory to this core regulation is
REVERB or ROR which respectively add negative or positive transcriptional control upon
Bmal1 expression through a ROR-response element in the Bmal1 promoter. Additional
depicted square and circular shapes indicate and emphasize the existence of paralogs as
well as other proteins within these large activator and repressor complexes. Bmal1, brain
and muscle ARNT-like protein 1; ccgs, core clock genes; CLOCK, circadian locomotor
output cycles kaput; Cry, cryptochrome; Per, period; REVERB, reverse orientation c-erb;
ROR, retinoic acid receptor related orphan receptor; RRE, ROR response element.
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The accessory positive and negative loops primarily affect Bmal1 gene expression
through ROR response elements, in which REVERBα or its paralog REVERBβ repress
Bmal1 expression. The positive accessory regulators are the RORs- α,β,γ; through the
same promoter motif, these regulators may enhance transcription of Bmal1 (Figure 2).
The negative core constituents, the PERs, are regulated tightly by a sequential
phosphorylation cascade that is mediated by casein kinases 1δ and ε. This mechanism
has been elucidated by Partch and coworkers (Hunt, et al., 2017). The other major player
in the complex, the CRYPTOCHROMES, under AMPK-mediated phosphorylation, will
degrade with circadian rhythmicity (Lamia, et al., 2009) (Figure 2). Importantly, this
highlighted a mode by which glucose depletion directly impacts the clock in an AMPKdependent manner (Lamia, et al., 2009).
Not only do PERs and CRYs undergo a vast array of modifications and
translocations about the cell, these proteins also reside in intricately complex
heteromultimeric protein conglomerates that are typically heavier than twenty
megadaltons (Aryal, et al., 2017). Considering the dependability of the clock, it seems that
this feat of moving such large complexes about the cell would require certain
superhighways that are consistently tracked, from day to night. This is where the interest
in the linker of cytoskeleton and nucleoskeleton LINC complex arose. Several proteins
involved in the LINC were found bound to BMAL1 in a differential manner in SPHK1-/adipocytes compared to control adipocytes by mass spectrometry proteomics analysis
(Anderson and Tomaino, data not shown).
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1.5.ii. Evolution and the Philosophy of the Clock
Circadian rhythm evolved due to the rotation of the Earth, which gives rise to day
and night. Due to the axis of the Earth and the location in space with respect to the sun
as it revolves around the sun, further patterning is driven into the molecular gears of our
being. With day and night come other changes, including such fluctuations in temperature,
animal and human activity, the humidity, availability of resources. Naturally, these
phenomena drive the fitness of species to exploit the contrasting fruits that night and day
separately may bring to bear.
Thus, such processes like photosynthesis obviously occur during the hours at
which the sun shines above (Dodd, et al., 2005; Hennessy and Field, 1991). Due to the
finite availability of the sun hours, plants have evolved to make best use of their necessary
resource. Other less sun-trinsic and -dependent processes can be put off until the time it
is dark.
In a human, many processes have a fluctuation with the day and night. For
example, body temperature fluctuates throughout the day, with the body decreasing
temperature in the evening (Clark, et al., 1939; Morrison, et al., 2014; Tabarean, et al.,
2010; Zhao, et al., 2017). Moreover, immune cell egress and homing are circadian, with
the immune cell surveillance making their presence known throughout the lymph and
bloodstream during the day and at night returning to the lymph nodes, thymus, and other
homes to undergo repair, selection, etc. (Druzd, et al., 2017). Moreover, skeletal muscle
strength, heart contractility and output, lung respirometry, vascular tone, gastrointestinal
motility all are governed by the pattern of day and night (Atkinson and Reilly, 1996; Conroy
and O’Brien, 1974; Davidson, et al., 2005; Durgan and Young, 2010; Gifford, 1987;
Konturek, et al., 2011; Layer, et al., 1987; Panza, et al., 1991; Spengler and Shea, 2000).
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Amazingly and stunningly, the circadian clock, which is present in virtually all cell
types, undergoes one entire round of its transcriptional translational feedback loop in
approximately 24 hours. That is, the cell autonomous molecular time tracker has a freerunning period of ~24 hours. Without a light pulse, a growth factor, feeding or starvation
pulse, a temperature pulse, a hypoxic pulse, an acidic pulse, or pressure loading, the
molecular clock maintains its 24-hour periodicity (Adamovich, et al., 2016; Ranieri, et al.,
2015; Rensing and Ruoff, 2002; Walton, et al., 2018). This periodicity fluctuates slightly
from organism to organism with some being sub 24 and some being supra 24 hours, but
this usually does not vary by more than 60 minutes. This truly highlights the biology of
Earth, and that this particular pervasive mechanism ceases its utility on another planet or
in a different solar system.
Because of the Earth’s axis, some areas on Earth lack the typical equatorial day
and night. For instance, the Scandinavian peninsula, near the North Pole, has periods of
the year in which the day is shrouded in perpetual darkness and other periods of the year
in which blackout curtains are necessary for a decent night’s sleep. Considering that the
climate gets harsher and more extreme towards the poles of the Earth, it is reasonable to
presume that the circadian molecular clock evolved from beings living in the more
constant, temperate environments within the vicinity of the Equator, in the tropics.
This wieldy 24-clock makes itself readily apparent in instances of daylight savings
time in which the change of just one hour markedly induces physiological changes in the
human (Manfredini, et al., 2019; Roenneberg, et al., 2019). What’s more, humans
voluntarily undergo jetlag when they fly from one region of the Earth to another. Moreover,
humans (who are a diurnal species) suffer, physiologically speaking, when undertaking a
shift-work occupation to make a living (Esquirol, et al., 2009; Karlsson, et al., 2009; Ramin,
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et al., 2015). Interestingly, these several phenomena described here most likely would
never apply to any other animal, but only happens to humans due to our artificial means
of living with airplanes and lightbulbs. This undoubtedly highlights the discordance
between the industrialized society we know today and the unfathomable age of the Earth
that has been undergoing its 24-hour day, day-in and day-out, for its existence. Thus,
approximately 2 centuries’ worth of man-made upending to this Earthly day and night
rhythm would certainly and unmistakably lead to deleteriously existential outcomes,
namely health consequences (Karlsson, et al., 2001; Zimmet, et al., 2019).
The circadian clock accomplishes and executes its functions day after day with
almost certainty. We may not know if tomorrow will come but our circadian clock
anticipates it to be so, and thus rolls on, cycle after cycle. This is orchestrated by a series
of transcriptional and translational events, as well as posttranslational and epigenetic
events, as well as localization/location/geography of the cell. Beautiful strides in circadian
research have been made for some decades, but many advances have seen their glory
since the nineties to the present. Much of this has culminated to the coveted Nobel Prize
in Medicine and Physiology to three extraordinary circadian science researchers. As of
the writing of this dissertation there is yet to be discovered the true reason for why humans
need sleep. The actual identities of molecules that build up to cause sleep pressure are
still waiting to be uncovered and fully defined. Some even speculate that another Nobel
Prize stands to be won for the true meaning and understanding of human sleep. It is
important to note that sleep and wake activities constitute a type of circadian rhythm, but
circadian rhythm itself describes any natural processes that follow a cyclical pattern of
behavior, activity, expression, etc., that occur on “about-a-day’s” time, or from Latin, “circa
dia.” Although circadian rhythm and sleep are closely related, they are different entities. It
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is worth saying, however, that if a human suffers from a sleep disorder, such as insomnia
or sleep apnea, they are intrinsically going to disrupt their circadian rhythm as well. This
could lead to other downstream maladies pertaining to processes (e.g., metabolism) that
would rather rely on a robust behavioral circadian pattern than a disrupted, disjointed one.
For example, the thyroid is a target of disrupted circadian rhythm, since the thyroidstimulating hormone (TSH) is secreted from the pituitary gland in a circadian manner to
ultimately stimulate the production of hormones thyroxine (T4) and triiodothyronine (T3)
(Brabant, et al., 1990; Ikegami, et al., 2019; Konlouri, et al., 2013; Leso, et al., 2020). In
an experiment in which healthy human subjects were directed to sleep only 4 hours per
night for 6 night to simulate an accumulation of sleep debt, the authors found that the
plasma of these subjects at the end of the experiment had no rhythmic production of
thyrotropin (upstream of TSH) and strikingly that T4 was strongly elevated at all times of
the day compared to normal sleep conditions (Spiegel, et al., 1999). The increase in
thyroid hormones was also corroborated by an analysis showing that nightshift workers
had markedly high levels of circulating TSH (Leso, et al., 2020). In addition, at the cellular
level, T3 is required for the function of brown adipose tissue and temperature regulation,
which is a circadian-governed process (Giralt, et al., 1990; Hernández & Obregón, 2000;
Obregón, et al., 1987, 2008; Wyatt, et al., 1999). T3, retinoic acid, transferrin, and insulin
are some constituents of serum-free cell culture media necessary to maintain
mesenchymal cell viability. Interestingly, T3 hormones also interact with retinoic acid
binding proteins, which have opposing dual roles in adipocyte differentiation whereby T3
promotes chromatin re-ordering for mesenchymal stem cell differentiation, but once the
cell is committed to an adipocyte lineage, T3 is involved in repression of several genes
(Wei, 2012). Coincidentally, the promoter region for the cellular retinoic acid binding
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protein (CRABPI) has a dihydrosphingosine- and ethanol-responsive promoter (Wei,
2012). This is important because the circadian clock mechanism is composed of the
retinoic acid-related orphan receptors, RORs and REVERBs, which could have potential
interplay in this context of ligand binding.
On the other hand, circadian rhythm disorders, which, in humans, have been linked
genetically to the Pers and casein kinases, seem to elicit, quite predominantly, disordered
sleep phenotypes, such as advanced sleep phase syndrome (Parsons, et al., 2014; Toh,
et al., 2001; Xu, et al., 2005; Xu, et al., 2007). Thus, it may seem semantical and overly
nuanced to dissociate and define the uniqueness of circadian rhythm and sleep/wake
cycles, but the distinction is valid and important. When speaking about circadian rhythm
at large, it usually is quite rare that the same circadian researcher is also an expert in the
five human electroencephalographic wave patterns of human sleep in the brain.
With regard to the circadian clock, the systems are essentially mirror images of
one another, but from kingdom to kingdom, the proteins and genes are named differently.
The system studied for the work herein was the mouse circadian clock in the white adipose
tissue. Thus, implications for human disease and other outcomes are speculative.
Regardless, work from animal (mouse) studies, such as these, provide insight and targets
for future work.
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1.5.iii. Circadian Protein Dynamics
Nuclear import and export are also essential functions of the molecular clock, and
these would appear to be implicated in LINC-associated biological processes. One group
of authors studied the interaction of BMAL1:CLOCK heterodimer with ribonucleic acid
export 1 (RAE1) and nucleoporin protein NUP98, of the nucleoporin complex and mRNA
export machinery (Zheng, et al., 2019). Knockdown of RAE1 results in the increase of
BMAL1 and CLOCK expression, due to decreased ubiquitination, with concomitant
increased transcriptional luciferase reporter activity from Per and Cry loci (Figure 2). RAE1
promotes BMAL1 shuttling and regulates degradation and activity of CLOCK:BMAL1
heterodimer. While the BMAL1 and CLOCK expression were high in RAE1 knockdown
conditions, PER2 and CRY1 proteins failed to reach control amplitudes in expression; in
other words, the protein expression was rather low in the knockdown cells compared to
control. The ultimate conclusion from this study was that the shuttling of the
BMAL1:CLOCK heterodimer is much related to its activity as a transcription factor and to
its protein stability (Zheng, et al., 2019). It seems when nuclear shuttling is disrupted, there
is an increase in the positive limb proteins, but this does not necessarily translate to a
constitutively high output marker expression. Paradoxically, the data showed that the Per
and Cry mRNA transcript expression was high, but that the protein expression was not, in
the absence of RAE1 and nuclear shuttling (Zheng, et al., 2019).
The commanding work by Lee and colleagues demonstrates unintuitive and
paradoxical patterns in the BMAL1 and CLOCK heterodimer, with one of the most striking
being that BMAL1-mediated transcriptional activation occurs with a concomitant
degradative action on BMAL1, thus especially depleting nuclear levels (Kwon, et al.,
2006). Furthermore, the nuclear export and localization sequences are key for the
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shuttling of BMAL1 between the nucleus and cytoplasm and for mediating CLOCK
degradation. That is, if BMAL1 does not shuttle, CLOCK protein does not degrade.
Overexpression of tagged BMAL1 or CLOCK resulted in the lower expression of the other
(Kwon, et al., 2006). Interestingly, CLOCK overexpression partitions it to the cytoplasm in
a strong manner. On the other hand, overexpression of both CLOCK and BMAL1 together
abolishes the cytoplasmic expression of CLOCK (Kwon, et al., 2006). It is well-established
too, that in order for the BMAL1:CLOCK transactivator to function, there must be reciprocal
histone marks that promote the work of these activators in a temporal fashion (Zhu, et al.,
2020; Takahashi, 2017).
BMAL1 stability is in part mediated by GSK3β phosphorylation action on Ser17
and Thr21. After phosphorylation occurs, BMAL1 is primed for ubiquitylation. It is noted
that BMAL1 is a phosphoprotein targeted by various kinases (Sahar, et al., 2010).
It is important to note that posttranslational modifications have a strong impact on
the transcriptional outputs of BMAL1, meaning that targets’ period lengths may depend on
the posttranslational modification status of BMAL1. MAPK phosphorylates BMAL1 at
Ser527, Thr534, Ser599. It was found that phosphorylated MAPK is able to phosphorylate
BMAL1 and affect downstream transcriptional programs, although protein dynamics
regulating BMAL1 stability were not described (Sanada, et al., 2002). The sites for MAPK
action are conserved among many vertebrate species for BMAL1, but these sites are not
present in BMAL2 (Sanada, et al., 2002). Casein kinase 2α phosphorylates BMAL1
(Tamaru, et al., 2009). Tamura et al. showed that S90 was a necessary phosphorylation
site for nuclear translocation (Tamaru, et al., 2009). CLOCK has been shown to possess
histone acetyltransferase properties and can acetylate BMAL1 at a highly conserved
residue, Lys537 (Hirayama, et al., 2007). Dimerization is necessary for the acetylation of
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BMAL1 by CLOCK (Hirayama, et al., 2007). This acetylation in complex helps the
recruitment of CRY1 to the complex (Hirayama, et al., 2007). CLOCK, and not PER or
CRY, is necessary for proper BMAL1 sumoylation. Lysine 259 is the conserved residue at
which sumoylation occurs (Cardone, et al., 2005).
The group of Gruissem has done stunning work in an Arabidopsis model, in which
they characterize light-responsive and time-dependent gene expression and correlate this
with histone posttranslational modifications (Baerenfaller, et al., 2016). For example, the
genes that peaked in the end of the day also had the strongest acetylated histone signal
at K9 and K27 on genes that peak at the end of the day. In accordance with high
expression and high acetylation in a small subset, ChIP-sequencing across the entire
genome showed the acetylation signature at histone 3 lysines 9 and 27 was strongest at
loci of genes expressed highly at the end of the night when assessed at the end of the
night. Moreover, the acetylation signal is absent in the respective opposite time of the day
genetic loci in both cases presented here, thus showing that the acetylated histone has a
positive effect on its transcriptional targets, whether they peak in the day or the night
(Baerenfaller, et al., 2016). Essentially, permissive and repressive states of chromatin are
governed by posttranslational modifications, and these occur with day/night rhythmicity.
The group of Naef found that distal enhancer sites and respective transcription
start sites for certain genes displayed, pairwise, that H3K27ac marks oscillated at more
than 1000 of these pairs, which are hypersensitive to DNAse I treatment, also suggestive
that these marks would lead to transcription without latency (Sobel, et al., 2017).
Moreover, the phase of H3K27ac chromatin occupancy over 24 hours was significantly
correlated with the phase of RNA Polymerase II chromatin occupancy.
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In an effort to dissociate diurnal feeding and fasting cycles from the circadian cycle,
Sobel and coworkers also found that transcription at E-boxes was positively correlated
with CREB and D-box motifs and negatively correlated with elements that bind REVERBα,
RORs, SREBP, and FOX (Sobel, et al., 2017) (Figure 2). In Bmal1-/- mice, the ablated
circadian rhythm, generated by BMAL1 and CLOCK, is somewhat compensated
peripherally by other cues, like feeding and fasting, that impinge on regulatory elements
associated with CREB, FOX, and SREBP, truly demonstrating the robust nature of
nutrient-sensing and its potential to synchronize oscillating transcripts (Sobel, et al., 2017).
Using ChIP-Sequencing, Feng and colleagues showed that HDAC3 is recruited to
its genetic targets in a circadian manner in a mouse liver model (Feng, et al., 2011).
HDAC3 is known to be part of the REV-ERBα repressor complex, which also includes
NCoR (nuclear corepressor) (Feng, et al., 2011). HDAC3 was found to be bound to
chromatin strongly in the inactive period in vivo, at ZT10. Moreover, the acetylation signal
at H3K9 was decreased comparatively to the active period. Thus, the HDAC was
performing deacetylase enzymatic activity. Unintuitively, however, the genetic loci at these
epigenetic occurrences were undergoing active transcription. This further affects RNA
Polymerase II binding, as the HDAC3 repressor complex kicks it off. The authors go on to
describe the system by pointing out that HDAC3 protein levels did not fluctuate over a
circadian time course in vivo. What’s more, NCoR, which helps to impart the repressive
activities of the REV-ERBα and HDAC3 complex, also binds at its targets with diurnal
rhythmicity. To conclude the study, Feng et al. determined a physiological role for the
circadian recruitment of HDAC3 to liver transcriptomic targets. They found that the most
significantly affected cellular program was lipid metabolism, and they concluded that
depletion of REV-ERBα and/or HDAC3 led to a fatty liver phenotype. When qualifying
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these results, it is important to remember the other isoforms of proteins involved in these
complexes (Feng, et al., 2011).
Moreover, Hong and coworkers here showed the circadian occupancy of HDAC3
at circadian genes in mouse skeletal muscle (Hong, et al., 2017). Another intriguing aspect
to Hong’s story was that skeletal muscle-specific HDAC3-knockout mice had worse
glucose utilization, were apparently insulin resistant (HOMA-IR), but they had better
muscle endurance. The authors made a point to discuss this paradoxical finding and that
apparent contradictions to the logically-thinking scientist do exist (Hong, et al., 2017).
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1.5.iv. Concluding Remarks about Circadian Rhythm
To conclude, the molecular circadian clock is an evolutionary cycle-generator that
evolved to anticipate and align biochemical/behavioral/physiological processes with the
Earthly day and night (Gerhart-Hines and Lazar, 2015). Almost all cells have this
autonomous ticking clock, which highlights the pervasive ubiquity of circadian rhythm
(Mohawk, et al., 2012; Takahashi, 2017). Thus, cells are poised to be affected by
alterations in the clock. Moreover, tissue specificity arises for circadian rhythmicity in
genes, based on the nature of the organ (Qu, et al., 2018; Storch, et al., 2002; Zhang, et
al., 2014). Aside from the molecular core clock (Figure 2), other aspects have circadian
rhythmicity and directly contribute to top-level circadian manifestations in physiology, with
some examples including: posttranslational modifications, epigenetic modifications, and
temporal spatial positioning of cellular synthesis and degradation hubs (Aguilar-Arnal and
Sassone-Corsi, 2015; Aviram, et al., 2016; Dyar and Eckel-Mahan, 2017; Kim, et al., 2013;
Ryzhikov, et al., 2019; 2019a).
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1.6. Sphingosine Kinase 1/S1P Regulation
1.6.i. S1P as an aPKC Ligand
The

intracellular

actions

of

S1P

are

far

less

understood

than

the

paracrine/autocrine actions it exerts through its GPCRs at the cellular surface. For
example, Kajimoto and colleagues demonstrated the utilization of S1P as a second
messenger by atypical protein kinase C (aPKC) isoenzyme zeta within the catalytic
domain to stimulate kinase activity (Kajimoto, et al., 2019). Despite the newness in this
thinking, S1P is shown to act still in its canonical pro-growth (through an anti-apoptotic
mechanism) manner (Kajimoto, et al., 2019).
PKC’s are long known to be stimulated by calcium and diacylglycerol, a well-known
second messenger (Huang, 1989). After that, the atypical PKC’s were then discovered to
be stimulated by phosphatidylserine (Orr and Newton, 1992). And as recently as 2019, it
is now recognized that aPKC isozymes can be stimulated by S1P, a simple yet potent
signaling bioactive lipid (Kajimoto, et al., 2019).
Basic residues Arg375 and Lys399 are part of the PKC substrate binding pocket,
interacting with the negatively charged phosphate group in S1P; Arg375 was shown to be
critical for the S1P-induced kinase action (Kajimoto, et al., 2019). Asparagine, glutamine,
and valine seem to line the path touching the nonpolar part acyl chain of S1P (Kajimoto,
et al., 2019). These are hydrophobic and negatively charged. Glycine and cysteine seem
to react with the amino group of the S1P molecule (Kajimoto, et al., 2019). Many of these
observed effects occurred in conditions of non-serum-containing media as well as
micromolar concentrations of S1P, usually around 30 µM to 100 µM, which is highly
unusual for the study of S1P signaling through receptors, which all have Kd’s around 20
nM (Kajimoto, et al. 2019).
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1.6.ii. S1P as an Enhancing Cofactor for TRAF2
Lys-63-linked polyubiquitination occurs on the protein RIP1 as a result of TNFα
treatment. Typically, this particular residue linkage results in a signaling cascade
associated with ubiquitination rather than the typically thought of K48-linked ubiquitin,
which sends many proteins to the proteasome for degradation (Alvarez, et al., 2010).
TNFα treatment stimulates the phosphorylation of IκBα, and this is shown to be
dependent on SPHK1, and it was shown in a few cells types. Moreover, TNFα treatment
can stimulate the production of S1P within the cell as well as secretion into the cell culture
media. A positive control used for SPHK1 activation was phorbol myristate acetate and
ionomycin (Alvarez, et al., 2010). I have avoided this in my work due to the off-target
effects of PMA. It tends to activate other kinases besides SPHK1. VPC23019, which
antagonizes S1P receptors 1 and 3 was shown to have no effect on the phosphorylation
status of IκBα when treated in conjunction with S1P, implicating that the ensuing cellular
response upon S1P treatment was due to actions distinctly inside the cell. Stunningly,
these effects were observed at 100 nM concentrations of S1P, which is thought to be an
acceptable dosing range for extracellular receptor signaling, however, this cascade is
side-stepped while S1P acts in concert with TNFα and its associated factors.
While TNFα potently phosphorylates IκBα and SPHK1 at Ser225, it does not affect
ERK phosphorylation. On the other hand, S1P treatment stimulates ERK1/2
phosphorylation while failing to stimulate any IκBα phosphorylation at 100 nM. Counter to
that, 10 µM, a whopping high concentration of S1P, was able to mimic the effects of TNFα
(10 ng/mL) treatment. Moreover, the downstream transcription factor NFκB activity was
measured through a reporter assay indicating that S1P and TNFα, when treated together
and at the high concentration, markedly induce the expression of the reporter. This
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solidifies a role for S1P to mediate a transcriptional program. Typical pathways stimulated
by the NFκB pathway tend to steer toward survival, proliferation, lymphogenesis, and
inflammation. These are all very well-accepted broad-stroke roles of S1P.

“Molecular modeling of S1P into the RING domain of the crystal structure of TRAF2
24 revealed that it docked remarkably well in a 16 Å long binding cavity consisting
of a hydrophobic region (F45, L58, A59, L62, A90, F91 and F92) and positively
charged region (R43 and R97), which may stabilize the phosphate group of S1P.”
(Alvarez, et al., 2010)

RIP1 undergoes K-63-linked polyubiquitination to serve as part of a scaffold for
signaling events at the plasma membrane transducing through second messengers to
reach the IKK complex, which ultimately induces NFκB activation. RIP1 polyubiquitination
was shown by Alvarez and colleagues to be dependent on S1P, when induced by the
TNFα E3 ubiquitin ligase TRAF2 (TNFα receptor-associated factor) (Alvarez, et al., 2010).
Moreover, they demonstrated that TRAF2 has the ability to directly bind S1P, and that
TRAF2 co-immunoprecipitates with RIP1. What’s more, they confirmed that this binding
was specific for TRAF2, and that, remarkably, S1P could not detectably bind RIP1 in vitro
(Alvarez, et al., 2010).
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1.6.iii. S1P as a TERT Stabilizer
With regard for a noncanonical role of S1P, Ogretmen, Selvam, and coworkers
show that SPHK2 is the isozyme majorly responsible for the observed effect through use
of the SPHK2 inhibitor, ABC294640 in which telomerase reverse transcriptase (TERT)
protein decreases within 8 hours of ABC treatment (Selvam, et al., 2015). TERT
overexpression resulted in the abundant increase of 17C-S1P (d17:1 sphingoid backbone)
generation upon

17

C-sphingosine feeding. Asp684 is identified as an integral residue

responsible for the interaction between S1P and TERT (Selvam, et al., 2015). They used,
interestingly, a biotin-conjugated S1P to pull-down avidin, which revealed binding of
TERT. Oddly, ubiquitination of TERT is stimulated upon SPHK2 inhibition with the ABC
compound, thus implicating that decreasing the S1P would result in heavy ubiquitination
(Selvam, et al., 2015). On the other hand, the S1P effects on TRAF2 do the opposite, in
which lots of S1P around helps to ubiquitinate the target (Alvarez, et al., 2010). In the case
of TERT, however, the lysine ubiquitination is K48, which leads to proteasomal
degradation, whereas the TRAF2 ubiquitination cascade results in signaling scaffold
maintenance and formation.
Overall, TERT stability is decreased when SPHK2 is ablated. Thus, lack of S1P is
promoting ubiquitin mediated proteasome degradation. S1P saves TERT stability by
decreasing binding of its respective E3 ubiquitin ligase partner MKRN1 (Selvam, et al.,
2015). This is made possible by S1P binding the Asp684 residue within an TERT
quadruplex of α helices, and this results in a dissociation of MKRN1 from TERT (Selvam,
et al., 2015). Serines 921 and 992 also contribute to the binding of S1P within the TERT
α helical loops (Selvam, et al., 2015).
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1.6.iv. S1P as a Class I HDAC Inhibitor
The Spiegel lab identified SPHK2-generated S1P in the nucleus had effects on
histone deacetylases 1 and 2 (HDAC) (Hait, et al., 2009). Isolated nuclei were subjected
to lipidomics and indicated that overexpressed Sphk2 resulted in significant accumulation
of S1P in the nucleus. Moreover, western blotting of fractionated cells, down to the
chromatin, showed that histone H3 and SPHK2 proteins resided solely in the chromatin
post-nuclear fraction (Hait, et al., 2009). Moreover, histone H3 protein was found to coimmunoprecipitate with sphingosine kinase 2. The signal for H3K9 acetylation more than
doubled compared to control, when cells were transfected with an overexpression vector
for Sphk2 (Hait, et al., 2009). In the converse experiment in which siRNA was utilized to
knockdown each of the isozymes of SPHK, they observed a disappearance of the band
for acetylated H3K9. It is important to note that acetylated histone 3 lysine residue 9 is
typically associated with transcriptional activation when tested in the lab (Gates, et al.,
2017; Heintzman, et al., 2007). 5-minute treatment with 1 µM S1P and dhS1P also induced
the acetylation of H3K9. Although not central to their story, Hait and coworkers found that
knockdown of SPHK1 significantly depleted the cytoplasmic proportion of S1P, while
eliciting no effect on the nuclear content of S1P nor dhS1P. SPHK2 knockdown, on the
other hand, had no effect on cytoplasmic S1P concentrations, but it did significantly
decrease nuclear S1P and dhS1P signal. S1P-conjugated beads were shown to coimmunoprecipitate HDAC1 as well as HDAC2 (Hait, et al., 2009). S1P and dhS1P
treatments decreased recombinant HDAC1 activity. Overexpressing SPHK2 and also
overexpressing SPHK2 in the presence of PMA, an activator of SPHK, the H3K9ac
pulldown yielded a strong qPCR signal at chromatin promoter loci for p21 and c-fos. P21
is important in inducing cell cycle arrest, but at the same time it inhibits apoptosis, a
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function consistent with the signaling qualities of S1P (Harper, et al., 1993; Harper, et al.,
1995). Moreover, c-fos is an early transcription gene, and it generally indicates a cell is
active in its transcription, which is also supported by the pro-mitogenicity of S1P (Hait, et
al., 2009; Morgan and Curran, 1989).
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1.6.v. Overall Remarks about S1P
Overall, the work of Hait, Alvarez, Selvam, and Kajimoto have propelled S1P into
the intracellular signaling space intellectually, through mechanisms not heretofore
described in the more typical extracellular signaling mode that many understand (via the
5 S1P GPCRs). From Alvarez and coworkers, we do not find whether SPHK1 or SPHK2
specifically contributes to the effects elicited by S1P, but nevertheless, the effects are
strikingly differential and particular compared to Shan’s work in the Ogretmen lab (Selvam,
et al., 2015). Alvarez found that S1P binds cytosolic TRAF2, an E3 ubiquitin ligase, to
promote its polyubiquitin chain-making on RIP1, an important scaffolding protein in IKK
and NFκB signaling and transcription mediation (Alvarez, et al., 2010). Interestingly, this
ubiquitin modification on K63 does not promote proteasomal degradation, but it promotes
the formation of the signaling scaffold to transduce signals from the TNFα receptor and
TRAF2 through to the IKK complex (Alvarez, et al., 2010). In a different context,
Ogretmen’s group showed that S1P promoted TERT stability in the nucleus, by binding
within its α helices to disrupt TERT’s cognate E3 ubiquitin ligase, MKRN1, to thus prevent
K48 polyubiquitination and subsequent proteasomal degradation (Selvam, et al., 2015).
Interestingly, S1P acts to promote one E3 Ub ligase and in the other case acts to disrupt
an E3 Ub ligase. Despite this, the target proteins in both cases remain more stable.
Moreover, S1P directly binds TRAF2 E3 ubiquitin ligase in the cytosol, while S1P directly
binds the ligase’s target, TERT in the nucleus. For the TRAF2 binding in the cytoplasm,
an arginine residue was essential for grabbing the phosphate on the S1P molecule to
obtain ligase activity (Alvarez, et al., 2010). Serine was also noted to be essential in
stabilizing the negatively charged phosphate of S1P in this pocket (Alvarez, et al., 2010).

36

Leucine and phenylalanine residues also line the TRAF2 RING domain pocket with
contacts in the nonpolar sphingoid backbone of S1P (Alvarez, et al. 2010).
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1.6.vi. New Roles for Nuclear S1P
Seo and coworkers demonstrated a role for sphingosine kinase 1 inside the cell at
the level of nuclear viral replication and nuclear export within a host. It was found that viral
infection induces the expression of SPHK1 protein as well as its phosphorylated form
within 24 hours. Inhibition of SPHK1 with SKI-II dose-dependently reduces the viral titer in
human lung cells (Seo, et al., 2013). Inhibition with the same drug similarly decreased the
expression of several viral proteins, such as matrix, nonstructural, and nucleoprotein.
Phospho p65 signal is weakened post viral infection in the presence of SKI-II compared
to control, which indicated that components of the NFκB pathway, stimulated by viral
infection, lose their signaling capacity in the absence of SPHK1 action (Seo, et al., 2013).
Dimethylsphingosine, as a sphingosine kinase 1 inhibitor, was used in the presence of
influenza infection to block phosphorylation of RanBP3, which is critical for the transport
of the viral particles out of the nucleus (Lindsay, et al., 2001). ERK and AKT inhibitors
were shown to decrease phosphorylation of the same during conditions of flu infection
(Seo, et al., 2013). These results were recapitulated with SKI-II on pAKT and pERK, and
pRanBP3, all showing less phosphorylation (Seo, et al., 2013). This study did not
differentiate between the two kinases except in the beginning in which they specifically
used siRNA against Sphk1 to show dependent decreases in viral protein expression. None
of the experiments showed the converse, in which exogenous S1P treatment was utilized
or overexpression constructs or pharmacological upregulation of the kinase. Seo and
colleagues showed in an earlier study that exogenously applied S1P did not affect flu
replication (Seo, et al., 2010). SKI-II seemed to have more potent suppressive effects on
viral proteins than did SK1-I. Moreover, SKI-II specifically decreased the cytosolic viral
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protein, but not the nuclear viral protein. They quantified this by relative cytosolic to nuclear
expression of viral nucleoprotein (Seo, et al., 2013).
In another interesting work, Hait and colleagues demonstrate a role for SPHK2derived S1P as a positive modulator of HIF1α (Hait, et al., 2020). Strikingly, they suggest
and show that S1P has the ability to bind HIF1α within its PAS B pocket (Hait, et al., 2020).
What is even more curious is that HIF1α belongs to the same group of basic helix-loophelix transcriptions as BMAL1, CLOCK, and the PERIOD proteins, to name some.
Moreover, three separate works described roles for crosstalk of hypoxia and the clock
(Adamovich, et al., 2016; Peek, et al., 2017; Wu, et al., 2017).
Measurements of sphingolipids in epithelial cells show that sphingosine,
dihydrosphingosine, and ceramide are present in both the cytoplasm and nucleus, with a
greater constituent present in the nucleus (Fu, et al., 2018). Meanwhile, S1P is also
detectable in both cell fractions, but both pools are at equal concentrations, thus begging
the question as to how nuclear S1P, confined to such a smaller space, is affecting nuclear
programs in the cell. The Pynes and their coworkers demonstrated a role for SPHK1 and
S1P localized at the nucleus as a biomarker of survivability in breast cancer (Ohotski, et
al., 2013). Importantly, only sphingosine kinase 1 can utilize dihydrosphingosine to make
dihydrosphingosine-1-phosphate, and only sphingosine kinase 2 can utilize FTY-720 to
generate phosphorylated FTY-720 (Fu, et al., 2018).
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CHAPTER 2

SPHINGOLIPIDS IN ADIPOSE TISSUE: WHAT’S TIPPING THE SCALE?
(ANDERSON*, Lambert*, Cowart, 2018)

Review Manuscript
(*co-first-authorship)
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2.1. Introduction
2.1.i. Sphingolipids are Bioactive Lipids Linked to Obesity
In addition to their roles as structural membrane components, sphingolipids
including ceramides and sphingosine-1-phosphate (S1P), regulate many signaling
pathways related to the development of obesity and the metabolic syndrome. The aberrant
production of these bioactive lipids has been linked to insulin resistance andβ-cell
dysfunction, low grade inflammation, ectopic lipid deposition, cardiovascular disease and
non-alcoholic fatty liver disease (NAFLD) (Cantrell Stanford, et al., 2012; Meikle and
Summers, 2017; Montefusco, et al., 2018). In addition to potential intracellular mechanistic
roles played by sphingolipids in these processes, obesity is associated with elevated
circulating levels of several sphingolipid species in rodents and humans (BlachnioZabielska, et al., 2012a; Samad, et al., 2006). Therefore, many mouse models have been
developed to target distinct aspects of the sphingolipid metabolic pathway and these have
revealed various roles of sphingolipids in obesity-associated disease processes (Table 1).
As much of the pathophysiology associated with obesity may arise from adipose tissue
dysfunction, mechanisms for sphingolipids in adipose tissue homeostasis is a growing
focus of sphingolipid research in the context of obesity and related pathology. This review
will focus on the current understanding of sphingolipids in adipose tissue.
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Table 1. Sphingolipid knockout models and adipose tissue phenotypes.
Mouse Strain
Adipocyte-specific deletion
of Sptlc1

Adipocyte-specific deletion
of Sptlc2

Myeloid deletion of Sptlc2
Inducible acid ceramidase
overexpression in adipose
tissue

Constitutive Cers2
haploinsufficiency
Constitutive Cers5
knockout

Adipose Tissue
Phenotype
-Reduced adipose tissue
-Increased pro-inflammatory
gene expression
-Increased adipocyte size
-Increased fibrosis
-Increased cell death
-Reduced WAT and BAT
-Smaller adipocytes
-Increased expression of
thermogenic genes in WAT
-Increased browning of WAT
-Reduced adipogenic and
lipolytic gene expression in
BAT
-Increased lipid oxidation
-Increased adipose
inflammation

References

-No effect on HFD induced
adipose inflammation, IR
-Redistribution of adipose
tissue on HFD (more
gonadal, less mesenteric
adipose tissue)
-Reduced fibrosis
-Reduced immune cell
infiltration/pro-inflammatory
gene expression
-Increased glucose uptake
-Increased adiposity

(Camell, et al., 2015)

-Reduced adipose tissue
mass on HFD
-Protection from hypertrophy
on HFD
-Protection from insulin
resistance
-Reduced pro-inflammatory
cytokines
-Up-regulation of both
lipolytic and lipogenic genes

(Gosejacob, et al., 2016)
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(Alexaki, et al., 2017)

(Chaurasia, et al.,
2016a; Lee, et al., 2017)

(Xia, et al., 2015)

(Raichur, et al., 2014)

Constitutive Cers6
knockout

Brown adipose tissuespecific Cers6 knockout
Constitutive Sphk1
knockout

Constitutive S1P lyase
knockout
Constitutive sphingomyelin
synthase 1 knockout

Constitutive sphingomyelin
synthase 2 knockout

GM3 synthase knockout

-Reduced adiposity
-Reduced adipocyte size
-Reduced adipose
inflammatory markers
-Reduced BAT lipid droplet
size
-Reduced adiposity
-Reduced energy
expenditure
-Reduced adipose
inflammation
-Increased adipose tissue
mass
-Decreased adipocyte size
-Enhanced insulin signaling
-Reduced adipose tissue
mass
-Reduced adipose tissue
mass with age
-Reduced adipocyte size
-Increased oxidative stress
-Reduced adipose tissue
mass on HFD
-Protection from PPARγ and
CD36 increase on HFD
-Reduced gWAT and sWAT
mass on control diet
-Reduced Mesenteric and
subcutaneous adipose
tissue mass on HFD
-Reduced TNFα on HFD
-Increased IL-10 and
Adiponectin on HFD

(Turpin, et al., 2014)

(Turpin, et al., 2014)

(Ross, et al., 2013;
Wang, et al., 2014)

(Bektas, et al., 2010)
(Yano, et al., 2013)

(Mitsutake, et al., 2011)

(Nagafuku, et al., 2015)

Table 1. Sphingolipid knockout models and adipose tissue
phenotypes. (Lambert, J.M., Anderson, A.K., Cowart, L.A. (2018) Sphingolipids in
Adipose Tissue: What’s Tipping the Scale? Advances in Biological Regulation 70: 1930.)
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2.1.ii. Adipose Tissue Biology
Adipose tissue is in constant metabolic flux as it must respond to ever-changing
energy requirements. It is distributed throughout the body in distinct depots, which vary in
size, function, and gene/protein expression. The primary function of adipose tissue is
storage of energy as triglyceride, which is regulated by triacylglycerol anabolic and
catabolic pathways, lipogenesis and lipolysis, respectively. Adipose tissue also serves as
an endocrine organ via the secretion of many hormones and cytokines, also referred to
as adipokines. Adipokines elicit a multitude of effects on the adipose tissue itself and also
overall metabolic physiology by direct and indirect mechanisms. Two major adipokines
include adiponectin, which mediates glucose homeostasis and fatty acid catabolism, and
leptin, which regulates satiety. Altered levels of adipokines including these are implicated
in many disease states, including obesity (Sulaieva, et al., 2018). Additionally, the
thermogenic function of adipose tissue has emerged as a topic of major interest in recent
years. Brown and beige adipocytes are rich in mitochondria and Uncoupling Protein 1,
which allows for generation of heat. Activation of brown adipose tissue in rodents garners
protection from obesity by increasing energy expenditure, though whether this is
paradigmatically similar in adult humans remains controversial. Thus, a focus on
conversion of white adipocytes to oxidative brown adipocytes has been an attractive area
of therapeutic interest (Cannon and Nedergaard, 2004). While most of the mass of the
tissue comes from the adipocytes, a variety of other cell types are present including stem
cells, preadipocytes, vascular endothelial cells and immune cells. However, adipose tissue
mass is modulated primarily at the level of the adipocyte largely through either hyperplasia
or hypertrophy, as well as cell death. For example, both white and brown adipocytes are
generated via hyperplasia, where stem cells residing in the adipose tissue undergo
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differentiation. This is referred to as adipogenesis. Impairments in this process are thought
to compromise adipose tissue function and contribute to obesity-related pathologies. In
contrast, adipocyte hypertrophy occurs under conditions that necessitate the existing
adipocytes to take on a larger lipid load, including impaired adipogenesis and diet induced
obesity. Moreover, mounting evidence suggests that adipogenesis/hyperplasia maybe
beneficial; adipose tissue expansion by hypertrophy is in fact deleterious, as it promotes
adipose tissue inflammation and adipocyte cell death. Importantly, sphingolipids have
been implicated in many of these diverse processes and functions of adipose tissue
(Berry, et al., 2016; Rosen and Spiegelman, 2014; Tang and Lane, 2012).
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2.2. Sphingolipid Synthesis and Metabolism
Discovered at the turn of the twentieth century, sphingolipids were an “enigma” just
like the Greek sphinx, as neurochemist Thudichum, who first described them, opined.
Some of the first sphingolipids discovered were in the brain, thus giving rise to such names
as sphingomyelin and cerebrosides (Merrill, et al., 1997). Even so, it is now appreciated
that sphingolipids are ubiquitous in eukaryotic cells as critical components of cell
membranes (Levy and Futerman, 2010; Pruett, et al., 2008). Although their role is longestablished as structural membrane lipids, research from the late 1980's and 1990's
provided unequivocal evidence that they function as vital signaling molecules (Hannun,
1996). This notion also gains support from studies that demonstrate mice lacking certain
enzymes in the sphingolipid biosynthesis pathway die in utero (Hojjati, et al., 2005; Ishii,
et al., 2002; Li, et al., 2002; Liu, et al., 2000; Yamashita, et al., 2002). Sphingolipids are
defined by the sphingosine backbone, a long chain amino alcohol. De novo synthesis in
the cytoplasmic face of the endoplasmic reticulum (ER) begins with the condensation of a
saturated fatty acid (usually palmitate) and serine (Figure 3). This is catalyzed by the
sphingolipid biosynthetic rate-limiting enzyme, serine palmitoyltransferase (SPT), to form
3-ketosphinganine. Next, 3-ketosphinganine is reduced to dihydrosphingosine by the
action of 3-ketosphinganine reductase. A fatty acyl group is then added to
dihydrosphingosine to form dihydroceramide through the actions of 1 of 6
(dihydro)ceramide synthase enzymes (dhCERS1-6). This fatty acyl group can vary in
chain length, and this is dictated by the specificity of certain CERS isoforms for the
utilization of particular acyl CoA species. Dihydroceramide is then desaturated to form
ceramide. From this point, ceramide can be interconverted into a number of different
metabolites,

including

sphingomyelin,

ceramide-1-phosphate,
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glucosylceramide,

galactosylceramide, and sphingosine. Indeed, ceramide can be reformed through
recycling by re-acylation of sphingosine or breakdown of sphingomyelin. Sphingosine can
then be phosphorylated by either isoform of sphingosine kinase (SPHK1, 2) to form S1P,
which is the final step in the biosynthetic pathway before exiting via the S1P lyase as
hexadecenal and phosphoethanolamine, which may be used for the synthesis of
glycerophospholipids. Importantly, while ceramides and S1P are the subject of most
studies

addressing

sphingolipid

signaling,

the

“complex

sphingolipids,”

e.g.,

sphingomyelin, glucosylceramides, and their derivatives are orders of magnitude more
abundant.
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LC, long chain.

Tipping the Scale? Advances in Biological Regulation 70: 19-30.)

(Lambert, J.M., Anderson, A.K., Cowart, L.A. (2018) Sphingolipids in Adipose Tissue: What’s

Figure 3. Sphingolipid biosynthesis pathway.

While ceramides are synthesized de novo largely in the ER, they are also
generated by hydrolysis of sphingomyelin (mediated by sphingomyelinase). Furthermore,
ceramides undergo catabolism in lysosomes by acid ceramidase. This not only produces
sphingosine, the key substrate for sphingosine kinases (discussed below) but allows
generation of ceramides via what is termed the “salvage” pathway in which ceramide is
hydrolyzed and the resulting sphingosine is re-acylated back to ceramide. This process,
which seems to serve fundamental roles in remodeling the acyl chain composition of the
intracellular ceramide pool, is localized to the late endosome or lysosome (Levy and
Futerman, 2010). While S1P is a key signaling molecule, its modes of biosynthesis,
degradation, and signaling are paradigmatically distinct from those of ceramide.
Sphingosine kinases occur as two isoforms, Sphingosine Kinases 1 and 2. (SPHK1 and
2, respectively). These enzymes have numerous locations. They are cytosolic but can
translocate to the plasma membrane upon phosphorylation. The isoforms share partially
distinct intracellular localization, as SPHK2 has been found in the nucleus, and SPHK1
may be found in the ER (Pitson, et al., 2005; Siow, et al., 2011; Wattenberg, 2010). S1P
is generated at the plasma membrane through the hydrolysis of ceramide, generating
sphingosine, the substrate for SPHK. Phosphorylation of sphingosine yields S1P, which
signals in part through one of its five G-protein coupled receptors. Export of S1P occurs
via transporters such as SPNS2 and ABC transporters and enables paracrine and
endocrine signaling. While export of S1P may also be required for autocrine S1P signaling,
structural information on the S1P receptor suggests that S1P formed at the plasma
membrane might undergo lateral diffusion through membrane lipid to bind the receptor,
whose active site is accessible to the plasma membrane bilayer (Donoviel, et al., 2015;
Fukuhara, et al., 2012; Hisano, et al., 2011; Parrill, et al., 2012; Pyne and Pyne, 2017;
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Takabe, et al., 2008; van Meer, et al., 2006; Yamada, et al., 2018). There are reports that
S1P receptors are internalized through endocytic vesicles and can thus be found
intracellularly. However, it is not known whether signaling occurs through these endocytic
S1P receptors (Spiegel and Milstien, 2003). Mounting evidence suggests that S1P
originating from a certain cell type or from within or outside the cell may have differential
signaling capacities. Thus, more work is needed to delineate the roles of S1P in specific
cell types, but also to assess the downstream effects on paracrine/endocrine effector cells.
The balance among sphingomyelin, ceramide, and S1P is mediated by the action
of sphingomyelin synthase/sphingomyelinase, ceramide synthases/ceramidases as well
as SPHKs, the S1P lyase, and the S1P phosphatase. Extracellular stimuli cause dynamic
flux between these pools and therefore sphingolipids comprise a “rheostat,” where
ceramide levels promote differentiation, senescence, autophagy, and apoptosis, while its
downstream metabolite, S1P tends to promote cell division and migration. Therefore, cells,
by modification of sphingolipid metabolism, drastically alter their processes. Accordingly,
the careful and intricate balance of these metabolites is critical for cell homeostasis and
function. Interconversion between these distinct lipid species is orchestrated not just by
transcriptional regulation of the anabolic or catabolic processes, but also in some cases
by the availability of substrate (Johnson, et al., 2002; Lee, et al., 2008; Pitson, 2011; Ross,
et al., 2013).
The sphingolipid pathway is highly relevant in the context of metabolic disease,
because it is known to be driven at least in part by the oversupply of saturated fatty acids
(required for de novo biosynthesis), as occurs in dyslipidemia associated with obesity.
Although the adipocyte is specialized to store large quantities of lipid, there comes a
tipping point at which lipids can no longer be transported into the adipocyte, and they
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consequently spill out into circulation for deposition in peripheral tissues not equipped to
take on such a burden. Ectopic lipid deposition indeed is another hallmark of obesity and
is one of the theorized causes for the downstream pathologies associated with obesity
and the metabolic syndrome (Kraegen, et al., 2001; Ross, et al., 2014). For example, in
skeletal muscle and liver, ceramides have been implicated in insulin resistance of these
tissues. This process, which is often referred to under the general term “lipotoxicity,”
ensues as hepatic steatosis develops, pancreatic β-cells die, skeletal muscle becomes
insulin resistant, and atherosclerosis is instigated. Sphingolipids play major roles in the
etiologies of these pathologies. Only recently, studies have begun to address the potential
impact of sphingolipids on the biology of the adipocyte in order to comprehend the
underlying causes of obesity and the metabolic syndrome.
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2.3. Sphingolipids in Adipogenesis
While excess adipose tissue is generally recognized as deleterious to health,
expansion of adipose tissue is necessary for storage of lipids and is therefore critical to
health. In this regard, subcutaneous adipose tissue expansion is understood to be more
metabolically

favorable

than

expansion

of

the

visceral/abdominal

depots

(mesenteric/epididymal depots in rodents). Additionally, as mentioned above, expansion
of adipose tissue mass is most healthfully accomplished via adipocyte hyperplasia, which
occurs through adipo-genesis. This process is mediated by a tightly regulated transcription
factor cascade in which stem cells undergo a metabolic and structural transformation into
lipid droplet-containing adipocytes. It is often described in two phases. First, stem cells
become preadipocytes committed to the adipocyte lineage defined by expression of
preadipocyte factor 1 (PREF1) and C/EBPs, then undergo maturation, which is marked by
extracellular matrix remodeling, unilocular lipid droplet formation, and expression of
peroxisome proliferator-activated receptor gamma (PPARγ), adiponectin, fatty acid
binding protein 4 (FABP4), leptin, and others (Cawthorn, et al., 2012; Hudak and Sul,
2013; Tang and Lane, 2012). Evidence for a role of sphingolipids in this process is
emerging, including from studies demonstrating that several mouse models targeting
sphingolipid genes display phenotypes involving impaired adipogenesis (Table 1).
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Table 1. Sphingolipid knockout models and adipose tissue phenotypes.

Mouse Strain
Adipocyte-specific deletion
of Sptlc1

Adipocyte-specific deletion
of Sptlc2

Myeloid deletion of Sptlc2
Inducible acid ceramidase
overexpression in adipose
tissue

Constitutive Cers2
haploinsufficiency
Constitutive Cers5
knockout

Adipose Tissue
Phenotype
-Reduced adipose tissue
-increased pro-inflammatory
gene expression
-increased adipocyte size
-Increased fibrosis
-increased cell death
-Reduced WAT and BAT
-Smaller adipocytes
-Increased expression of
thermogenic genes in WAT
-Increased browning of WAT
-Reduced adipogenic and
lipolytic gene expression in
BAT
-Increased lipid oxidation
-Increased adipose
inflammation

References

-No effect on HFD induced
adipose inflammation, IR
-Redistribution of adipose
tissue on HFD (more
gonadal, less mesenteric
adipose tissue)
-Reduced fibrosis
-Reduced immune cell
infiltration/pro-inflammatory
gene expression
-increased glucose uptake
-Increased adiposity

(Camell, et al., 2015)

-Reduced adipose tissue
mass on HFD
-Protection from hypertrophy
on HFD
-Protection from insulin
resistance
-Reduced pro-inflammatory
cytokines
- Up-regulation of both
lipolytic and lipogenic genes

(Gosejacob, et al., 2016)
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(Alexaki, et al., 2017)

(Chaurasia, et al.,
2016a; Lee, et al., 2017)

(Xia, et al., 2015)

(Raichur, et al., 2014)

Constitutive Cers6
knockout

Brown adipose tissuespecific Cers6 knockout
Constitutive Sphk1
knockout

Constitutive S1P lyase
knockout
Constitutive sphingomyelin
synthase 1 knockout

Constitutive sphingomyelin
synthase 2 knockout

GM3 synthase knockout

-Reduced adiposity
-Reduced adipocyte size
-Reduced adipose
inflammatory markers
-Reduced BAT lipid droplet
size
-Reduced adiposity
-Reduced energy
expenditure
-Reduced adipose
inflammation
-Increased adipose tissue
mass
-Decreased adipocyte size
-Enhanced insulin signaling
-Reduced adipose tissue
mass
-Reduced adipose tissue
mass with age
-Reduced adipocyte size
-Increased oxidative stress
-Reduced adipose tissue
mass on HFD
-Protection from PPARγ and
CD36 increase on HFD
-Reduced gWAT and sWAT
mass on control diet
-Reduced Mesenteric and
subcutaneous adipose
tissue mass on HFD
-Reduced TNFα on HFD
-Increased IL-10 and
Adiponectin on HFD

(Turpin, et al., 2014)

(Turpin, et al., 2014)

(Ross, et al., 2013;
Wang, et al., 2014)

(Bektas, et al., 2010)
(Yano, et al., 2013)

(Mitsutake, et al., 2011)

(Nagafuku, et al., 2015)

Table 1 (reprinted). Sphingolipid knockout models and their adipose
tissue phenotypes. (Lambert, J.M., Anderson, A.K., Cowart, L.A. (2018)
Sphingolipids in Adipose Tissue: What’s Tipping the Scale? Advances in Biological
Regulation 70: 19-30.)

54

Sphingolipid delta (4)-desaturase (DEGS1) catalyzes the final step in the de novo
synthesis of ceramides and is decreased in obesity. This leads to accumulation of
ceramide precursors, the dihydroceramides. While ceramides per se are a focus of
abundant research, few specific roles for the dihydroceramides have been discovered.
Interestingly, however, pharmacological inhibition of DEGS1 in both mice and 3T3-L1
preadipocytes and genetic knockdown in vitro impaired both adipogenesis and
lipogenesis. Similarly, treatment of 3T3-L1 cells with dihydroceramide, concomitant with
the induction of adipogenesis led to impaired differentiation and reduced expression of
PPARγ, the master regulator of adipogenesis. Cells with depletion of DEGS1 via siRNAmediated knockdown, maintained high levels of mRNA encoding PREF1, a preadipocyte
marker, suggesting they do not leave the preadipocyte stage. These findings suggest that
conversion of dihydroceramide to ceramide may be important during early events of
adipogenesis (Barbarroja, et al., 2014).
Sphingolipid

biosynthesis

is

initiated

by

a

multimeric

enzyme,

serine

palmitoyltransferase, of which the catalytic subunit is SPTLC1. Deletion of Sptlc1
specifically in adipose tissue in mice led to cell death. These mice showed normal
development of adipose tissue early in life, but increased cell death and inflammation as
they aged (Alexaki, et al., 2017). Similar results were observed in constitutive knockout of
sphingomyelin synthase 1 (SMS1) (Yano, et al., 2013), which generates sphingomyelin
and thus reduces intracellular ceramide via the consumption of ceramide as substrate.
Because SMS1 and DEGS1 decrease versus increase ceramide, respectively, the
similarity in phenotypes that were observed may arise not from absolute ceramide content
but rather alterations in the ratio between ceramides and precursors or downstream
metabolites. Or other metabolites altogether may underlie these phenotypes. For
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example, mice bearing adipocyte-specific deletion of Sptlc2 demonstrated significantly
reduced adipose tissue mass and also hepatic steatosis. Coinciding with this, alterations
in the expression of genes involved in adipogenesis (Pparγ, Fabp4, Cebpα, and Srebp1c)
were observed concomitant with reduced S1P and S1PR1 in the Sptlc2 knockout (Lee, et
al., 2017).
S1P has been shown to be both pro- (Hashimoto, et al., 2009; Mastrandrea, 2013)
and anti-adipogenic (Hashimoto, et al., 2015; Jeong, et al., 2015). Constitutive deletion of
SPHK1 led to increased adipose tissue mass and a corresponding increased expression
of pro-adipogenic genes upon high fat feeding. Strikingly, despite increased adiposity,
these mice were metabolically healthy, suggesting that SPHK1 deletion encouraged
adipose tissue expansion. FTY720, a structural analog of sphingosine, acts as a functional
antagonist of S1PR1 when phosphorylated by causing internalization of the receptor.
Treatment of 3T3-L1 cells with phosphorylated FTY720 decreased adipogenesis.
Additionally, FTY720 injection of mice on a high fat diet reduced adiposity (Moon et al.,
2012). Though more information on mechanisms will be important, ceramide, sphingosine
and SPHK levels decrease throughout adipogenesis and inversely correlate with lipid
droplet content (Choi, et al., 2011; Mastrandrea, 2013). This suggests that their downregulation may be important for adipocyte maturation.
While ceramides and S1P have received by far the most attention, data show that
GM3 ganglioside is the most abundant ganglioside in adipose tissue and is elevated in
adipose tissue from obese mice. Tissue GM3 may not arise from adipocytes, per se, as
adipose tissue macrophages produce sphingolipids such as GM3, and macrophage
depletion improved adipogenesis in vitro in mesenteric stromal vascular cells. Constitutive
knockout of GM3 synthase also improved adipogenesis of mouse embryonic fibroblasts
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(MEFs). Consistent with this, GM3 knockout mice displayed reduced epididymal and
subcutaneous adipose tissue mass on a standard chow diet, and decreased mesenteric
and subcutaneous adipose tissue mass, combined with less inflammation, on a high fat
diet (Nagafuku, et al., 2015). Similarly, pharmacological inhibition of glycosphingolipid
synthesis by treatment with N-(5-adamantane-1-yl-methoxy)-pentyl-1-deoxynojirimycin
(AMP-DNM) improved adipogenesis, leading to metabolically healthy adipose tissue
expansion in mice fed a high fat diet (van Eijk, et al., 2009). These findings provide a hint
that pharmacological targeting of these pathways may eventually serve as a therapeutic
strategy.
An important caveat to these experimental approaches is that manipulation of
anabolic and/or catabolic pathways through genetic or pharmacological means affects
metabolite pools both upstream and downstream of the intended target. Therefore, it is
important to interpret data keeping in mind these potential mechanisms. However, from
these studies it is clear that disrupting the sphingolipid balance has a negative impact on
adipogenesis. More research will be required to understand the mechanistic basis for
changes in these genes, enzymes, and subsequently their metabolites in pathological
contexts.
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2.4. Sphingolipids in Adipocyte Metabolism
Depending on the needs of the animal, adipocyte metabolism switches between
lipolysis and lipogenesis, which are opposing metabolic processes. This ability to switch
requires coordination of the regulation of many players in these molecular pathways. The
adipocyte must properly coordinate these pathways to adapt to the differing energy
demands and caloric consumption of sleeping and waking phases in diurnal animals.
Sleeping necessitates adipocyte lipolysis, in which lipid droplet neutral triglycerides are
catabolized to their constituents, fatty acid and glycerol, by a series of sequential enzymes
that are tightly regulated and specific for triacylglycerol, diacylglycerol, monoacylglycerol
(TAG, DAG, and MAG respectively). Lipolysis tends to increase when the activity of AMPK
increases (Daval, et al., 2006). Moreover, when AMPK is activated, this generally lowers
glucose concentration in the circulation (Jordan and Lamia, 2014).
In the fed state, energy storage is the metabolic priority. This occurs via
lipogenesis, the process by which fatty acids and/or triglycerides are taken up from the
circulation by adipocytes to be esterified into the lipid droplet for later use as energy when
the organism is in need. Other than these hallmark processes which are abundantly
studied, the adipocyte must make choices among other metabolic pathways including
glycolysis, β-oxidation, glyceroneogenesis, and sphingolipid synthesis (Chavez and
Summers, 2003; Duncan, et al., 2007; Ferreira, et al., 2017; Franckhauser, et al., 2002;
Hodson, et al., 2013; Kersten, 2001; Krycer, et al., 2017; Larsen and Tennagels, 2014;
Miller, et al., 2015; Romero, et al., 2015; Rotondo, et al., 2017).
Data support numerous roles of sphingolipids in adipocyte metabolism. One key
finding is the observation that lipolysis-driven inflammation required SPHK1 (Wang, et al.,
2014). Isoproterenol, which agonizes β-3 adrenergic receptors, is a commonly-used
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reagent for studying lipolysis due to the inherent receptor mechanism of catecholamineinduced increases in cAMP and PKA, which stimulate the activity of lipolytic enzymes
(Greenberg, et al., 2001). In both mouse gonadal adipose tissue and 3T3-L1 adipocytes,
isoproterenol induced the expression of Sphk1 mRNA. Also, depletion of SPHK1
abrogated the lipolysis-mediated production of interleukin 6 (IL-6) (Wang, et al., 2014). In
support of a role for S1P in lipolysis was the observation that glycerol release was
increased by S1P treatment in a dose-dependent fashion (Jun, et al., 2006). Thus, the
lipolysis metabolic pathway is affected by the SPHK axis. More studies will be needed to
determine the role of S1P as the effector or the affected in this scheme.
It is widely accepted that stimulation of lipolytic pathways occurs via cAMP.
Interestingly, adenylyl cyclase, the enzyme responsible for cAMP production, is typically
found at the membrane localized to lipid rafts, which are known to contain higher
concentrations of sphingolipids and cholesterol than the surrounding plasma membrane.
Considering this interplay, the membrane dynamics of the adipocyte and its relationship
with sphingolipids poses intriguing questions for scientific inquiry. Furthermore, cAMP is
not only important for lipolysis, but it is one of the major effectors of early adipogenesis
(Cooper, 2003). In addition, elevated cAMP is typically associated with decreased leptin,
which intuitively suggests that these opposing characters (leptin, lipolytic mediators) must
work in temporally discrete modes. Lipolysis occurs when circulating insulin and glucose
are low, which indicates the organism is in an energy deficient state. Thus, fatty stores
can be liberated through lipolysis to be provided to other organs for energetic support. On
the other hand, if an organism is fed, adipocyte-derived leptin levels should increase, thus
signaling to the hypothalamus the state of satiety and suppression of hunger.
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A recently emerging concept in adipocyte metabolic biology is the role of the
intrinsic adipocyte circadian clock as a key player in regulation of adipocyte metabolism.
Major effectors of lipolysis, such as ATGL and HSL, and other effectors of lipogenesis,
such as PPARγ, are under the control of the circadian transcription program. The
adipocyte is specialized to communicate with the rest of the body with its immense
secretion of numerous adipokines as well as lipids. The liver, one of its well-appreciated
crosstalk partners, has a robust circadian clock that can mediate feeding and fasting
rhythms. The role of sphingolipids in circadian rhythm is still largely unexplored, despite
the fact that circulating lipids are known to fluctuate with 24-h rhythmicity. Adiponectin and
leptin also rise and fall according to circadian patterns (Shostak, et al., 2013, 2013a;
Unger, et al., 2013). Studies examining the effect of time of day on feeding and the
downstream consequences have revealed numerous intriguing mechanisms. For
example, mice fed a high fat diet restricted only to the waking portion of the day completely
recovered from metabolic aberrancies, such as insulin resistance, compared to ad libitum
fed controls (Chaix, et al., 2019; Hatori, et al., 2012). Considering that the adipocyte is at
the crux of whole-body metabolic regulation, and that the circadian system is intertwined
with metabolism, one would be amiss to disregard these important details. At the very
least, researchers may consider aligning media changes and experimental initiation, or
time restricted feeding in addition to high fat diet feeding.
One of these circadian regulated adipokines, adiponectin is associated with
improved insulin sensitivity. Treatment of mice and MEFs with adiponectin reduces
ceramide content by enhancing ceramidase activity and leads to increased production of
the metabolite S1P. Additionally, deletion of adiponectin receptors led to reduced
ceramidase activity, and elevation in ceramide content. These results suggest that the
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protective effects of adiponectin against the development of insulin resistance may be in
part due to degradation of ceramides (Holland, et al., 2011). The Holland group also found
that inducible adiponectin deletion during the final two weeks of a six-week high fat feeding
regimen, resulted in elevated ceramides, reduced sphingosine, S1P, and sphinganine-1phosphate, and a variety of metabolic abnormalities (Xia, et al., 2018). Aside from major
findings in lipolysis and adiponectin, the role of sphingolipids in other facets of adipocyte
metabolism are worth further investigation.

61

2.5. Sphingolipids in Adipose Tissue Inflammation and Insulin Resistance
Pathological obesity is often associated with low grade inflammation within the
adipose tissue. In addition to lipotoxicity, inflammation and glucocorticoid excess are the
major mechanisms of insulin resistance. Infiltration of pro-inflammatory immune cells such
as macrophages, paired with increased expression of inflammatory cytokines, including
tumor necrosis factorα (TNFα), IL-6, interleukin 1β (IL-1β), monocyte chemoattractant
protein (MCP1) and inducible nitric oxide synthase (iNOS) and reduced expression of antiinflammatory interleukin 10 (IL-10) and adiponectin are indicators of adipose inflammation.
As inflammation progresses, infiltrating macrophages accumulate around dying
adipocytes, forming what are referred to as crown like structures. Inflammation, in addition
to lipotoxicity, impairs adipose function, including glucose uptake (reduced GLUT4
translocation to the plasma membrane) and lipogenesis, which contribute to insulin
resistance, locally within adipose tissue and systemically. Studies investigating the role of
sphingolipids in insulin resistance have primarily focused on liver, skeletal muscle, and
pancreas, however there is evidence that sphingolipids generated within the adipose
tissue are effectors of systemic and localized insulin signaling. Treatment of 3T3-L1 cells
with sphingolipids induces pro-inflammatory gene expression; for example, treatment with
soluble ceramide analogues induced TNFα, MCP1, and IL-6. TNFα was also induced by
sphingosine and S1P. MCP1 was induced by sphingosine, and IL-6 was induced by
sphingosine and S1P. Consistent with this, inhibition of de novo ceramide synthesis with
myriocin increased expression of anti-inflammatory M2 macrophage genes. This occurred
with increase in IL-10 (anti-inflammatory) and decrease in IL-6, MCP1, and TNFα (proinflammatory). Together these results suggest that de novo ceramide synthesis promotes
inflammation (Samad, et al., 2006).
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There is a well-established role for ceramide in promoting insulin resistance. One
mechanism by which ceramide affects insulin signaling in adipocytes is through inhibition
of the AKT/PKB signaling pathway via ceramide-mediated stimulation of PP2A, which
antagonizes phosphorylation of AKT in response to insulin receptor-mediated signaling
(Zhang, et al., 2012). Inhibition of the AKT pathway then reduces GLUT4 translocation to
the plasma membrane, which reduces glucose uptake. Experimental evidence for this
includes the observation that raising ceramide levels in 3T3-L1 cells by addition of
ceramide or ceramide activators including saturated fatty acids prevented insulin
activation of the AKT pathway (Stratford, et al., 2004; Summers, et al., 1998). This activity
of ceramide has been observed in many other cell types (Salinas, et al., 2000; Schubert,
et al., 2000).
Another mechanism of insulin resistance is through inflammatory pathways, which
are activated in both immune cells and adipocytes resulting in the production of proinflammatory cytokines. Ceramide has been shown to induce the NLRP3 inflammasome,
which activates caspase-1 and IL-1β secretion, both of which impair insulin signaling
through caspase-1 upregulation. Palmitate also induces IL-1β, however myriocin does not
inhibit this upregulation suggesting that de novo ceramide synthesis is not required for its
induction. To determine if de novo ceramide synthesis in macrophages is responsible for
adipose tissue inflammation and insulin resistance in diet induced obesity, a myeloidspecific Sptlc2 knockout mouse was generated. This had no effect on adipose tissue
inflammation or insulin resistance suggesting that de novo ceramide synthesis in
macrophages is not required for these pathologies (Camell, et al., 2015). Another activator
of ceramide synthesis is the mTOR pathway. Deletion of mTORC1 from adipose tissue
was shown to increase de novo ceramide synthesis, leading to increased adipose tissue
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inflammation, despite reduced adiposity. Treatment with myriocin prevented this
inflammation (Chimin, et al., 2017).
Glucosylceramides have also been implicated in the development of adipose
tissue inflammation and insulin resistance. GM3 ganglioside is elevated in obesity and
abundant in adipose tissue. TNFα treatment of 3T3-L1 adipocytes induced GM3
expression in addition to insulin resistance. GM3 treatment also induced insulin
resistance. Treatment with an inhibitor of glucosylceramide synthase reversed the
impaired insulin signaling (Tagami, et al., 2002). These effects have also been observed
in vivo. Ob/ob mice treated with glucosylceramide synthase inhibitor AMP-DNM reduced
levels of GM3 and reversed their insulin resistant phenotype, in addition to reducing
adipose tissue inflammation (van Eijk, et al., 2009). Additionally, genetic ablation of GM3
prevented systemic insulin resistance due to high fat diet (Nagafuku, et al., 2015;
Yamashita, et al., 2003). GM3 localizes at caveolae in the plasma membrane of
adipocytes where it regulates insulin receptor localization. GM3 forms a complex with the
insulin receptor and mobilizes it away from caveolae which prevents insulin signaling
(Kabayama, et al., 2007).
SPHK and S1P have also been studied with regards to their impact on adipose
tissue inflammation and insulin resistance. Both palmitate and LPS treatment have been
shown to stimulate SPHK activity in vitro in many experimental systems including rat
primary adipocytes. This occurred concomitant with an increase in pro-inflammatory
cytokines. This increase in pro-inflammatory gene expression was suppressed by
treatment with SPHK1 inhibitor (SK1-I), indicating that there is an SPHK1 dependent
mechanism for adipose inflammation (Tous, et al., 2014). Additionally, SPHK1 expression
and activity has been shown to be induced in macrophages in genetic and diet induced
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obesity. This has been recapitulated in vitro with palmitate treatment of RAW264.7
macrophage-like cells which also induced SPHK1 expression and activity, along with S1P
levels. SPHK2 was unchanged with palmitate treatment. Palmitate treatment in the
presence of SK1-I was associated with decreased cell survival, indicating that SPHK1
activity and the S1P it produces protects macrophages from lipotoxicity induced cell death
(Gabriel, et al., 2017), which has previously been reported in the context of TNFα and LPS
using RAW264.7 cells (Hammad, et al., 2008). Another group used macrophages lacking
both SPHK isoforms to demonstrate that SPHK is not necessary for inducing inflammation
in macrophages but leads to elevated autophagy (Xiong, et al., 2013). Alternatively,
constitutive knockout of SPHK1 in mice has been shown to be protective against proinflammatory gene ex-pression and recruitment of adipose tissue macrophages in diet
induced obesity. This occurred concomitantly with improved insulin signaling in adipose
tissue and protection from systemic insulin resistance. Pharmacological inhibition of
SPHK1 in obese mice reversed adipose inflammation and impairments in insulin signaling
(Wang, et al., 2014). These studies highlight the overall importance of sphingolipids in
adipose insulin signaling and inflammatory pathways.
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2.6. Sphingolipids in Brown Adipose Tissue
Brown adipose tissue is thought to be the metabolic panacea of obesity due to its
literal fat burning potential. The high mitochondrial content of this depot distinguishes it in
color and function from the white adipose, as it uncouples fat oxidation from ATP
production to generate heat. S1P was explored in the functioning of brown adipose tissue.
S1P is known to be carried in the bloodstream on apolipoprotein M (ApoM) on HDL
particles, as well as albumin (Christensen, et al., 2016; Christoffersen, et al., 2011). In the
brown adipose tissue, it is known that lipoproteins interact with lipoprotein lipase as well
as the fatty acid transporter CD36 at the interface of the brown adipocytes and the
endothelium. An ApoM knockout mouse has been used to assess its function in adipose
tissue with some striking findings in brown adipose tissue. For example, histological
analysis of brown adipose tissue revealed a dramatic decrease in lipid droplets with a
concomitant increase in mitochondria. This finding was coupled with increased Glut4
mRNA expression, implicating a potential role for S1P in GLUT4 translocation and insulin
signaling. Also intriguing was the differential activity in the ApoM-/- brown adipose tissue,
in which uptake of radiolabeled oleic acid was increased in the brown adipose tissue
relative to control mice. These findings highlight the specificity of fatty acids utilized by the
adipocyte in response to a change in sphingolipid dynamics (Christoffersen, et al., 2018).
The Summers group has also published widely in the field of brown adipocyte biology.
They have found, in the context of high fat diet, myriocin induced browning markers, such
as Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) and
PR domain containing 16 (PRDM16) in subcutaneous adipose tissues. This was
associated with increased circulating adiponectin (Chaurasia, et al., 2016). They also
found that cold exposure decreased ceramide levels in both gonadal and subcutaneous
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adipose depots. Cold exposure, a common experimental method to assess browning
activity, upregulated miR-144-3p in brown adipose tissue of mice. Indeed, through miRNA
sequencing and pathway analyses, it was shown that modulation of miR-144-3p was
concomitant with increased expression of Sphk2 mRNA brown adipose tissue (Tao, et al.,
2015). In light of these intriguing findings, a mechanism linking SPHK and browning is
open for investigation, as the benefits of browning existent white fat could be used
therapeutically to combat obesity and its associated pathologies.
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2.7. Human Data and Relevance
As described above, rodent studies have provided insight into the various roles of
sphingolipids in adipose tissue. Many groups have demonstrated that sphingolipids levels
are elevated in the plasma and tissues of obese, insulin resistant humans (Adams, et al.,
2004; Blachnio-Zabielska, et al., 2012a; Kowalski, et al., 2013). Furthermore, weight loss
through bariatric surgery, is associated with decreases in plasma ceramides that correlate
with a reduction in plasma TNFα and improvements in insulin sensitivity (Huang, et al.,
2011). However, relatively few studies have looked at sphingolipids specifically in human
adipose tissue. They have been measured by a few groups in the context of obesity, type
2 diabetes, and fatty liver disease. Adipose tissue from obese subjects has been
associated with higher ceramide (Blachnio-Zabielska, et al., 2012a; Candi et al., 2018;
Turpin et al., 2014), dihydroceramide (Blachnio-Zabielska, et al., 2012), sphingosine
(Blachnio-Zabielska, et al., 2012a), dihydrosphingosine (Blachnio-Zabielska, et al.,
2012a), S1P (Blachnio-Zabielska, et al., 2012a), and sphingomyelin (Turpin, et al., 2014)
content. Additionally, expression of enzymes involved in the de novo synthesis of
ceramides (Spt1, Spt2, ceramidase, sphingomyelinase) was elevated in obesity and
exacerbated by insulin resistance (Blachnio-Zabielska, et al., 2012). Of the ceramide
synthases, only CERS6 was found to correlate with BMI and blood glucose levels (Turpin
et al., 2014). Similarly, C16 ceramide, produced preferentially by CERS5 and CERS6, was
shown to negatively correlate with adiponectin (Blachnio-Zabielska, et al., 2012a). A study
of subjects with or without type 2 diabetes revealed higher sphingolipid content
(ceramides,

dihydroceramides,

dihexosylceramides

and sphingomyelins)

in the

subcutaneous but not visceral adipose tissue of those with type 2 diabetes (Chaurasia, et
al., 2016). Additionally, individuals with fatty liver were shown to have higher levels of
68

adipose

ceramides,

sphingomyelin

and

inflammation

(Kolak,

et

al.,

2007).

Sphingomyelinase expression was elevated, but genes involved in de novo ceramide
synthesis were not, suggesting that ceramides are generated through the breakdown of
sphingomyelins in this context (Kolak, et al., 2012). In general, these results suggest that
elevated adipose tissue sphingolipids are associated with less favorable metabolic
outcomes. It is important to consider that differences in adipose depot sampling, dietary
intake, and variations in lipidomics methods likely contribute to experimental outcomes
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2.8. Conclusions
Increasing evidence implicates sphingolipids at the crossroads of obesity and
adipose tissue dysfunction (summarized in Figure 4). Dyslipidemia, a hallmark of obesity
and its associated comorbidities, perturbs sphingolipid synthesis and metabolism. More
research is needed to elucidate the molecular mechanisms by which sphingolipids
regulate adipose function. The structural diversity of the sphingolipid class of lipids and
their abundance in adipose tissue alludes to an exciting future in the discovery of their
functions, and contribution to adipose tissue homeostasis.
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Figure 4. Healthy (top) versus unhealthy (bottom) adipose tissue.
Healthy adipose tissue requires functional insulin signaling, adipogenesis, and lipid
storage. It is marked by balanced production of sphingolipids, high adiponectin production,
and release of anti-inflammatory cytokines from resident M2 macrophages. In the
pathological state, elevated levels of sphingolipids are released, in addition to excess free
fatty acids (FFAs), and pro-inflammatory cytokines from M1 macrophages. GM3 interferes
with insulin receptor localization to caveolae, while elevated ceramides and proinflammatory cytokines interfere with downstream signaling aspects of insulin signaling.
Aberrant sphingolipid synthesis, inflammation, and excess FFAs also interfere with
adipogenesis and lipogenesis. (Lambert, J.M., Anderson, A.K., Cowart, L.A. (2018)
Sphingolipids in Adipose Tissue: What’s Tipping the Scale? Advances in Biological
Regulation 70: 19-30.)
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CHAPTER 3

DEPLETION OF ADIPOCYTE SPHINGOSINE KINASE 1 LEADS TO
CELL HYPERTROPHY, IMPAIRED LIPOLYSIS, AND NON-ALCOHOLIC
FATTY LIVER DISEASE
(ANDERSON, et al., 2020)
Primary Research Manuscript
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3.1. Introduction
Obesity precipitates a variety of conditions including type 2 diabetes,
cardiovascular pathology, non-alcoholic fatty liver disease, and others (Dal Canto, et al.,
2019; Aguilar-Salinas and Viveros-Ruiz, 2019). The molecular mechanisms connecting
obesity to its downstream pathologies are not fully understood and are likely multi-faceted,
however, data support major contributions from alterations in bioactive lipid metabolism
and signaling. Among these, metabolism of sphingolipids including ceramide and
sphingosine-1-phosphate is altered in obese humans and in mouse models of obesity and
contribute to obesity-induced pathology (Choi and Snider, 2015; Geng, et al., 2015;
Hannun and Obeid, 2018; Wang, et al., 2014). Indeed, it is well-established that ceramide,
a principal signaling sphingolipid, plays a role in insulin resistance (Chavez, et al., 2003;
Chavez and Summers, 2012; Cowart, 2009). On the other hand, ceramide can be
interconverted to sphingosine-1-phosphate (S1P) through the action of ceramidases and
sphingosine kinases (SK), SPHK1 and SPHK2. SPHK1 and its product S1P have also
been identified as contributors to metabolic disease at least in part due to the welldocumented pro-inflammatory signaling pathways through the S1P G protein-coupled
receptors and downstream activation of NFκB signaling and other pathways of
inflammation (Japtok, et al., 2015; Lee, et al., 2015; Wang, et al., 2014).
The Cowart lab and others have shown that SPHK1 and its product S1P are
increased in several tissues in obese humans and mice including liver, skeletal muscle,
and adipose tissue (Geng, et al., 2015; Ross, et al., 2013). The Cowart group also showed
that SPHK1 is induced by saturated fatty acids, which are elevated in the circulation of
individuals with metabolic disease (Geng, et al., 2015; Ross, et al., 2013). Therefore,
because S1P is generally a pro-inflammatory lipid mediator, and because outcomes of
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obesity include systemic inflammation, a pathway dependent upon SPHK1/S1P could
serve as a primary mechanism by which lipid excess contributes to pathology. Supporting
the link between SPHK1 and obesity, a previous study provided evidence that SPHK1
deficiency in mice was associated with enhanced insulin sensitivity and reduced proinflammatory signaling in adipose tissue of animals fed obesogenic diets (Ross, et al.,
2013). As adipose tissue inflammation is thought to be a key driver of obesity-related
pathophysiology (Gustafson, et al., 2007; Scherer, 2006), we speculated that SPHK1
expression in adipose tissue may mediate pro-inflammatory signaling, thereby promoting
metabolic disease.
In this study, we generated a mouse strain lacking SPHK1 in adipose tissue
(SK1fatKO). These animals were challenged with high fat diet feeding for 18 weeks to
assess the contribution of adipocyte SPHK1 to metabolic homeostasis, adipose tissue
function, inflammation, and systemic glucose tolerance. In contrast to expected findings,
mice exhibited components of metabolic phenotypes even on control diet, and outcomes
of high fat feeding were exacerbated in these mice including increased weight gain,
impaired glucose clearance, and adipocyte hypertrophy. Adipocytes and adipose explants
showed impaired lipolysis and dysregulation of lipolytic machinery. Moreover, the livers of
these mice displayed NAFLD pathophysiology. Thus, SPHK1 serves a previously
unidentified essential homeostatic role in adipocytes that protects from obesity-associated
pathology. These data may have implications for pharmacological targeting of the
SPHK1/S1P signaling axis.
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3.2. Results
Previous studies demonstrated that sphingosine kinase 1 (SPHK1) increased in
adipose tissue of type 2 diabetic humans and in diet-induced obesity in mice (Wang, et
al., 2014). Moreover, in that study, global depletion of SPHK1 protected mice from high
fat diet-induced insulin resistance and systemic inflammation. Because adipose tissue is
a central regulator of metabolic homeostasis, and adipocyte dysfunction is thought to
underlie much of the downstream pathophysiology of obesity including insulin resistance
and inflammation (Kusminski, et al., 2016; Scherer, 2006), we sought to test the role of
SPHK1 intrinsic to the adipocyte in these processes. To this end, mice with an adipocytespecific deletion of SPHK1 (SK1fatKO) were generated using mice harboring a Sphk1 allele
with Loxp sites flanking exons 3-6. These mice were crossed with mice carrying a
transgenic Cre recombinase enzyme driven by the adiponectin promoter (Allende, et al.,
2004). We confirmed gene depletion in the adipose tissue genomic DNA by PCR using an
upstream primer 5’ to exon 1 and a downstream primer 3’ to exon 6, which should produce
a 600-bp product only in the modified Sphk1 gene. This product was indeed amplified and
visualized by agarose gel (Supplemental Figure 1A, B), confirming gene depletion.
Because SPHK1 depletion can be compensated by upregulation of SPHK2, mRNA for
Sphk2 was measured in gonadal white adipose (gWAT) homogenates of these mice
(Supplemental Figure 1C). No upregulation of SphK2 was observed, indicating this was
not a confounding factor for data interpretation in these studies (Supplemental Figure 1C).
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Supplemental Figure 1. Sphk1 knockout in the adipocyte and effects
on Sphk2 and insulin. A. Schematic floxed Sphk1 gene construct, with loxP sites
surrounding exons 3 through 6. Cre expression, under the control of the adiponectin
promoter, generates a ~600 base pair fragment upon excision. B. Representative agarose
electropherogram indicating the excised 600-base pair amplicon in the mutant and not the
control. Flox primer pairs forward and reverse 2 were used to generate this band. C. Sphk2
message was not concomitantly upregulated in the SK1fatKO gonadal adipose tissue due
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to loss of Sphk1. D. Induction of Sphk1 mRNA in gonadal adipose tissue homogenates in
response to high-fat feeding. E. S1P levels determined by LC:MS/MS lipidomics in
gonadal adipose tissue homogenates. F. AUC assessment of ipGTT, calculated differently
from Fig. 5E, by first normalizing to the differences in baseline fasting glucose. G. Fasting
serum insulin.
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To test effects of adipocyte-specific depletion of SPHK1 in pathophysiology in dietinduced obesity, SK1fatKO mice and their adiponectin-CRE:SK1+/+ control counterparts
were subjected to either a high fat diet (HFD) or a control low glycemic isocaloric diet (CD)
for 18 weeks. Mice on control diet exhibited low levels of Sphk1 mRNA (Supplemental
Figure 1D). Adipose tissue homogenates from SK1fatKO mice exhibited some basal
elevation of Sphk1, however, this is likely due to expression in other adipose tissue cell
types. Similar to previous findings, HFD feeding robustly induced Sphk1 mRNA in gWAT
homogenates from control mice, and this was significantly attenuated in SK1fatKO mice,
again, with residual message likely resulting from other adipose tissue cell types (e.g.,
immune cells, fibroblasts, vascular endothelial cells, etc.) (Supplemental Figure 1D). S1P,
the enzymatic product of SPHK1 was also very low in gWAT in control diet feeding but
robustly induced by HFD feeding (Supplemental Figure 1E). While adipose tissue
homogenates showed similar S1P levels in SK1fatKO and WT mice, S1P is found in µM
amounts in plasma and even higher amounts in whole blood from erythrocytes (Allende,
et al., 2004; Kharel, et al., 2020; Yatomi, et al., 1997), and therefore it is likely that these
high levels obscured the differences in tissue S1P that would be expected based on
reduced mRNA in the HFD-fed SK1fatKO mice. These data also suggest that SPHK1 in
adipocytes does not contribute to circulating levels of S1P, but rather acts in a localized
fashion within the tissue.
Previous studies indicated that, though Sphk1-null mice were protected from
insulin resistance and inflammation induced by high fat feeding, weight gain was
comparable to that of control mice (Wang, et al., 2014). In contrast, while HFD-feeding
increased weights of both SK1fatKO mice and control mice steadily over the first 8 weeks,
by 8-10 weeks of the feeding course, SK1fatKO began to gain notably more weight on HFD
78

compared to control (Figure 5A). Indeed, by the end of the feeding course, the percent
weight gain on CD and HFD was significantly greater in the SK1fatKO compared to controls
(Figure 5B). Further analyses suggested that weight gain arose from expansion of both
the gonadal (gWAT) and subcutaneous inguinal (iWAT) white adipose depots (Figure 5C).
On the other hand, retroperitoneal white adipose tissue (retroWAT) and intrascapular
brown adipose tissue (BAT) depots did not exhibit such wet weight differences as gWAT
and iWAT between genotypes (Figure 5C). Remaining differences in weight between
genotypes were most likely due to remaining subcutaneous fat (axial, gluteal, and other
compartments beneath the skin) throughout the animal which we observed in mutant
animals upon dissection (data not shown). Therefore, in contrast to whole-body depletion
of Sphk1, adipocyte-specific depletion exacerbated diet-induced obesity, suggesting a
distinct role for adipocyte SPHK1 in inhibiting diet-induced obesity.
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Figure 5. High fat diet-induced weight gain and systemic glucose
intolerance. A. Mouse body weights over 18-week high fat diet study. B. Percent weight
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(Figure 5 legend continued.)
gain between final weight at sacrifice and initial starting weight at diet commencement. C.
rom left to right, gonadal (gWAT), subcutaneous (inguinal) fat pad (iWAT), retroperitoneal
(retroWAT) fat pad, and brown adipose (BAT) weights at sacrifice. D. After 18 weeks of
high fat feeding, an intraperitoneal glucose tolerance test (ipGTT) was administered over
2 hours, at the same time in the afternoon for each animal, following a 6-hour fast. E. The
corresponding area under the curve analysis for ipGTT. F. Baseline fasting glucose shown
as mg/dL as measured from whole tail blood droplets. G. HOMA-IR calculated from fasting
blood glucose concentration and fasting blood insulin concentration.
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Though SK1fatKO mice were more obese than their control counterparts, obesity
does not always coincide with metabolic disease (Samocha-Bonet, et al., 2014), indicating
a possibility for SK1fatKO, despite their increased adiposity, to be protected from deleterious
metabolic outcomes of obesity including impaired glucose clearing, a marker of insulin
resistance. To test this, we performed glucose tolerance tests (GTT). As expected, high
fat feeding impaired glucose clearing in control mice; however, these tests showed
exacerbation of impaired glucose clearance in HFD-fed SK1fatKO mice compared to
controls, both in kinetics of clearance and area under the curve assessments (Figure 5D,
E). Fasting glucose was also elevated (Figure 5F), and normalization of blood glucose in
the GTT to basal glucose also demonstrated a significant elevation of area under the curve
in CD- and HFD-fed SK1fatKO mice relative to control mice (Supplemental Figure 1F).
Averaged fasting serum insulin trended strongly to increase in HFD-fed mutant mice
relative to controls, and, though statistical significance was not reached (p = 0.1319,
Supplemental Figure 1G), pairing fasting glucose with fasting insulin for each individual
revealed a marked and significant increase in HOMA-IR in the HFD-fed SK1fatKO relative
to controls (Figure 5G). Together, these data support a role for adipocyte SPHK1 in
suppressing HFD-induced obesity and subsequent deficiencies in glucose clearance.
Increased fat mass can arise from either adipocyte hypertrophy (increase in cell
size) and/or hyperplasia (increase in adipocyte number). While adipocyte hyperplasia may
underlie the phenomenon of ‘healthy obesity,’ i.e., WAT expansion with numerous smaller
adipocytes and little inflammation or fibrosis, hypertrophic adipocytes more closely
correlate to insulin resistance (Vishvanath and Gupta, 2019). Because the obese, insulin
resistant phenotype was exacerbated in SK1fatKO mice, we hypothesized they would show
greater hypertrophy with high fat feeding than controls. Upon histological examination, we
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found that the gonadal adipocytes in SK1fatKO mice were markedly larger than those of
control mice even with CD feeding, and this was further increased with HFD feeding
(Figure 6A, B). Quantification of mean area showed an approximately 2-fold larger size in
SK1fatKO on HFD relative to controls (Figure 6C).
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Figure 6. Adipocyte hypertrophy in SK1fatKO gWAT. A. Confocal microscopy
of representative sections of gWAT shown by H&E staining. B. Quantification of gWAT
adipocyte size, as shown by a frequency distribution. C. Adipocyte size displayed as the
mean ± S.E.M. D. Pro-inflammatory adipokine leptin (Ob) mRNA expression.
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The hypertrophic adipocyte phenotype is generally considered more closely linked
with overall metabolic perturbations and adipocyte dysfunction, and therefore the larger
adipocytes observed in SK1fatKO mice suggested there could be a general disruption of
key adipocyte functions (Jo, et al., 2009; Muir, et al., 2016). The endocrine function of
adipose tissue is essential for metabolic homeostasis, and aberrant adipokine production
and signaling is a key feature of obesity-induced metabolic disease and closely associated
with adipocyte size (Scherer, 2006). For example, hyperleptinemia and leptin resistance
occur in human obesity and mouse models, and leptin secretion by human adipocytes
correlated directly with adipocyte size (Skurk, et al., 2007). Consistent with this, HFD
increased leptin mRNA in SK1fatKO to a greater extent than in control mice (Figure 6D).
Serum leptin trended modestly higher in SK1fatKO mice upon HFD feeding, however, this
did not meet criteria for statistical significance (Supplemental Figure 2A). Adiponectin,
produced by adipocytes, is a protective factor in the context of metabolic disease and acts
on multiple cell types and tissues for anti-atherogenic and anti-diabetic effects.
Adiponectin production is decreased in obesity and inversely correlated with
adipocyte hypertrophy. Adiponectin mRNA from adipose tissue homogenates was
modestly reduced in SK1fatKO mice on CD, consistent with larger basal adipocytes;
however, no differences were observed between SK1fatKO and control mice on HFD
(Supplemental Figure 2B). In mouse sera, adiponectin levels were higher in female mice
generally, but showed no differences by diet or genotype. In males, however, high fat
feeding

reduced

circulating

adiponectin

by

50%

(Supplemental

Figure

2C).

Notwithstanding, significant sex differences were not observed in other measures,
suggesting decreased adiponectin could not explain the robust exacerbation in insulin
resistance observed in both male and female SK1fatKO mice. Adiponectin receptors (highly
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expressed in the liver) are thought to have intrinsic ceramidase activity (Holland, et al.,
2011). Liver ceramides and hexosylceramides were measured among groups, which
indicated that, while no major effects were observed in the high fat diet-fed condition, low
glycemic control diet-fed SK1fatKO mice had increased C22:0 and C:24 ceramides, and
decreased C18:0 and C22:0 hexosylceramides in their livers (Supplemental Figure 2D,
E).
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Supplemental Figure 2. Adipokine crosstalk with liver sphingolipid
metabolism. A. Fasting serum leptin. B. Gonadal white adipose tissue adiponectin
mRNA expression. C. Serum adiponectin as shown by Western blot. Quantification shown
at right per respective membrane, separated by sex. D. Liver ceramides determined by
LC:MS/MS lipidomics. E. Liver hexosylceramides determined by LC:MS/MS lipidomics.
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Inflammation in gWAT is closely associated with adipocyte hypertrophy and is
thought to couple obesity to insulin resistance (Andersson, et al., 2008; Gustafson, et al.,
2007, 2009; Hardy, et al., 2012). Moreover, a previous study showed that Sphk1-null mice
were protected from inflammation upon high fat feeding (Wang, et al., 2014). Inflammation
in gWAT was assessed by several markers. First, mRNA of macrophage marker F4/80
was measured, and data showed that expression was similar in both wildtype and SK1fatKO
mice on CD though there was a trend to increase in HFD-fed mutant mice relative to
control mice on HFD. (Figure 7A). Consistent with this, the macrophage chemoattractant
protein marker Mcp1 increased by HFD-feeding in both strains but was not significantly
different between strains (Figure 7B). Crown-like structures (CLSs) in gWAT were
identified, and negligible differences in numbers were found between genotypes, although
CLSs tended to be less frequent in females compared to males (Figure 7C, and data not
shown). Partially consistent with previous work showing protection from pro-inflammatory
cytokine expression in obesity in SPHK1-null mice, HFD-fed SK1fatKO mice showed strong
trends toward decreased Il-6 and Tnfα levels, though these did not reach statistical
significance (Figure 7D, E). As F4/80 does not necessarily indicate macrophage
polarization status (e.g., M1 vs. M2), M2 macrophage markers were also assessed. Arg1
showed no changes (Figure 7F); however, there was a pronounced increase of Tgf-β1 in
SK1fatKO on HFD (Figure 7G). Assessment of neutrophil infiltration by myeloperoxidase
puncta visualization and quantification showed little if any difference between wildtype and
SK1fatKO mice (Supplemental Figure 3A, B). In summary, relative to HFD-fed control mice,
SK1fatKO mice showed more fat mass, exacerbated glucose intolerance, and basal
adipocyte hypertrophy, which was exaggerated upon high fat feeding. However, while
adipocyte hypertrophy is linked to inflammation and impaired adipokine production,
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increases in these measures in the gWAT of SK1fatKO relative to control mice were modest,
at best, and largely negligible, suggesting other links between adipocyte-specific depletion
of SPHK1, obesity, and impaired glucose clearance.
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Figure 7. Inflammation within the adipose tissue. mRNA was isolated from
gWAT homogenates from mice of both genotypes on both diets. After cDNA preparation,
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(Figure 7 legend continued.)
real-time PCR was used to measure message for the indicated proteins A. Inflammatory
adipocytokine F4/80 (Emr1). B. Pro-inflammatory M1 macrophage Mcp1 (Ccl2). C.
Representative crown-like structures shown by brightfield H&E in gWAT from high fat-fed
mice. D. Pro-inflammatory Il-6 transcript. E. Pro-inflammatory Tnfα transcript. F. M2
macrophage marker Arg1. G. M2 macrophage marker Tgf-β1.
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Supplemental Figure 3. High fat fed SK1fatKO gonadal fat pads
have fewer infiltrating neutrophils. A. Myeloperoxidase, strongly associated
with pro-inflammatory neutrophil oxidant activities, expression in gWAT. Insets show an
adipocyte outlined by a fine dotted line and clusters of neutrophils with the classical
horseshoe-shaped nuclei are denoted by the heavy dashed circles as well as asterisks.
B. Quantification of myeloperoxidase puncta.
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Other than endocrine function, adipocytes perform lipogenesis and lipolysis to
contribute to metabolic homeostasis. Therefore, we hypothesized that SPHK1 may play a
role in regulating these processes. Lipolysis increases with fasting to release FFA into
circulation where they can be distributed to peripheral organs and tissues for energy
production in the context of low glucose (Frubeck, et al., 2014). To test whether lipolysis
may be impaired in SK1fatKO mice, we assessed serum NEFA in fasted HFD-fed mice.
These data demonstrated a 20-25% reduction in serum NEFA in HFD-fed SK1fatKO mice
(Figure 8A). To test whether this was due to deficient adipose tissue lipolysis, glycerol
release of explants of gWAT from SK1fatKO mice was measured. Consistent with decreased
fasting NEFA observed in vivo, explants from mutant mice released only ~50% of the
glycerol released by explants of control mice (Figure 8B). These differences were only
observed in basal lipolysis, as isoproterenol-stimulated lipolysis showed no differences
between wildtype and mutant explants (data not shown). Consistent with this, critical
mediators of adipocyte lipolysis including adipose triacylglycerol lipase (ATGL), CGI-58,
and FABP4 (fatty acid binding protein 4) were all lower in SK1fatKO mice at basal and/or
HFD-fed conditions (Figure 8C, D). In general, levels of these proteins were lower in
mutant mice, with females showing statistically significant differences and males mirroring
this trend (Figure 8D, densitometry values shown in Supplemental Table 1). Therefore,
adipocyte SPHK1 plays a role in basal lipolysis and likely contributes to fasting circulating
NEFA.
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Figure 8. Fasting serum NEFA, basal glycerol release, and lipolytic
proteins are reduced in SK1fatKO mice. A. Serum non-esterified fatty acids were
measured from mice fasted for 6 hours. B. Gonadal white adipose tissue explants were
incubated in fatty acid-free media for 48 hours and media glycerol was measured. Media
glycerol was normalized to the weight of tissue utilized in each well. C. Western blot protein
analysis of lipolytic proteins (ATGL, CGI-58, FABP4) from gonadal white adipose tissue.
Protein loading was normalized by stain-free total loading, as well as vinculin. D. Band
intensities were quantified by densitometry using ImageJ and graphed separately as
males (left) and females (right).
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Supplemental Table 1. Densitometry values calculated by ImageJ for
Western blots and graphs shown in Figure 8C, D. F, female; M, male.
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Adipocyte hypertrophy and impaired function arise when adipocytes reach their
capacity for lipid storage, at which point ectopic lipid deposition occurs in other organs and
tissues including liver (Haczeyni, et al., 2018). Thus, livers in SK1fatKO mice were tested
for pathology consistent with non-alcoholic fatty liver disease. HFD-fed SK1fatKO mice
showed over 2-fold increase in liver TAG relative to control mice fed HFD (Figure 9A), and
this was consistent with Oil Red O staining of neutral lipid, which showed increased lipid
and also that both male and female mice exhibited macrosteatosis (Figure 9B). Liver
steatosis can arise from several mechanisms including increased lipid uptake, decreased
lipid secretion, or increased lipogenesis. Because serum NEFA were lower in SK1fatKO,
increased uptake seemed an unlikely mechanism. However, lipogenic machinery Dgat2
and Fasn mRNA were significantly elevated on control and/or HFD (Figure 9C, D). In
addition to steatosis, further evidence of progression of non-alcoholic fatty liver disease
(NAFLD) included Mcp1 and Tnfα increase in HFD-fed SK1fatKO (Figure 9E, F). Fibrogenic
activity was suggested by elevated Col1a1 mRNA, which increased in male mutant mice
(Figure 9G). Data were separated by sex to illustrate that male mice more strongly exhibit
the effects of liver fibrosis than female mice, who showed no significant increase. This is
consistent with data showing that females of reproductive age exhibit less fibrosis in
NAFLD (Ballestri, et al., 2017).
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Figure 9. Serum triacylglycerol, liver lipid accumulation, and
lipogenesis. A. Total liver triacylglycerols. B. Oil Red O-stained sections of HFD
condition, separated by sex. C. Liver lipogenic gene expression of Fasn. D. Liver lipogenic
gene expression of Dgat2. E. Liver pro-inflammatory cytokine marker Mcp1I mRNA
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(Figure 9 legend continued.)
expression. F. Liver pro-inflammatory cytokine marker Tnfα mRNA expression. G. Liver
pro-fibrogenic expression of Col1a1, separated by sex, males on left, females on right.
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3.3. Discussion
Previous data from the Cowart lab and others indicated that sphingosine kinase 1
was involved in pathological mechanisms related to metabolism in various tissues,
including adipose, muscle, liver, and pancreas (Aguilar-Salinas and Viveros-Ruiz, 2019;
Geng, et al., 2015; Qi, et al., 2013; Ross, et al., 2013). Furthermore, previous studies have
shown that constitutive deletion of SPHK1 elicits protection from high fat diet-induced
diabetes and inflammation (Wang, et al., 2014). Given the importance of adipose tissue
function on whole-body metabolism and its role in the development of the metabolic
syndrome, the goal in this study was to determine whether adipocyte SPHK1/S1P plays a
specific role in pathophysiology associated with obesity. Specifically, as S1P is largely a
pro-inflammatory lipid mediator, and adipose tissue inflammation occurs in obesity and is
thought to underlie maladaptive responses to obesity, we hypothesized that depletion of
adipocyte Sphk1 would be protective in the obese context. Surprisingly, however,
physiological characterization of SK1fatKO mice revealed that SPHK1 depletion from
adipocytes exacerbated outcomes of diet-induced obesity in mice. Specifically, SK1fatKO
mice gained more weight, had hypertrophic adipocytes, and had decreased glucose
tolerance relative to controls, and they exhibited liver steatosis and inflammation indicative
of a NASH phenotype. These findings suggest that adipocyte SPHK1 is required for
normal systemic metabolic homeostasis and also can at least partially attenuate some
negative outcomes of obesity.
As the product of SPHK1, sphingosine-1-phosphate, is an established immune cell
chemoattractant, we were surprised to see little impact of SPHK1 depletion on adipose
tissue inflammatory markers in HFD-fed mice. Though two key indicators of an
inflammatory phenotype, Tnfα and IL-6, showed a trend toward decrease in SK1fatKO on
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HFD relative to controls on HFD, these measures did not reach statistical significance.
Additionally, neutrophil infiltration, previously shown to be influenced by the S1P signaling
axis in liver (Allende, et al., 2011), was not notably different in adipose tissue between
genotypes in this study. As yet undiscovered outcomes of SPHK1 depletion in adipocytes
therefore must outweigh the potential protection from inflammation. This is intriguing, as
adipose tissue inflammation is thought to be a central link between obesity and insulin
resistance. Therefore, as these animals had an exacerbated metabolic phenotype with no
increase in inflammation, this study essentially de-couples adipose tissue inflammation
from insulin resistance. This also indicates that the protection from adipose tissue
inflammation in obesity as previously observed in the constitutive SPHK1-null mouse
arose from SPHK1 in other cell types and not adipocytes. Therefore, the findings suggest
that SPHK1 has homeostatic roles in adipocytes in the obese context, an idea that has
not been appreciated before.
While molecular mechanisms by which SPHK1 regulates adipocyte function and
resulting metabolic homeostasis, some findings from this study may shed light on roles of
adipocyte SPHK1 in obesity. First, decreased lipolytic enzymes were observed in SK1fatKO
mice, consistent with lower fasting NEFA, lower glycerol release of explants, and larger
adipocytes. This suggests a fundamental role for SPHK1 in facilitating lipolysis in obesity;
as unrestrained lipolysis elevates NEFA in metabolic disease, and because SK1fatKO
animals had reduced NEFA, this might present a strategy for modulation of circulating
lipids.
Second, TGF-β1 was much higher in SK1fatKO adipose tissue homogenates on
HFD than that of control mice on HFD. TGF-β1 is largely anti-adipogenic and promotes
adipocyte de-differentiation (Zamani and Brown, 2011), which could potentially underlie
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the hypertrophic adipocyte phenotype. This idea is supported by findings that deletion of
SMAD3, a downstream signaling effector of TGF-β1, decreased adipocyte size (Tan, et
al., 2011). Numerous studies across a variety of experimental contexts place TGF-β1
upstream of SPHK1, especially in the context of fibrosis (Sato, et al., 2003; Trojanowska,
2009); our results suggest that SPHK1 negatively regulates TGF-β1, which not only
presents an additional relationship between the SPHK1 and TGF-β1 axis but also
suggests a negative feedback loop that is potentially important in adipocyte regulation.
Third, adipocyte hypertrophy is strongly associated with adipose tissue
inflammation, which is thought to contribute to systemic insulin resistance in obesity
(Hajer, et al., 2008; Scherer, 2006). However, as previously discussed, SK1fatKO mice had
little if any differences in HFD-induced gWAT inflammatory markers which actually trended
toward a decrease relative to control mice. This suggests that, though SPHK1 may
mediate inflammation downstream of adipocyte hypertrophy, a beneficial role of SPHK1
in regulating adipocyte size and lipolysis is supported by our findings here, suggesting
dual and opposing roles for adipocyte SPHK1 in obesity.
Despite lowered trends in lipolysis, mutant mice were still highly glucose intolerant
and heavier compared to their control counterparts (Figure 5A, B, D). This finding stands
in contrast to other lipolysis-deficient models, such as Atgl knockout mice which have
vastly different body temperatures and drastic ectopic cardiac lipid deposition compared
to control mice, whereas we did not observe such changes (data not shown) (Haemmerle,
et al., 2006). Furthermore, in a model of pharmacological inhibition of lipolysis, in which
mice were treated with the compound Atglistatin, adipocyte size was decreased and body
weight was significantly lowered compared to untreated mice, which also contrasts to the
greater weight gain and adipocyte hypertrophy observed here in SK1fatKO animals (Figure
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5A, B, 7C) (Schweiger, et al., 2017). These apparent discrepancies suggest that, though
lowering ATGL may protect from pathology associated with obesity, other effects of
SPHK1 depletion outweigh any potential protection. Furthermore, combined with the
effects on ABHD5 and FABP4, this may indicate an overall lesser ability to perform
lipolysis in adipose tissue from mutant mice (Figure 8C, D). Intriguingly, ATGL-null mice
do not exhibit differences in basal adipose glycerol release compared to control,
suggesting that other lipases contribute to lipolytic products secreted from the tissue
(Haemmerle, et al., 2006). This could include other players such as G0S2, FSP27,
HILPDA, and/or PNPLA3 (which were not assessed here) (Schreiber, et al., 2019; Yang
and Mottillo, 2020).
In this study we adhered to recent imperatives to study both sexes. In general,
data were similar between male and female animals. In some instances, trends were the
same and statistically significant within each sex, but combining sexes led to greater
variation and therefore higher p-values. In cases where data from each sex would lead to
different conclusions, data were presented separately for male and female animals. For
example, serum levels of adiponectin, an insulin-sensitizing adipokine that is largely
beneficial in the metabolic context, were lower in male mice. On the other hand, Col1a1
expression was higher in male mice. In general, these findings agree with current literature
on sex differences in cardiometabolic disease. Additionally, because the major
phenotypes described did not differ between sexes (e.g., decreased glucose tolerance,
adipocyte hypertrophy, Tgf-β1 expression on HFD, etc.), parameters that were distinct
between sexes do not likely underlie the common phenotypes. For some investigators,
however, these differences may be of interest.
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While inter-organ crosstalk in obesity is of increasing interest, the mechanism(s)
by which Sphk1 depletion in adipocytes causes NAFLD symptoms are not understood.
Normally, the liver serves as a short-term reservoir for excess circulating lipid from the diet
and adipose tissue lipolysis, along with lipids generated by the liver through de novo
lipogenesis. NAFLD progresses as lipid supply exceeds the rate at which the liver can
utilize or export it. Impairments of glucose signaling and adipose tissue expansion, along
with adipose inflammation and toxic lipid overload all contribute to the development of
steatosis. NAFLD progression is multifaceted and it is increasingly evident that adipose
tissue impairment is directly involved, but these mechanisms are not fully defined (Azzu,
et al., 2020). We show elevation of machinery for de novo lipogenesis, which may explain
simple steatosis in the liver; however, mechanisms by which this could occur from ablation
of SPHK1 in adipocytes will require further study to uncover. A recent study suggested
that extracellular vesicles from adipocytes could deliver TGF-β1 to hepatocytes, where it
is pro-fibrotic (Koeck, et al., 2014). Indeed, we observed increased Tgf-β1 in adipocytes
and increased expression of Col1a1 in liver in SK1fatKO animals on HFD. While reduced
glucose tolerance and adipose expandability are likely contributors to the steatosis
observed in high fat diet-fed SK1fatKO mice, further studies will be required to determine
mechanisms mediating SPHK1-dependent adipocyte-liver crosstalk.
In conclusion, as SPHK1 generates sphingosine-1-phosphate, a pro-inflammatory
lipid mediator, and its global depletion protected from numerous metabolic phenotypes in
diet-induced obesity in mice, we hypothesized that its depletion in adipocytes would also
protect from pathological outcomes associated with high fat feeding. However, we found
that adipocyte-specific depletion of SPHK1 led to exacerbated glucose intolerance,
adipocyte hypertrophy, and impaired lipolysis, supporting a beneficial role for SPHK1 in
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adipocytes in the obese context. In addition to revealing novel functions of SPHK1 in
adipocytes, our findings may have implications for targeting the SPHK/S1P axis for
therapeutic advantage in multiple contexts.
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3.4. Experimental Methods
Generation of Adipocyte-Specific Sphk1 Knockout (“SK1fatKO”) Mouse
Adipocyte-specific Sphk1 knockout mice (SK1fatKO) were generated by crossing B6; FVBTg(Adipoq-cre)1Evdr/J (Jackson Laboratory strain 010803) and B6N.129S6-Sphk1tm2Cgh/J
(Jackson Laboratory strain 019095) (Pappu, et al., 2007). Heterozygous mice were
crossed to generate homozygous flox/flox or +/+ breeding pairs. Genotype was confirmed
using primers for the floxed Sphk1 and Adipoq-Cre. Cre-mediated homologous
recombination removes exons 3-6 from the Sphk1 gene (Supplemental Figure 1A). WT
mice were all Cre carriers. Primers used for genotyping were as follows:
Cre1

5’ ACGGACAGAAGCATTTTCCA 3’

Cre2

5’ GGAGTGCCATGTGAGTCTG 3’

Cre3

5’ CTAGGCCACAGAATTGAAAGATCT 3’

Cre4

5’ GTAGGTGGAAATTCTAGCATCATCC 3’

Flox F

5’ GGAACCTGGCTATGGAACC 3’

Flox R1

5’ ATGTTTCTTTCGAGTGACCC 3’

Flox R2

5’ AATGCCTACTGCTTACAATACC 3’.

Gene depletion was confirmed by PCR amplification of a shortened fragment of the Sphk1
gene in adipocyte genomic DNA from flox/flox:CRE/CRE mice, further described below
and shown in Supplemental Figure 1.

Animal Model
All animal experiments conformed to the Guide for the Care and Use of Laboratory
Animals and were in accordance with Public Health Service/National Institutes of Health
guidelines for laboratory animal usage. The experimental groups consisted of male and
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female WT and SK1fatKO C57BL/6 mice. Mice were housed in the animal facility at the
Medical University of South Carolina (in vivo studies), and Virginia Commonwealth
University (ex vivo studies). Food and water were provided ad libitum, except when fasting
was required (e.g., glucose tolerance testing). Animals were maintained on a 12h:12h
light:dark cycle and ambient temperature was steadily 21° Celsius (C). Animals were
randomized to a high saturated fat diet (HFD) (Envigo, TD.09766) (60% kcal provided by
milkfat) or an isocaloric low fat diet (CD) (Envigo, TD.120455) (17% kcal provided by lard)
at 6 weeks of age, and diets were administered for 18 weeks (n = 8-10 per group). On the
day of sacrifice, mice were fasted for 6 hours, and mice were euthanized humanely by
isoflurane (Hospira, Inc., Lake Forest, IL) followed by cardiac puncture. Cardiac blood was
prepared for non-hemolyzed serum, aliquoted, and stored at -80° C until further analysis.
Tissues were collected accordingly as fresh fixed in 10% neutral buffered formalin or fresh
snap frozen in liquid nitrogen and stored at -80° C until further processing. All experiments
were performed under clean conditions, were approved by the Medical University of South
Carolina Institutional Animal Care and Use Committee, the Virginia Commonwealth
University Institutional Animal Care and Use Committee, the Ralph H. Johnson Veterans
Affairs Medical Center, and the Hunter Holmes McGuire Veterans Affairs Medical Center.

Glucose Tolerance Test
Intraperitoneal glucose tolerance tests were performed on mice after 8 weeks of diet
feeding (i.e., 14 weeks of age). Mice were fasted for 6 hours, before conducting a glucose
tolerance test, generally 0830 hr to 1430 hr. Blood was collected through a nick in the tail
and analyzed neat using a One Touch UltraSmart Blood Glucose Monitoring System at
fasting for baseline blood glucose concentration. Mice received a sterile 2 mg/kg D108

glucose injection. Blood glucose was then assessed 15, 30, 60, and 120 minutes after
glucose injection.

Bioplex
Serum cytokines (insulin, leptin) were measured using a multiplex adipokine assay
service, akin to an ELISA method (Eve Biotechnologies).

Triglyceride Assay
Liver tissue homogenates were prepared according to the manufacturer’s instructions with
modifications (StanBio, 2200-225). Approximately 50 mg of liver tissue was homogenized
in 300 μL of solution of 2:1 100% EtOH and 30% KOH, respectively. This was vortexed
and allowed to incubate in a 60° C water bath for 5 hours until the solution turned a
translucent yellow with a visible pellet at the bottom. Then, 1.08 volumes of 1 M MgCl2
was added to the tube and vortexed to reach a milky consistency and left on ice for 10
minutes. Following this, tubes were vortexed and centrifuged for thirty minutes at 18,500
× g at ambient temperature. The supernatant was collected, diluted 1:10 with 1x PBS, and
subjected to the triglyceride assay according to the manufacturer’s instructions. In order
to normalize to protein concentration by BCA, an aliquot was taken from the homogenate
prior to water bath incubation, dried down, and resuspended in 1x PBS. 10 μL of sample
and standards were assayed with 250 μL of the triglyceride reagent. Water was used as
a blank. Absorbances were read after 5 minutes’ incubation at 37° C at 500 nm.
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qPCR
Total RNA was isolated from gonadal adipose tissue and liver tissue homogenized in
Trizol (Invitrogen, 15596026) followed by RNeasy mini kit (Qiagen, 74106) extraction and
column purification. RNA integrity in tissue was assessed using the Agilent 2100
Bioanalyzer by the MUSC Proteogenomics Facility. All RNA samples had RIN > 7. cDNA
was synthesized from 1 μg of total RNA using iScript Advanced cDNA Synthesis Kit (BioRad, 1708890). Real time PCR was performed using a CFX96 Real-Time System (BioRad) and SSoAdvanced Sybr (Bio-Rad, 172-5272). The following primers were used: Tbp
(Qiagen, PPM03560F), Ppia (Qiagen, PPM03717B), Tnfα (Qiagen, PPM03113G). Mean
normalized expression was calculated by normalizing to the geometric mean of reference
genes Ppia and Tbp in gonadal adipose tissue (i.e., root2[Cq gene 1 × Cq gene 2]) using
the 2-ΔΔCt method. Mean normalized expression was calculated by normalizing to the
expression of Hmbs1 in liver tissue. Other primers are listed below:
Gene
Tbp
Ppia
Hmbs1
Adipoq
Arg1
Dgat2
Fasn
F4/80
Il-6
iNOS
Mcp1
Sphk1
Sphk2
Tgf-β1

Forward (5' to 3')
AAGGGAGAATCATGGACCAG
GAGCTGTTTGCAGACAAAGTTC
ATGAGGGTGATTCGAGTGGG
TGTTCCTCTTAATCCTGCCCA
TGGCTTGCGAGACGTAGAC

Reverse (5' to 3')
CCGTAAGGCATCATTGGACT
CCCTGGCACATGAATCCTGG
TTGTCTCCCGTGGTGGACATA
CCAACCTGCACAAGTTCCCTT
GCTCAGGTGAATCGGCCTTTT

GAGGGGTCTGGGCGATGGGGCAC

CGACGGTGGTGATGGGCTTGGAGT

GACTCGGCTACTGACACGAC
TCATGGCATACCTGTTCACC
TAGTCCTTCCTACCCCAATTTCC
TTCCATGCTAATGCGAAAGG
TTAAAAACCTGGATCGGAACCAA
GAGTGCTGGTGCTGCTGAA
CACGGCGAGTTTGGTTCCTA
TGGCGTTACCTTGGTAACC

CGAGTTGAGCTGGGTTAGGG
GAATGGGAGCTAAGGTCAGTC
TTGGTCCTTAGCCACTCCTTC
GCTCCTCTTCCAAGGTGCTT
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GCATTAGCTTCAGATTTACGGGT

AGGTTATCTCTGCCTCCTCCA
CTTCTGGCTTTGGGCGTAGT
GGTGTTGAGCCCTTTCCAG

Basal Lipolysis Assay for Non-esterified Fatty Acids
Sera from mice and cell culture media containing only fatty acid-free bovine serum albumin
were prepared for non-esterified fatty acid assay according to the manufacturer’s
instructions (Wako Diagnostics, 999-34691, 995-34791, 991-34891, 993-35191, 27676491). Briefly, 5 μL of sample (neat or diluted 1:10), calibrators, and blank were added
in duplicate to a 96-well plate. 200 μL of Color Reagent A solution was added and
incubated at 37° C for 5 minutes. Absorbance at 550 nm was acquired. Next, 100 μL of
Color Reagent B solution was added and incubated at 37° C for 5 minutes. Absorbance
was read once more at 550 nm. After subtracting the blanks, the first reading was
subtracted from the second reading to obtain the final absorbance, and concentrations
were determined by standard curve normalization.

Glycerol Assay
Protocol was adapted from Sigma. 25 µL cell culture media was assayed in duplicate in a
96-well plate. 100 µL of free glycerol reagent (Sigma, F6428) was added per well and
incubated for 5 minutes at 37° C. Absorbance at 540 nM was measured on a
spectrophotometer. Relative concentrations of glycerol were determined by normalization
to a standard curve. Tissue explants glycerol release was normalized to tissue weight.

Lipolysis in Adipose Tissue Explants (ex vivo)
Gonadal adipose tissue was harvested from WT and SK1fatKO mice at 4-6 weeks of age.
Tissue was cut into ~12 mg pieces. Two pieces were added to each well of a 12-well plate
in 1 mL of DMEM/F12 (Corning, 10-090-CV) + 1% FAF BSA (Thermo Fisher Scientific,
9704100) and 1% penicillin streptomycin antimycotic solution (Sigma, A5955-100ML).
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Explants "rested" in the incubator overnight at 37° C and 10% CO2. The next day, explants
were transferred using clean forceps to new 12-well plates containing fresh media. Media
was collected after 24 hours for glycerol measurement.

Histology and Immunohistochemistry
Fresh liver tissue was snap frozen in liquid nitrogen. 10-µm frozen sections were prepared
for measurement of hepatic neutral lipid accumulation by Oil Red O staining. Sections
were counterstained with hematoxylin. Paraffin sections were prepared with adipose and
liver tissue fixed in 10% neutral buffered formalin (1 hour). Adipose sections were stained
with hematoxylin and eosin (H&E) for adipocyte size analysis. Slides were imaged on a
light microscope (Leica DMI1 microscope, Leica MC170 HD camera), and only for the
adipose H&E was a fluorescence microscope utilized for better contrast with a 555 laser.
For immunofluorescence histology, sections were subjected to antigen retrieval overnight
at 60° C in 10 mM sodium citrate, 0.05% Tween 20 pH 6.0 buffer. Slides were blocked
using 5% donkey serum (host secondary antibody species). Slides were imaged on a
Zeiss FV10i fluorescent microscope for myeloperoxidase (R&D Systems, AF3667, goat
anti-mouse MPO, 15 µg/mL), a marker of infiltrating inflammatory immune cells.
Secondary detection antibodies were from Life Technologies: Alexa 488 (Invitrogen, A11055, donkey anti-goat, 1:2000) and ToPro3 to stain nuclei (Thermo Fisher Scientific,
T3605, 1:2000). Ten representative images per slide were analyzed by fluorescence
intensity of puncta using ImageJ software.
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Lipid Measurements
Sphingolipids were measured using liquid chromatography/tandem mass spectrometry at
the Virginia Commonwealth University Lipidomics and Metabolomics Core and performed
using previously published methods (Haynes, et al., 2009; Shaner, et al., 2009).

Western Blotting
Gonadal adipose tissue was homogenized in RIPA buffer with protease and phosphatase
inhibitors (Thermo Fisher Scientific, 78446) using a Dounce homogenizer for at least 30
strokes, or until visibly homogenized. Homogenates were vortexed well and centrifuged
at 10,000 ⨯ g for 10 minutes at 4° C. The resulting infranatant (below fat cake, and above
cell debris pellet) was transferred to a new tube with an insulin syringe (28.5G). Protein
content was quantified using a BCA protein determination assay (Thermo Fisher Scientific,
23225). Homogenates were diluted 1:10 in RIPA with 2% SDS to minimize lipid
interference in the BCA assay. 10 μg protein was used for western blotting. Nonhemolyzed mouse sera was diluted in PBS 1:20, and isovolumetric amounts of diluted
sera plus loading buffer was loaded for western blotting. gWAT proteins and sera proteins
were separated by SDS-PAGE (Bio-Rad Criterion TGX Stain-Free precast gels), and
transferred to nitrocellulose membranes, and sera proteins were transferred to PVDF
membranes. The membranes were blocked for 1 hour in 5% BSA. Proteins were detected
using (gWAT) HRP-linked anti rabbit secondary (1:5000; Cell Signaling Technology, 7074)
or (sera) StarBright-700-linked anti rabbit secondary (1:2,500; Bio-Rad, 12004161), Clarity
ECL Western Blotting Substrate (Bio-Rad, 1705061) for HRP, and a ChemiDoc Imaging
System (Bio-Rad, 17001401, 17001402). Blots were assessed for protein expression of
adiponectin (1:2000; Cell Signaling Technology, 2789), adipose triglyceride lipase (ATGL)
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(1:2000, Cell Signaling Technology, 2439), ABHD5 (CGI-58) (1:1000, Novus Biologicals,
NB100-5-7850), and FABP4 (1:2000, Cell Signaling Technology, 2120). Vinculin (1:2,000;
Cell Signaling Technology, 4650) and stain-free total protein were used to determine even
loading. Band intensity was quantified using ImageJ.

Statistical Analysis
All values are presented as mean ± SEM. For single pairwise comparisons of normally
distributed data sets, a Student’s t-test was performed. For multiple comparisons of
means, a one-way ANOVA with Tukey-Kramer post hoc test was performed. p < 0.05 was
considered statistically significant. All hypothesis tests were conducted using Graphpad
Prism 8 software. Experiments were performed in both male and female mice; data are
shown by sex only where there were statistically significant differences between male and
female experimental groups.
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CHAPTER 4

ADIPOCYTE SPHINGOSINE KINASE 1 REGULATES HISTONE
MODIFIERS TO DISRUPT CIRCADIAN FUNCTION

(ANDERSON, et al., 2020)
Primary Research Manuscript
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4.1. Introduction
Biology abounds with compensatory and reversible mechanisms. Indeed,
organismal fitness arises from the ability to rebound from stimuli and return to basal
homeostasis. One such example of rebounding is the apparent de novo biosynthesis of
sphingolipids, a class of lipids specialized in signaling functions that range from cell
survival, apoptosis, growth, proliferation, differentiation, and others (Hannun and Obeid,
2018; Harrison, et al., 2018; Ogretmen, 2018). To “rebound” from nutrient overload, the
free fatty acid palmitate (or other fatty acid species, such as myristate) may be shunted to
the sphingolipid biosynthesis pathway to condense with an amino acid such as serine to
generate sphingolipids (see Figure 3) (Russo, et al., 2012). Ultimately, a delicate balance
is achieved among the levels of these lipid structural and signaling metabolites in the cell,
including:

sphingomyelin,

ceramide,

glycosphingolipids,

ceramide-1-phosphate,

sphingosine, and sphingosine-1-phosphate (S1P) (Breslow and Weissman, 2010;
Harrison, et al., 2018; Snider, et al., 2019). The subject of this work is sphingosine kinase
1, responsible for the catalysis of sphingosine phosphorylation, thereby generating a
bioactive signaling sphingolipid, S1P, capable of a wide variety of functions, ranging from
intracellular to autocrine and paracrine signaling (Hannun and Obeid, 2018; Ogretmen,
2018; Takabe, et al., 2008). Sphingosine kinase 1 (SPHK1) is widely studied for its role
as an oncogenic kinase, highly stimulated by most growth factors, including the growth
factor cocktail used to synchronize cultured cells for circadian analysis (Hatoum, et al.,
2017; Kapitonov, et al., 2009; Kleuser, et al., 2001).
Circadian rhythm research, the study of biological patterns that follow the day, is
gaining greater traction due to the Nobel Prize awarded in Medicine or Physiology in 2017
to circadian researchers, thus boosting interest and popularity. Circadian rhythm evolved
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to compensate for and anticipate the day and night phenomena generated by the rotation
of the Earth on its axis as it revolves around the sun (Dunlap and Loros, 2017; GerhartHines and Lazar, 2015). Fitness and viability of many organisms depended on seeking
food during the hours of sunlight and resting by shelter in the hours of darkness (Egli,
2017). Humans experience a highly disruptive circadian pattern in today’s 24/7 artificiallylit society (Brown, et al., 2019; James, et al., 2017; Pilorz, et al., 2018). This disruption is
far too great to be compensated and has therefore wrought itself in pathological
manifestations including but not limited to obesity, cardiovascular disease, organ failure,
cancer, metabolic syndrome, thyroid dysfunction, and compromised immune function
(Asher and Schibler, 2011; Ikegami, et al., 2019; Johnston, et al., 2016; Truong, et al.,
2016).
The circadian clock oscillator is understood at the molecular level as a
transcriptional translational feedback loop that has an intrinsic, free-running periodicity of
approximately 24 hours. The positive limb of the core loop is comprised of BMAL1 and
CLOCK which heterodimerize as transactivators to enhance the expression, by binding Ebox elements, of their targets the PERIODs (1, 2, 3) and CRYPTOCHROMEs (1, 2), of
the negative core loop; REV-ERBs (α, β), of the negative accessory loop; and RORs (α,
β, γ), of the positive accessory loop (see Figure 2). As PERIOD and CRYPTCHROME
build up, these protein products heterodimerize in a large complex to translocate to the
nucleus to repress BMAL1:CLOCK activity, thereby leading to net decreases in their
(PER:CRY) levels due to this lack of transcription as well as coordinated ubiquitinationmediated degradation. Once PER:CRY complexes are degraded, BMAL1:CLOCK mayreinitiate another cycle of transcription (reviewed in Hardin and Panda, 2013).
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Interestingly, findings in the last decade point to circadian oscillations in the
sphingolipid biosynthetic system (Brunkhorst, et al., 2019; Druzd, et al., 2017; Hogenesch,
et al., 2013-2018; Loizides-Mangold, et al., 2017). The Cowart lab was previously
interested in the role of SPHK1 in the adipocyte, which is also a strongly circadiangoverned cell type (Bray and Young, 2007; Shostak, et al., 2013; 2013a; van der Spek, et
al., 2012). Moreover, the Cowart lab previously identified a role for adipocyte SPHK1 in
the maintenance of liver homeostasis, highlighting the impact of adipose:liver crosstalk
(Anderson, et al., 2020; Cai, et al., 2018; Rosso, et al., 2019; Ye, et al., 2017).
Furthermore, many investigators have shown that histone modifications and their
circadian regulation are highly coordinated in the liver to affect numerous metabolic
outcomes, such as cholesterol synthesis and secretion (Cox and Takahashi, 2019; Ferrell,
et al., 2015; Kovář, et al., 2010; Sobel, et al., 2017). Precedence also existed for S1P
influencing the activity of histone-modifying enzymes (Hait, et al., 2009, 2020). Therefore,
the hypothesis was that SPHK1 was a circadian-controlled gene in adipocytes and that
lack of SPHK1 may influence the circadian features of the adipocyte. This hypothesis was
tested by subjecting wildtype and SPHK1-depleted primary adipocytes to standard
circadian synchronization procedures in culture and tested the effects of synchronization
on Sphk1 and, conversely, the effects of SPHK1 depletion on circadian gene and protein
expression as well as adipocyte functional processes such as circadian histone
modifications.
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4.2. Results
The Cowart lab and others have empirically highlighted the multifaceted roles of
sphingosine kinase 1 (SPHK1) in metabolic disorders and obesity (Anderson, et al., 2020;
Geng, et al., 2015; Ross, et al., 2013; Wang, et al., 2014). Specifically, in high fat dietinduced obesity, adipocyte sphingosine kinase 1 contributes to maintenance of lipolysis
and adipocyte size (protection from hypertrophy) as well as protection from liver steatosis
(Anderson, et al., 2020). Since metabolism and adipocyte processes like lipolysis are
tightly coupled with the circadian clock, we wondered if sphingosine kinase 1 may be
regulated by the clock (Chaix et al., 2019; Lemmer and Oster, 2018; Shetty, et al., 2018;
Zimmet, et al., 2019). Even more intriguing were the mRNA Sequencing findings from the
gWAT of control diet-fed WT and SK1fatKO mice from that study in which several circadian
transcripts were either elevated or depleted (Supplemental Figure 4). All animals for the
dataset were sacrificed at Zeitgeiber Time (ZT) 9 (meaning 9 hours after the light stimulus
turns on in the animal housing facility, where 6 a.m. is “lights-on” and ZT0; i.e., 6 a.m + 9
hours = ZT9) and fasted for 6 hours prior to sacrifice.
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Supplemental Figure 4. SK1fatKO gWAT mRNA Sequencing analysis.
gWAT from pooled samples of male and female C57/bl6J mice (WT or SK1fatKO) harvested
at ZT9 was analyzed by paired-end fragments per kilobase million mRNA Sequencing and
expressed as fold change over wildtype. Ccrn4l, carbon catabolite repression 4-like
protein (also known as nocturnin); Npas2, neuronal PAS containing 2; Per1, period 1;
Ptgds, prostaglandin D2 synthase; Pparα, peroxisome proliferator activated receptor
alpha; Rorα, β, γ, retinoic acid related orphan receptor alpha, beta, and gamma; Slc9a3,
solute carrier family 9 member A3.
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It is already known that AP-1 and PPARα binding elements exist in the sphingosine
kinase 1 promoter (Huang, et al., 2014; Lan, et al., 2011; Paugh, et al., 2009; Ross, et al.,
2013). A genomic database search for the canonical 5’-CACGTG-3’ E-box element in the
Sphk1 gene/promoter proved to be present almost 2 kilobases from the transcriptional
start site (TSS) as well as another E-box immediately proximal to the TSS, about 300 base
pairs upstream (Figure 10A). In an in vitro primary adipocyte model, we found that Sphk1
did have a circadian oscillation over 24 hours, with a cosinor R2 value of 0.76 (Figure 10B,
D). The canonical negative accessory Reverbα (Nr1d1) message was measured to
demonstrate a proof of principle for the circadian cell culture assay (Figure 10C, D). In the
mouse primary adipocyte model, measuring SPHK1 protein was not possible due to lack
of a commercially-available, reliably specific antibody for the mouse SPHK1 protein, as
every antibody tested yielded a predicted SPHK1 band in SPHK1-/- cells (Anderson, data
not shown).
Next, chromatin immunoprecipitation (ChIP) analysis of the same regions of the
Sphk1 promoter were assayed for the presence of the transactivator complex BMAL1 and
CLOCK. Moreover, concomitant pulldowns for acetylated histone 3 lysine 27 (H3K27ac)
were performed as positive controls for transcriptional activation marks. Cell
synchronization was accomplished by administering a serum-shock (50% horse serum
and 50% DMEM) to growth-arrested matured primary adipocytes for 2 hours, followed by
a gentle wash and incubation for the next 46 hours in serum-depleted media. The time at
which serum shock commenced was considered “circadian time 0” (CT0). Performing
these pulldowns over a time course of 24 hours demonstrated a rhythmic signal of BMAL1,
CLOCK, and H3K27ac at the Sphk1 promoter regions of interest (Figure 10D, E). At some
points over this time course, signal for the core clock transactivator was not detectable
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over background, which suggested to us that indeed BMAL1 and CLOCK may contribute
to the regulation of Sphk1 expression, in part by time-dependent physical occupancy of
the Sphk1 E-boxes by the clock enhancer complex. In other words, BMAL1 and CLOCK
vacate the Sphk1 locus for some portion of the circadian period. According to the data
presented, it appears that activators occupy the Sphk1 promoter most from CT16-24
(Figure 10D, E).
To understand better the implications of these data, a lipidomics flux assay
assessed whether SPHK1 exhibits time-of-day-dependent efficiency in enzymatic activity.
First, cells were assessed at baseline, with only a synchronization stimulus to assess the
levels of endogenous S1P (Figure 10F). Thus, cells were treated with a bolus of
sphingosine substrate to determine turnover to

17

C-

17

C-sphingosine-1-phosphate (17C-S1P)

product. Consistent with the pulsatile expression of Sphk1, the generation of 17C-S1P, as
measured in cell culture and the cell lysates, showed time-dependent fluctuations (Figure
10G). Moreover, the values of 17C-S1P produced in cells and media were combined as a
single value to illustrate 17C-S1P production in toto (Figure 10H). As analyzed by goodness
of fit to a cosine curve, the production of 17C-S1P does not follow a circadian pattern as
strongly as the mRNA of Sphk1. This is suggestive that the enzyme could have timedependent enzymatic efficacy, or that there is time-dependent buildup of the enzyme to
handle a larger substrate-to-product turnover, or perhaps other mechanisms relating to
the S1P phosphatases (1 and 2) or lyase, but were not explored here.
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Figure 10. Sphk1 is a circadian gene in adipocytes. A. Pictorial
representation of the Sphk1 promoter, in which multiple E-boxes reside, including
positions -1800 and -300 base pairs from the transcription start site (TSS) (adapted from
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(Figure 10 legend, continued.)
Ross and Cowart, et al., 2013). B. Sphk1 mRNA expression in primary adipocytes over
24 hours. C. mRNA expression of Reverbα (Nr1d1) over 24 hours in the same primary
adipocytes. D. Cosinor analysis (as described in Methods) of mRNA expression of Sphk1
and Nr1d1. E. Presence of BMAL1 and CLOCK at the promoter E-box loci in Sphk1 DNA.
Anti BMAL1 and CLOCK antibodies were used to immunoprecipitate chromatin at the
specified promoter locations of Sphk1 DNA. F. H3K27ac is a mark of active transcription
and was immunoprecipitated side-by-side with (E.) at the indicated Sphk1 DNA promoter
loci. F. Wildtype adipocytes were synchronized, and cells and media were collected at the
indicated timepoints and assessed by LC:MS/MS for native endogenous S1P. G.
Following synchronization, wildtype adipocytes

17

C-S1P production as measured by

LC:MS/MS over a circadian time course when fed 5 µM

17

minutes prior to each harvest. H. From (G.), total levels of

C-sphingosine for exactly 30

17

C-S1P from cells and media

combined were graphed over time and subjected to a cosinor analysis to show overall
generation of 17C-S1P. The raw data points are the thin blue line and the cosinor fit is the
thick darker line. For (D., E., F., G.), the data shown is one representative example of
three independent experiments. CT, circadian time (CT0 is the time at which
synchronization serum shock media is administered); MESOR, midline estimating statistic
of rhythm ZT, Zeitgeber time
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Over the last couple years, precedence has emerged in the literature for circadian
regulation of sphingolipid-associated genes. For example, the circaDB database curated
by the Hogenesch group demonstrates a vast array of sphingolipid genes that fluctuate in
various tissue types (Hogenesch, et al., 2013-2018). Indeed, of approximately 35,000
circadian genetic hits in mouse and 15,000 in human, Sphk1 was found to oscillate in two
mouse systems, a 3T3 cell line and the lung (Supplemental Figure 5A) (Hogenesch, et al.,
2013-2018; Hughes, et al., 2009; Zhang, et al., 2014). As measured by mRNA in mouse
gonadal white adipose tissue (gWAT), sphingosine kinase 1 (Sphk1) message had a nonconstant expression profile (Supplemental Figure 5B). Moreover, it was found that patient
plasma had oscillating S1P levels (Brunkhorst, et al., 2019). In addition, Scheiermann,
Oster, and colleagues convincingly demonstrated the oscillation of S1P receptor 1
(S1Pr1), and that this oscillation specifically drove the fluctuating presence of immune
cells in the bloodstream over the circadian day (Druzd, et al., 2017).
It is also already known that fatty acids oscillate in the bloodstream, and fatty acids
have been shown in numerous contexts to induce the sphingolipid de novo biosynthetic
pathway and some of its enzymatic genes, thus providing one mechanistic explanation for
the observed daytime-dependent changes in sphingolipids (Bray and Young, 2007; Geng,
et al., 2015; Gooley and Chua, 2014; Ross, et al., 2013; Russo, et al., 2012; Shostak, et
al., 2013; van der Spek, et al., 2012; Wang, et al., 2014; Wigger, et al., 2019).
Sphingolipidomics data in human skeletal muscle biopsies obtained over 24 hours were
highly suggestive of diurnal regulation of various sphingolipid species (Loizides-Mangold,
et al., 2017). The sphingolipid biosynthetic pathway represents a novel avenue for
manipulation by therapeutics coupled with strictly scheduled dosing, or, stated differently,
administration of sphingolipid-modifying drugs coupled with chronotherapy.
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Supplemental Figure 5. Sphk1 oscillates in 3T3 cells and murine lung
tissue. A. Sphk1 is a fluctuating gene in 3T3 cells and a bona fide circadian gene in
mouse lung tissue. These data are searchable at: http://circadb.hogeneschlab.org/, and
were accessed on 2020 February 2 for reproduction in this figure (Hogenesch, et al., 20132018; Hughes, et al., 2009; Zhang, et al., 2014). B. Sphk1 mRNA expression in gWAT
over time in 12hr-light:12hr-dark-entrained wildtype C57bl/6J mice.
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Considering the mRNA-Seq and in silico findings, the next step was to utilize a
controlled in vitro system for comparing the core clock transcripts in WT and SPHK1-/adipocytes. Due to previous work in the Cowart lab characterizing the metabolic
phenotype of mice lacking SPHK1 constitutively (SPHK1-/-), a model system was readily
available to dissect the consequences of SPHK1 depletion on the adipocyte circadian
clock and utilize primary cells from a genetic knockout animal. After a horse serum shock
synchronization, it was found that negative clock regulators, the Pers display a higher
amplitude in mutant cells compared to control (Figure 11A, B). Furthermore, the spike in
Bmal1 mRNA in the first 4 hours is the result of the serum shock synchronization protocol
(Figure 11A). For cosinor analyses of these data, the first 8 hours of data was not
considered since the system was re-equilibrating after the serum shock. Moreover, the
typical readout for BMAL1 transcriptional activity (but is not primarily engaged in the core
clock mechanism), Dbp (D-site of albumin promoter binding protein), also demonstrated
a higher amplitude in mutant cells compared to control (Figure 11A, B). Interestingly, the
positive regulator of Bmal, Rorγ maintained a stronger gene expression over 48 hours
compared to the mutant (Figure 11A, B). The corresponding cosinor analyses for the
mRNA expression profiles are shown in Figure 11C, which indicated across all genes that
SK1-/- adipocytes have stronger baseline levels of these transcripts and generally greater
amplitudes.
The protein levels for BMAL1 revealed lower expression levels in SPHK1-/adipocytes, while still oscillating (Figure 11D). Despite these findings, the amplitude for
BMAL1 expression oscillation was greater in SK1-/- adipocytes compared to control,
suggesting that the total levels of BMAL1 may not necessarily dictate the transcription of
its targets, but rather a larger change from peak to trough may be a larger driving factor
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(Figure 11E, F). These results were obtained after normalizing both densitometry datasets
to the “trough” value, which in both cases occurred at CT3. Therefore, the relative values
of the oscillating BMAL1 protein could be easily compared between SK1-/- and WT cells
for rhythmicity (Figure 11E). These values were plotted and analyzed for cosinor goodness
of fit (Figure 11F). At the nuclear level, the binding partner for BMAL1, CLOCK protein
expression within the nucleus increased with SPHK1 depletion (Figure 11G). This may
suggest that CLOCK protein is readily poised in SK1-/- cells to heterodimerize with BMAL1
or that CLOCK nuclear export is compromised or another mechanism. These findings led
to the overall conclusion that the adipocyte molecular circadian clock was compromised
without a functional sphingosine kinase 1.
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Figure 11. (Legend on following pages.)
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Figure 11. SPHK1 adipocytes have a dysfunctional circadian clock. A.
mRNA rhythms of Bmal1 (positive core loop gene), Dbp (canonical clock-controlled gene
(ccg)), Nr1d1 (also known as Rev-erbα; negative accessory loop gene), Per2 (negative
core loop gene), Per3, and Rorγ (positive accessory loop gene) in synchronized primary
matured WT and SPHK1-/- adipocytes over a 48-hour time course. Refer to Figure 2 on
page 13 for the molecular circadian clock. B. Cosinor fit curves of raw data presented in
(A.). C. Corresponding cosinor analysis values for MESOR (midline estimating statistic of
rhythm), amplitude, acrophase, and R2. D. Western blot of BMAL1 protein expression in
primary WT and SPHK1-/- matured adipocytes whole cell lysates across the circadian time
course. E. Cosinor fit curve for the densitometry normalized to the trough densitometry
value for each genotype in (D.). Solid lines indicate the cosinor curve, while black dashes
are WT and pink dashes are SK1-/-. F. Corresponding cosinor analysis of BMAL1 protein
expression. G. Nuclei of primary WT and SPHK1-/- matured adipocytes were isolated, and
CLOCK protein expression over 24 hours was measured by Western blot. # denotes
posttranslational modifications. Experiments were performed 3 times in 3 separate
preparations of primary cells for culture, and representative blots are shown for the trends
that were observed. Bmal1, brain and muscle ARNT-like protein 1; Dbp, D-site of albumin
promoter binding protein; Nr1d1, nuclear receptor subfamily 1 group D member 1; Per2,
3, period 2, 3; Rorγ, retinoic acid receptor-related orphan receptor gamma; SK1-/-,
sphingosine kinase 1 knockout (for brevity in figures).
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Having established that SPHK1 is circadian-regulated and that loss of this gene
and its functional protein product result in the loss of circadian functionality, the next
question to address was the consequence upon circadian clock-mediated transcriptional
function. Therefore, the expression patterns of common BMAL1:CLOCK targets were
assessed by immunoprecipitating the components of the transactivator complex at the
chromatin E-box regions of Per1, Reverbα, Dbp, and Pparγ to assay a gamut of targets
that span the negative regulators (Per1 and Reverbα) as well as the typical clockcontrolled target, Dbp, and peroxisome proliferator γ for its role in adipocyte function, as
a marker of mature adipocytes and of anabolic lipogenic capacity (Figure 12A). In
synchronized, naïve (non-transfected) adipocytes, BMAL1 and CLOCK were detected at
CT20 (20 hours after synchronization) at all promoters tested, with CLOCK occupancy at
the Reverbα (also known as Nr1d1) promoter being significantly lower in the mutant
compared to control, and downward trends in CLOCK occupancy in all other targets
(Figure 12A). On the other hand, BMAL1 occupancy at these loci was apparently
unchanged between genotypes, suggesting that the differences in transcriptional clock
output observed were not due to BMAL1 occupancy of the promoter.
Moreover, the histone marks associated with active chromatin (H3K9ac, H3K27ac)
are known to be circadian, and this led to assessing acetylated histone chromatin marks
as well (Baerenfaller, et al., 2016; Cox and Takahashi, 2019; Feng, et al., 2011; Kim, et
al., 2018; Sato, et al., 2017). In addition, a more abundant epigenetic marker, such as
H3K27ac, was a suitable positive control for the success of each ChIP batch, when
assessing in parallel the ChIP signals from natively low-expressed clock transcription
factors, such as BMAL1 and CLOCK (Figure 12A). Furthermore, S1P has been reported
to be a histone deacetylase (HDAC) inhibitor, which lent a novel hypothetical target for
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SPHK1-S1P action, in which cytosolic SPHK1 may generate S1P to be carried by HDAC
into the nucleus (Hait, et al., 2009). Intriguingly, both H3K9ac and H3K27ac occupancy
signal at the promoters of Dbp, Reverbα, Per1, and Pparγ2 were lower in mutant compared
to control in 3 out of 4 promoters for both acetylated histone H3 molecules (Figure 12B).
H327ac and H3K9 ac are thought to be marks of transcriptional activation, but they do not
seem to follow the transcriptional mRNA data. This could be explained possibly by other
histone modifications that have a stronger effect than the acetylated ones studied here,
such as H3K4me3, H4K12ac, H4K5ac, and H2BK12ac (Cox & Takahashi, 2019;
Nagahashi, et al., 2015; Zhang, et al., 2012). This finding led to the interest in the protein
expression of acetylated histones, so H3K27ac protein expression was assessed at the
same timepoint as the chromatin immunoprecipitations, CT28. It was observed that
H3K27ac protein expression was strongly diminished in SPHK1-/- adipocytes compared to
control (Figure 12C, D). This finding was in line with the decreased acetylated histones at
clock targets in SPHK1-/- cells. Given the histone findings, it was decided to assess the
acetylation pattern on H3K9 and H3K27 over a circadian time course. Strikingly, the
acetylation pattern on H3K9 was nearly absent in SPHK1-/- adipocytes compared to
control, and the expression pattern of H3K27ac was reversed in SPHK1-/- adipocytes
(Figure 12E). The loss of SPHK1, which is known to reside in the cytosol, has effects on
nuclear transcriptional and epigenetic regulation (Nishino, et al., 2019).
Given past findings that S1P affects nuclear chromatin-associated histones, the
product of SPHK1, S1P was added to adipocytes and chromatin immunoprecipitation of
H3K27ac was performed, and qPCR analysis of several clock targets as well as adipocyte
functional targets were carried out (Hait, et al., 2009). At lipolysis genes Atgl and Lipe
(also known as Hsl), lipogenic genes Pparγ2 and Pgc1α, and circadian clock genes Cry2,
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Dbp, Per2, and Per3, acetylated histone H3 signals tended to be increased with S1P
treatment compared to the albumin carrier alone (Figure 12F). At the very least, these
observations suggest that S1P (a pro-mitogenic bioactive lipid) is facilitating a chromatin
disposition that is poised for transcriptional activation.
To follow up further on S1P effects on chromatin modifiers, the temporal profile for
the proposed S1P-binding HDACs was characterized in WT adipocytes and adipocytes
lacking the S1P-generating kinase SPHK1 (Hait, et al., 2009). Important to this
experiment, cells were fractionated into cytosolic-enriched and nuclear-enriched fractions
to assess genetic the effects of depletion of SPHK1 on temporal-spatial dynamics of
HDAC expression. SPHK1-/- cells had increased expression of HDAC1 protein over time
in the cytosol compared to control, and this was paired with a decrease in the nuclear
expression of HDAC1 compared to control (Figure 12G). Little changes were observed
between cytosolic HDAC2 expression between cell genotypes, however nuclear HDAC2
in SPHK1-/- adipocytes was decreased compared to control, thus implicating a role for
SPHK1 in the nuclear/cytoplasmic localization of Class I HDACs, which could potentially
impact enzyme activity. Moreover, nuclear accumulation of HDAC3, another Class I
HDAC, was depleted in the nuclei of SPHK1-/- adipocytes compared to control (Figure
12H). Intuitively, less histone acetylation in SPHK1-/- adipocytes from the earlier ChIP
experiments would have suggested higher HDAC activity in SPHK1-/- cell or perhaps
higher protein expression, but the former has yet to be tested and the latter was not found
here within the nucleus. In addition, it has been shown by others that HDAC1 and HDAC2
can localize to the cytoplasm, not just the nucleus as canonically thought (Figure 12I).
Since Class I HDACs are known to bind S1P (Hait, et al., 2009), we were curious which
proportion of HDAC-bound S1P could be found in the cytosol and the nucleus, and it was
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found that HDAC1 and 2 can bind S1P, quite strongly in the nucleus, but there is residual
S1P bound to these proteins in the cytoplasm (Figure 12J). These data suggest, but do
not confirm, the possibility that HDAC1 and 2 could be loaded with S1P prior to exerting
effects within the nucleus.
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Figure 12. Loss of actively transcribing chromatin and CLOCK
occupancy in SPHK1-/- adipocytes and disruption of chromatin
modifiers. A. WT and SPHK1-/- primary adipocytes were synchronized and harvested
at CT28 for ChIP of BMAL1 and CLOCK at the promoters of Per1 (negative core loop
target), Reverbα (negative accessory loop target), Dbp (canonical/traditional, non-coreclock-mechanism BMAL1 target), and Pparγ (known circadian transcription factor,
involved in anabolic adipocyte lipogenesis, BMAL1 target). (See Figure 2, page 13.) B. A
mark of active transcription, acetylated histone 3 at lysines 9 and 27 (H3K9ac and
H3K27ac) was immunoprecipitated at the DNA loci of Per1, Reverbα, Dbp, and Pparγ in
synchronized WT and SPHK1-/- primary matured adipocytes at CT28. C. Western blot
analysis of H3K27ac in matured primary adipocytes from sWAT of WT and SPHK1-/- mice.
D. Quantification of the Western blot in (C.), displayed as relative acetylated histone3 K27
densitometry over total histone H3. E. Nuclear-enriched fraction of synchronized matured
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primary WT and SPHK1-/- adipocytes showing acetylated H3K9 and H3K27 expression
over 24 hours. F. WT synchronized primary matured adipocytes were treated with 150 nM
S1P for 30 minutes and cells were subjected to ChIP of H3K27ac at the promoters for
Atgl, Lipe, Pgc1α, Pparγ2, Cry2, Per2, Per3, Dbp, and at negative control Cbxypa (a
marker present in pancreas tissue, but not adipose tissue). G. Cytosolic- and nuclearenriched fractions of synchronized primary WT and SPHK1-/- adipocytes and Western
analysis of HDAC1 and HDAC2 proteins over 24 hours. H. Cytosolic- and nuclearenriched fractions of synchronized primary WT and SPHK1-/- adipocytes and Western
analysis of HDAC3 over 24 hours. I. From the Human Protein Atlas database online,
HDAC1- and HDAC2-positive staining in Hela and U251-MG cells is in the nucleus and
the cytoplasm. White arrows indicate positive staining in the cytoplasm. J.
Immunoprecipitations of HDAC1 and HDAC2 in fractionated WT cells followed up with
lipidomics analysis for S1P binding. Experiments were performed 3 times in 3 separate
preparations of primary cells for culture, and representative blots and ChIP batches are
shown for the trends that were observed. *p < 0.05. Atgl, adipose triglyceride lipase;
Cbxypa, carboxypeptidase A; Cry2, cryptochrome 2; Dbp, D-site of albumin promoter
binding protein); Lipe, hormone sensitive lipase; Pgc1α, peroxisome proliferator-activated
receptor gamma coactivator 1 alpha; Pparγ2, peroxisome proliferator-activated receptor
gamma 2; Per2, period 2; Per3, period 3.
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Finally, these adipocyte cellular effects demonstrated a role for SK1 in the
maintenance of the molecular circadian clock. Typical circadian transcripts were
increased, suggesting that SK1 and perhaps S1P may be involved in negative feedback
regulation of the clock. Furthermore, histone modifications, which are known to be
circadian, followed alternative patterns over time compared to control when assessing
protein expression. Could these changes at the cellular level be involved in maintaining
metabolic homeostasis?
We utilized WT mice and SK1fatKO (mice with an adipocyte-specific depletion of
SK1) to determine some overall metabolic parameters (Anderson, et al., 2020). Mice were
not fasted and serum was collected for analysis of lipids over a circadian time course.
Strikingly, it was found that serum cholesterol was significantly elevated compared to
control, and serum triacylglycerols also increased at early time points in the circadian
period (Figure 13A, B). These data suggested that the contribution of adipocyte SK1 is
critical for maintenance of liver functional homeostasis. In addition, animals were
subjected to noninvasive comprehensive monitoring, in which the respiratory exchange
ratio (RER), energy expenditure, physical activity, and food intake were measured. It was
found that the first half of the day (inactive period) tended to have the most differences,
with SK1fatKO mice demonstrating significantly increased RER, indicating more
carbohydrate energy utilization compared to control (Figure 13C, D).
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Figure 13. Energy homeostasis and liver metabolism are perturbed in
SK1fatKO. A. Serum cholesterol was measured in non-fasted male WT and SK1fatKO mice
at the indicated timepoints. ZT0 is 6 a.m. A white bar with a lightbulb and a black bar
indicate the lights’ status in the mouse room. B. Serum cholesterol was measured in nonfasted male WT and SK1fatKO mice at the indicated timepoints. C. Comprehensive lab
animal monitoring of 6 WT and 6 SK1fatKO male mice measured respiratory exchange ratio
as VCO2 over VO2, energy expenditure as kilocalories per 15-minute intervals, physical
activity as measured by beam breaks and reported as arbitrary units, and food intake
measured by grams per 15-minute intervals. WT in blue, SK1fatKO in red. D. Same data as
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(C.), but displayed as binned 2-hour intervals and shown as violin plots, with the median
bolded in a solid line, and the upper and lower quartiles in thinner, dashed lines. WT in
black, SK1fatKO in salmon.
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4.3. Conclusion
In conclusion, the work here demonstrated that genetic depletion of SPHK1 led to
defects in the adipocyte circadian clock with concomitant perturbations to the behavior of
histones at key adipocyte and circadian genetic loci (Figure 11, Figure 12). Moreover, it is
proposed that Sphk1 is a circadian gene in adipocytes, due to the expression profile of
Sphk1 mRNA over a circadian time course in wildtype primary adipocytes, the presence
of E-boxes in its promoter, as well as the presence of clock transcription factors
BMAL1:CLOCK at the promoter E-box sites in Sphk1 (Figure 10A, D, E). All in all, animals
lacking SK1 specifically in the adipocyte also showed enhancements in the respiratory
exchange ratio in the beginning of the day, along with increased serum levels of
cholesterol and triacylglycerol. Further investigation is needed to comprehensively
decipher the role of SPHK1/S1P as well as other sphingolipids in nuclear events such as
homeostatic circadian transcription.
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4.4. Discussion
With respect to the cyclical nature of reversible or counterregulatory mechanisms,
histone modifications (acetylation and deacetylation) and their modifiers are disrupted due
to loss of SPHK1. Consistent with the previously established notion that S1P is an inhibitor
of HDAC, we found that treatment with S1P could increase the acetylated histone H3
signal at several key adipocyte functional and circadian regulatory genes (Figure 12F)
(Hait, et al., 2009). It was expected that an SPHK1-null system would therefore be rampant
with HDAC activity with subsequently transcriptionally inactive chromatin. This was
demonstrated by decreased acetylated protein at two histone residues (K9 and K27) in
SPHK1-/- cells and decreased DNA qPCR signal from immunoprecipitated histones at
important adipocyte circadian loci (Figure 12C, E; A, B, respectively). Thus, SPHK1-/- cells
had lower overall acetylated histone signal at several circadian target genes, which is in
line with evidence that S1P, the product of SPHK1, is a histone deacetylase inhibitor (Hait,
et al., 2009). Future studies delineating a role for SPHK1 and S1P in chromatin
modifications should include ChIP-Sequencing as a method for a more comprehensive
analysis. Despite the ChIP findings, circadian clock transcripts had higher baseline
expression values and amplitudes in SK1-/- compared to control. This suggests that the
findings from amplified mRNA expression and decreased ChIP signal of H3K9ac and
H3K27ac may arise from activity at other histones or histone residues.
Nuclear/cytoplasmic localization of HDAC, on the other hand, was aberrant but not
suggestive, by mere protein expression, that HDAC1, 2, and 3-based deacetylation were
to blame for the observations made by ChIP of decreased acetylated histone in SPHK1-/adipocytes (Figure 12A, B, G, H, respectively). Another possibility is a differential effect of
SPHK1 on histone acetyltransferases (HATs). For example, CLOCK itself is a histone
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acetyltransferase, and the nuclear levels of which were found to be increased in SPHK1-/adipocytes compared to control (Figure 11G) (Doi, et al., 2006; Hirayama, et al., 2007).
Despite this, CLOCK occupancy at several key promoters for which it is known to bind,
trended towards decreases for several clock target genes involved in adipocyte
homeostasis (Figure 12A, B). Histone deacetylase and acetyltransferase enzymatic
activity assays should be utilized to determine the global effect of SPHK1 and S1P on their
activity. Moreover, other HDACs (for which there are several isoforms), may be more
active or overexpressed, besides HDAC 1, 2, 3, which could explain the decreased
acetylated histones found at the circadian and adipocyte gene promoters (Bagchi and
Weeks, 2019).
Figure 14 highlights a potential model by which SPHK1 and its product S1P may
influence the circadian clock. Histone modifications are known to be circadian and these
modifications influence whether genes are enhanced or repressed (Baerenfaller, et al.,
2016; Cox and Takahashi, 2019). S1P is known and has been shown here to influence
the modification status of histones (Hait, et al., 2009). Sphk1 mRNA expression and the
variations in the production of 17C-S1P demonstrate the cyclical nature of this lipid and its
kinase. Thus, a model to encompass these aspects shows that S1P may impart a layer of
control upon the circadian clockwork mechanism at the epigenetic level. Importantly, this
study highlights for the first time a novel loop by which a cycling bioactive lipid exerts some
control over the periodic oscillations of core clock genes and epigenetic machinery.
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Figure 14. Proposed model of SPHK1/S1P regulation of adipocyte
circadian rhythm. A. SPHK1 and S1P levels fluctuate over time, giving rise to a
temporally-controlled inhibition on Class I HDAC activity. Temporal control of HDACs
gives rise to chromatin conformations that enhance or repress transcription. B. Could
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HDACs be an intracellular S1P vehicle? This could provide one hypothetical explanation
for how cytosolic SK1 and S1P may influence HACDAC-dependent processes in the
nucleus.
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4.5. Experimental Methods
Cell Culture, Isolation of Stromal Vascular Fraction (SVF) and Differentiation to Mature
Adipocytes
Primary adipose-derived stem cells (ADSCs) were isolated from inguinal adipose tissue
of 3-8-week-old WT and SPHK1-/- mice (Allende, et al., 2004). Subcutaneous adipose
tissue was digested using 0.1% collagenase (Sigma, C6885) in digestion buffer (100 mM
HEPES, 120 mM NaCl, 50 mM KCl, 5 mM glucose, 1 mM CaCl , 1.5% BSA) in a 37⁰ C
2

shaking incubator (New Brunswick Scientific) (150 rpm) for 40 minutes. The digest was
filtered through a 100-µM cell strainer and centrifuged at 500 ˟ g for 5 minutes. The SVF
pellet was re-suspended in media, filtered through a 40-µM cell strainer and plated. Media
was changed after two hours to remove non-adherent cells. Cells were grown to
confluency in proliferation media (DMEM/F12 50:50 (Corning, 10-090-CV), 10% fetal
bovine serum (FBS) (Atlanta Biologicals), 1% penicillin streptomycin antimycotic cocktail
(MilliporeSigma, A5955). 48 hours post-confluency, differentiation was induced using 10
µg/mL insulin (Santa Cruz Biotechnology, sc-360248), 1 µM dexamethasone
(MilliporeSigma, D4902), 0.5 mM IBMX (Enzo Life Sciences, BMLPD1401000), and 1 µM
rosiglitazone (Cayman Chemical, 71740) for two days. Differentiation was maintained with
insulin for days 3-4 and proliferation media days 5-8. Mature adipocytes were visualized
under a brightfield microscope to assess lipid droplet formation, and plates with large lipid
droplets and >90% differentiation were used for experiments (Figure 15).

in vitro Circadian Rhythm
Unless otherwise noted, the in vitro circadian experiments are all performed in the same
manner, in which primary WT and SPHK1-/- ADSCs were brought to maturity, and on the
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day of the experiment, the cells were synchronized with 50% horse serum (Gibco, 26050070) and 50% DMEM/F12 for 2 hours. Following the horse serum shock, the cell
monolayer was gently rinsed once with warm 1x PBS and 2% fatty-acid-free BSA in
DMEM/F12 was kept on the cells for the duration of the experiment, which generally lasted
48 hours in toto.

S1P Treatment
WT primary matured, synchronized adipocytes were allowed to cycle for 24 hours, after
which, cells were treated with a final concentration 150 nM S1P (Avanti Polar Lipids,
860492) complexed to 4 mg/mL FAF BSA or 4 mg/mL FAF BSA without S1P and assayed
by ChIP for acetylated histone H3 signal at various adipocyte and circadian gene loci.

17

C-Sphingosine Treatment

WT primary matured, synchronized adipocytes were allowed to cycle for 24 hours, after
which, cells were treated with a final concentration 5 µM

17

C-sphingosine (Avanti Polar

Lipids, 860640) (dissolved in 100% ethanol) for exactly 30 minutes, collected immediately
with addition of phosphatase inhibitors, for an exact volume of media in a 5-mL borosilicate
glass tube and for a cell pellet in minimal PBS in a separate 5-mL borosilicate glass tube,
capped, and stored at -80° C until analysis by tandem liquid chromatography and mass
spectrometry lipidomics. This 30-minute procedure was repeated every 4 hours over a 24hour period to assay in situ the enzymatic turnover of
(Spassieva, et al., 2007).
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17

C-sphingosine to

17

C-S1P

Nuclear Extracts for Immunoprecipitation followed by Lipid Measurements
This method was developed in Hait, et al., 2009. WT primary matured, synchronized
adipocytes were allowed to cycle for 24 hours, after which, cells were harvested over a
time course. Cells were washed with cold PBS and re-suspended in buffer containing 10
mM HEPES (pH 7.8), 10 mM KCl, 0.1 mM EDTA, 1 mM Na3VO4, 1 mM DTT, 1:500
protease inhibitors (Sigma) and 0.2 mM PMSF, and incubated on ice for 15 min. NP-40
was added (0.75%) and cells were vortexed for 10 sec. Nuclei and supernatant
(“cytoplasm”) were separated by centrifugation at 1000 × g for 3 min at 4˚ C. Nuclei were
resuspended in buffer containing 20 mM HEPES (pH 7.8), 0.4 M NaCl, 1 mM EDTA, 1
mM Na3VO4, 1 mM DTT and 1:500 protease inhibitors and incubated on ice for 15 min.
Nuclear extracts were cleared by centrifugation at 14,000 × g for 5 min at 4˚ C. Equal
milligrams protein from each fraction was immunoprecipitated overnight at 4˚ C (rotating)
with 1 µg BMAL1, HDAC1, and HDAC2 antibodies, and the next day immunocomplexes
were captured with Protein A/G magnetic beads (Thermo Fisher Scientific, 88802) for an
additional 2 hours at 4˚ C, then washed extensively. Immunocomplexes were eluted in
100% methanol and tested by LC:MS/MS at the Virginia Commonwealth University
Lipidomics and Metabolomics Core facility for sphingolipids.

Lipid Measurements
Sphingolipids were measured using liquid chromatography/tandem mass spectrometry at
the Virginia Commonwealth University Lipidomics and Metabolomics Core and performed
using previously published methods (Haynes, et al., 2009; Shaner, et al., 2009).

17

C

sphingolipids were measured at the Medical University of South Carolina Shared
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Lipidomics Resource according to previously published methods (Bielawski, et al., 2010;
Spassieva, et al., 2007).

Chromatin Immunoprecipitation (ChIP)
Primary WT and SPHK1-/- matured, synchronized adipocytes were plated on 15-cm plates
per 2 ChIPs. Briefly, cells were washed twice with room temperature 1x PBS and the
dishes were then placed on an orbital rocker (Sigma, Z768502) in a measured volume of
freshly-made PBS solution containing 2 mM disuccinimidyl glutarate (DSG) (ProteoChem,
c1104) for 10 minutes. After 10 minutes, fresh 37% formaldehyde (Fisher, BP531-500)
was added directly to the solution to a final concentration of 1% and continued swirling
gently for another 12 minutes. Finally, the crosslinking reactions were quenched with
glycine at a final concentration of 125 mM for 5 additional minutes. Following, the solution
was discarded as hazardous waste and the cells were washed twice with cold 1x PBS.
The PBS was aspirated, and the cells were scraped into 1.8 mLs adipocyte hypotonic lysis
buffer (5mM PIPES pH 7.8, 10 mM KCl, 1% Igepal, plus protease/phosphatase inhibitors
and PMSF immediately before use) per 15-cm plate. The cells were collected in a Dounce
homogenizer and were sheared with 10 strokes of the Dounce until visibly dissociated.
The cells were also passed through a 22G needle to ensure disruption of the monolayer
but preservation of the nuclei. The resulting slurry was vortexed and kept on ice for 10
minutes. Next, the tubes were centrifuged at 8,500 ˟ g at 4° C for 8 minutes to remove a
significant fat cake at the top as well as the cytoplasmic infranatant and to leave the
nuclear pellet intact and undisturbed. The pellets were resuspended in the same lysis
buffer to wash excess adipocyte lipid from the nuclear pellet and vortexed. They were re
spun, and the pellets were saved. Next, the pellets were suspended in 600 µL sonication
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lysis buffer (50 mM Tris-HCl, pH 8.0, 10 mM EDTA, 1% SDS, and protease/phosphatase
inhibitors and PMSF fresh) per 15-cm plate. The 600 µL was split into two 1.5-mL
Eppendorf tubes of 300 µL, and then were sonicated (Branson 150, Branson Ultrasonics,
Danbury, CT) for 8 rounds of 30 seconds on, 30 seconds off in a 4° C water bath. The
resulting sonicate was then subjected to centrifugation at 18,000 ˟ g at 4° C to clarify the
chromatin. The chromatin supernatant was collected and split to two chromatin
immunoprecipitations as well as the 10% input control. Thus, approximately 500 µL of
recovered sonicate was split to 200 µL per ChIP plus a 20-µL 10% input. The ChIP
samples were diluted 1:10 with Dilution/Low Salt buffer (20 mM Tris-HCl pH 8.0, 150 mM
NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% SDS), pre-cleared with ChIP-grade Protein
A/G magnetic beads (Thermo Fisher Scientific, 26162)

for one hour, and

immunoprecipitated with 1 µg of antibody overnight at 4° C while rocking. The following
day, pre-equilibrated magnetic ChIP-grade Protein A/G beads were added to the samples
for 2 hours. They were then subjected to extensive washing on the magnetic rack,
performing two washes in Low Salt Buffer, 2 subsequent washes in high salt buffer (20
mM Tris-HCl pH 8.0, 500 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% SDS), 2
subsequent washes in LiCl Buffer (10 mM Tris-HCl pH 8.0, 500 mM NaCl, 1 mM EDTA,
1% deoxycholate, 1% NP-40, 0.25 M LiCl), and finally 2 washes in TE buffer (10 mM TrisHCl pH 8.0, 1 mM EDTA). After these 8 washes, 100 µL of ChIP elution buffer (0.1 M
NaHCO3, 1% SDS) was added to the beads, in addition to the reverse crosslinking
reagent, 4 µL of 5 M NaCl, and these were incubated overnight at 65° C. The next morning,
the samples were treated with RNase A (Thermo Fisher Scientific, EN0531) for 1 hour at
37° C, and after that, treated with Proteinase K (Thermo Fisher Scientific, EO0491) for 1
hour at 60° C. After this, the samples were subjected to DNA isolation and purification with
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a column-based washing approach (Zymo Research, D5205). The samples were eluted
from the column in 120 µL and 2 µL per well, assayed in triplicate, were used for real time
qPCR of the DNA.
Primers used for ChIP are shown below:
Method

Gene

Forward (5' to 3')

Reverse (5' to 3')

ChIP

Cbxypa1

CATGGTCAAGGGTGAAAG

CTGAGGTCTGAGGCCTTTTT

ChIP

Atgl

CGGCGGAGGCGGAGACGCT

TCCCTGCTTGATCCAGTTGGAT

ChIP

Dbp

AATGACCTTTGAACCTGATCCCGCT

GCTCCAGTACTTCTCATCCTTCTGT

ChIP

Lipe

GCTGCCCTGGGAGGATTAAGCC

CAAAAGCCTGAGAGGTTTCTCCGAG

ChIP

Nr1d1 (Reverbα)

ACGACCCTGGACTCCAATAA

CCATTGGAGCTGTCACTGTAGA

ChIP

Per2

CAACACAGACGACAGCATCA

TCCTGGTCCTCCTTCAACAC

ChIP

Per3

CTGCTCCAACTCAGCTTCCTTT

TTAGACAGCAAGGCTCTGGTTCT

ChIP

Pgc1α

GCAATTCAATTCGGGTCCATCTCACC

GGACTTCAGCGTGTTTGCATTCAGTAC

ChIP

Pparγ

CTGTACAGTTCACGCCCCTC

TCACACTGGTGTTTTGTCTATG

ChIP

Sphk1 -1800

TACACCGGGGCACGTGTGCATT

TCTTTCCCCCCAGGGAACACTA

ChIP

Sphk1 -300

ACTTTGTCCCACGTGCATGGA

TCCCGCTGACAAGGGGCCA

Antibodies for ChIP are shown below:
Application

Target Antibody

Host

Supplier Catalog #

ChIP
ChIP
ChIP
W.B. and ChIP
W.B. and ChIP

Mouse H3K9ac
Mouse H3K27ac
Normal IgG
Mouse BMAL1
Mouse CLOCK

Rabbit
Rabbit
Rabbit
Rabbit
Rabbit

Thermo
Thermo
Bethyl
Bethyl
Bethyl

Concentration or Dilution

710293
1 µg per IP
MA5-24671 1 µg per IP
P120-101 1 µg per IP
A302-616A 1 µg per IP
A302-618A 1 µg per IP

qPCR
Total RNA was isolated from cultured primary adipocytes or gonadal adipose tissue
homogenized in Trizol (Invitrogen, 15596026) followed by RNeasy mini kit (Qiagen,
74106) extraction and column purification. cDNA was synthesized from 1 μg of total RNA
using iScript Advanced cDNA Synthesis Kit (Bio-Rad, 1708890). Real time PCR was
performed using a CFX96 Real-Time System (Bio-Rad) and SSoAdvanced Sybr (Bio-Rad,
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172-5272). The primers used for cDNA qPCR and DNA CHIP-qPCR are shown in the
following tables. Mean normalized expression was calculated by normalizing to the
geometric mean of reference genes Ppia and Tbp in gonadal adipose tissue (i.e., root2[Cq
gene 1 ⨯ Cq gene 2]) using the 2-ΔΔCt method. ChIP normalization was carried out with a
10% input control. Primers for ChIP were tabulated in the ChIP section.
Method

Gene

Forward (5' to 3')

Reverse (5' to 3')

qPCR

Ppia

GAGCTGTTTGCAGACAAAGTTC

CCCTGGCACATGAATCCTGG

qPCR

Tbp

AAGGGAGAATCATGGACCAG

CCGTAAGGCATCATTGGACT

qPCR

Bmal1 (Arntl)

TGACCCTCATGGAAGGTTAGAA

GGACATTGCATTGCATGTTGG

qPCR

Dbp

CGTGGAGGTGCTTAATGACCTTT

CATGGCCTGGAATGCTTGA

qPCR

Nr1d1 (Reverbα)

qPCR

Per2

TACATTGGCTCTAGTGGCTCC
CCATCCACAAGAAGATCCTAC

CAGTAGGTGATGGTGGGAAGTA
GCTCCACGGGTTGATGAAGC

qPCR

Per3

CCCTACGGTTGCTATCTTCAG

CTTTCGTTTGTGCTTCTGCC

qPCR

Rorγ

GACTGGAGGACCTTCTACG

TCCCACATTGACTTCCTCTG

qPCR

Sphk1

GAGTGCTGGTGCTGCTGAA

AGGTTATCTCTGCCTCCTCCA

Cellular Fractionation for Nuclear and Cytoplasmic Enrichment
The Thermo NE-PER Kit (Thermo Fisher Scientific, 78835) was utilized to separate
cytoplasmic (post-nuclear) and nuclear fractions from matured primary white adipocytes,
with modifications. In a 10-cm dish, adherent mature adipocytes were gently rinsed twice
with 1x PBS on the dish, and excess was aspirated with a 200-µL plastic pipet tip from the
tilted dish. Next, ~400 µL of CER I solution was added to the monolayer, and adipocytes
were scraped into the solution. Importantly, the collected cells were then passed through
a 22G syringe 5 times to disperse the cell conglomerate but keep the nuclei intact. These
were vortexed and placed on ice for 10 minutes. Next, per the NE-PER protocol, 22 µL of
CER II solution was added and tube was vortexed vigorously and placed on ice for 2
minutes. The tube was centrifuged at 500 × g for 5 minutes at 4° C. The fat cake and
infranatant were collected to a separate tube (as the cytoplasmic/post-nuclear and fat cake
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components) while not disturbing the pellet at the bottom. The cytoplasmic tube was spun
again in the same manner so that the fat cake and cytoplasmic-enriched infranatant could
be separated. The cytoplasmic/post-nuclear infranatant was collected with a 28.5G insulin
syringe, avoiding as much lipid as possible, at which point this sample was ready for BCA
protein concentration determination. The tube with the pellet was cleaned of excess lipid
on the sides of the tube by wicking carefully with a Kimwipe (Kimberly-Clark Professional,
34120), and the pellet was resuspended in 200 µL of NER, passed 5 times through a 28.5
gauge insulin syringe to break up the pellet, sonicated for 20 seconds in a sonicator bath,
vortexed vigorously for 30 seconds, and placed on ice for 40 minutes. Finally, the nuclear
natant was collected as the nuclear-enriched fraction after a 20-minute spin at 4° C at
18,000 × g. Cytoplasmic and nuclear fractions were assessed by Western blot after
normalization by BCA. Nuclear fractions tended to be at least 5-fold lower in protein
concentration.

Western Blotting
Gonadal adipose tissue was homogenized in RIPA buffer with protease and phosphatase
inhibitors (Thermo Fisher Scientific, 78446) using a Dounce homogenizer for at least 30
pulses, or until visibly homogenized. Homogenates were vortexed well and centrifuged at
10,000 ⨯ g for 10 minutes at 4° C. The resulting infranatant (below fat cake, and above
cell debris pellet) was transferred to a new tube with an insulin syringe (28.5G). Cultured
adipocyte whole-cell homogenates were homogenized in RIPA buffer with 1 mM PMSF,
and protease and phosphatase inhibitors (Thermo Fisher Scientific, 78446). Cultured
adipocyte cell fractions were collected as described in Cellular Fractionation for Nuclear
and Cytoplasmic Enrichment. Protein content was quantified using a BCA protein
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determination assay (Thermo Fisher Scientific, 23225). 5-10 µg protein was used for
western blotting. gWAT whole-cell homogenates, cultured adipocyte whole-cell
homogenates, and fractionated adipocyte proteins were separated by SDS-PAGE, and
transferred to PVDF membranes. The membranes were blocked for 1 hour in 5% BSA.
Proteins were detected using HRP-linked anti rabbit secondary (1:5000; Cell Signaling
Technology, 7074), Clarity ECL Western Blotting Substrate (Bio-Rad, 1705061) for HRP,
and a ChemiDoc Imaging System (Bio-Rad, 17001401, 17001402). Blots were assessed
for protein expression of proteins shown in the table on the following page. Vinculin
(1:2,000; Cell Signaling Technology, 4650), Ponceau S, and stain-free total protein were
used to determine even loading. Band intensity was quantified using ImageJ.

Application Target

Antibody

Host

Supplier

Western
blot
Mouse HDAC1
Rabbit Bethyl
Western
blot
Mouse HDAC2
Rabbit Bethyl
Western
blot
Mouse HDAC3
Rabbit Bethyl
Western
Histone
Cell Signaling
blot
Mouse H3
Rabbit Technology
Western
Cell Signaling
blot
Mouse Lamin B1
Rabbit Technology
Western
Cell Signaling
blot
Mouse Vinculin
Rabbit Technology
Western
HRP-antiCell Signaling
blot
Rabbit Rabbit IgG Goat
Technology
W.B. and
ChIP
Mouse BMAL1
Rabbit Bethyl
W.B. and
ChIP
Mouse CLOCK
Rabbit Bethyl
Antibodies used for Western blotting analysis.

158

Catalog
#
A300713A
A300705A
A300464A

Concentration
or Dilution

1:2,000
1:2,000
1:5,000

4499

1:2,000

13435

1:1,000

4650

1:1,000

7074
A302616A
A302618A

1:5,000
1 µg per IP
1 µg per IP

Mice
Adipocyte-specific Sphk1 knockout (SK1fatKO) and WT C57BL/6 mice were utilized for in
vivo studies (Anderson, et al., 2020). WT and SPHK1-/- C57BL/6 mice were utilized for
primary cell culture preparations for adipocytes (Allende, et al., 2004; Pappu, et al., 2007).

Animal Model
All animal experiments conformed to the Guide for the Care and Use of Laboratory
Animals and were in accordance with Public Health Service/National Institutes of Health
guidelines for laboratory animal usage. The experimental groups consisted of male WT
and SK1fatKO C57BL/6 mice. Mice were housed in the animal facility at the Medical
University of South Carolina. Standard chow and water were provided ad libitum, except
when fasting was required (e.g., glucose tolerance testing). Animals were maintained on
a 12h:12h light:dark cycle and ambient temperature was steadily 21° C. For diurnal
experiments, unfasted WT and SK1fatKO mice were sacrificed at ZT0, 3, 6, 9, 12, 15, 18,
and 21, which corresponds to 6 a.m., 9 a.m., 12 p.m., 3 p.m., 6 p.m., 9 p.m., 12 a.m., and
3 a.m. At the time of sacrifice, mice were humanely euthanized by isoflurane (Hospira,
Inc., Lake Forest, IL) followed by cardiac puncture. Cardiac blood was prepared for nonhemolyzed serum, aliquoted, and stored at -80° C until further analysis. Tissues were
collected accordingly as fresh snap frozen in liquid nitrogen and stored at -80° C until
further processing. All experiments were performed under clean conditions, were
approved by the Medical University of South Carolina Institutional Animal Care and Use
Committee, the Virginia Commonwealth University Institutional Animal Care and Use
Committee, the Ralph H. Johnson Veterans Affairs Medical Center, and the Hunter
Holmes McGuire Veterans Affairs Medical Center.
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Serum Cholesterol and Triacylglycerol Measurements
Non-hemolyzed serum was tested for levels of total cholesterol (total free and total
cholesterol esters) and total triacylglycerol with commercially available kits (Cayman
Chemical, 10007640, 10010303). For the cholesterol assay, sera were diluted 1:300 using
a kit-provided buffer, and for the triacylglycerol assay, the sera were tested
undiluted/”neat.”

Noninvasive Comprehensive Lab Animal Monitoring System (CLAMS)
Male WT and SK1fatKO C57BL/6 mice, 12-16-weeks old, were housed at the Center for
Comparative Medicine at the University of Alabama at Birmingham under controlled
conditions (28 ± 1°C and 12-h:12-h LD cycle enforced by environmental chambers) within
a Comprehensive Laboratory Animal Monitoring System (CLAMS; Columbus Instruments
Inc., Columbus, OH). These studies were approved by the Medical University of South
Carolina Institutional Animal Care and Use Committee, the University of Alabama at
Birmingham Institutional Animal Care and Use Committee, and the Ralph H. Johnson
Veterans Affairs Medical Center. All mice were housed singly (n=6 per genotype), and
allowed to acclimatize to the CLAMS for 7 days prior to initiation of the experimental
protocol; during acclimatization, mice received standard rodent chow ad libitum.
Throughout all studies, water was provided in an ad libitum fashion. The chow provided in
all studies was Harlan NIH-31 Irradiated Open formula Mouse/Rat Diet (4.7% fat).
Continuous 24-hour monitoring of behavioral and physiological parameters was
performed using the CLAMS. Twenty-four-hour patterns of energy expenditure (indirect
calorimetry), physical activity (beam breaks), and food intake were measured.
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Cosinor Statistical Analysis
A single component cosinor nonlinear regression goodness of fit analysis was performed
in Graphpad Prism 8 according to definitions from accepted literature (Cornelissen, 2014;
Halberg, 1969; Halberg & Johnson, 1967; Morelli, et al., 2019; Refinetti, et al., 2007). The
equation used for this analysis was : f(t) = MESOR + A * Cos[(2 πt/T)+ Acrophase].
MESOR is the “midline estimating statistic of rhythm” and this value corresponds with the
rhythm adjusted mean of the dataset or “baseline” value. Amplitude (A) is calculated as
half the difference between the minimum and maximum, as defined by the cosinor fitted
curve. The acrophase is the measure of the time at which overall high values recur in each
cycle. R2 corresponds to how well the dataset fit the standard cosinor curve, with 1 being
a perfect fit. In other words, R2 is the resulting statistic that measures the percent variance
accounted for by the 24 h approximating waveform (Bray, et al., 2013). Time (t) is
presented in hours, where .5 hour is equivalent to 30 minutes. The constants in this
equation are 2 × π × 1/T, where T is assumed to be a period of 24 hours. Thus, 1/12 π =
0.2618.

General Statistical Analysis
All values are presented as mean ± SEM. For comprehensive lab animal monitoring
system, values are also presented as violin plots, showing the median in bold solid lines,
and the upper and lower quartiles in dashed black lines. For single pairwise comparisons
of normally distributed data sets, a Student’s t-test was performed. For multiple
comparisons of means, a one-way ANOVA with Tukey-Kramer post hoc test was
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performed. p<0.05 was considered statistically significant. All hypothesis tests were
conducted using Graphpad Prism 8 software.
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CHAPTER 5

SUMMARY AND PERSPECTIVE
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Although the subject matter of sphingolipids, the adipocyte, and the circadian clock
are esoteric entities to bring together, there exists the rationale to pay attention to their
interplay. We have described here functions for SPHK1 and S1P in adipocyte circadian
processes like lipolysis, organismal metabolic processes like glucose utilization and
clearance, and novel circadian histone modification.
Many lipid and nutrient species in the circulation are known to have circadian
expression patterns (Bailey, et al., 2014; Brunkhorst, et al., 2019; Gooley, 2016; Gooley
and Chua, 2014; Kessler, et al., 2018; Shostak, et al., 2013; van den Berg, et al., 2018).
Moreover, the adipocyte is poised to influence these circulating species due to its
extraordinary secretory capacity (Scherer, 2006; Sulaieva, et al., 2018). In addition, a
sprinkling of reports in the literature implicated sphingolipids as possibly being regulated
by circadian rhythm (Brunkhorst, et al., 2019; Druzd, et al., 2017; Loizides-Mangold, et al.,
2017). Quite importantly, it was emphasized that fatty acids directly impact sphingolipid
biosynthesis; that is, palmitate is the most common free fatty acid substrate utilized in de
novo sphingolipid biosynthesis, and palmitate (palmitic acid) is the most commonly found
free fatty acid in mammals, with 16 carbons in its acyl chain (Geng, et al., 2015; Ross, et
al., 2013; Russo, et al., 2012; Wang, et al., 2014). Therefore, the adipocyte, which
specializes in metabolizing and storing circadian fatty acids, would most likely influence
local adipocyte sphingolipid biosynthetic pathways.
At the beginning of the project, it was hypothesized that cycling fatty acids could
be eliciting a cyclic transcriptional activation signal for Sphk1. This possibility was not ruled
out, but instead the project focused on the E-boxes that were present in the Sphk1
promoter and found that BMAL1 and CLOCK transcription factors were detectable over
background at some time points but not all time points over 24 hours (Figure 10). To test
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the effect of fatty acids would have introduced a step further upstream from the disrupted
clock components being studied. Sphk1 is not particularly abundant in the healthy
adipocyte, so attempting to modify Sphk1 by fatty acids to then probe further downstream
circadian markers would have been murky at best. That would truly be a project in itself,
perhaps visualizing a labeled fatty acid as well as a transfected fluorescently-tagged
SPHK1 and further subjecting that to a circadian time course protocol.
The emphasis of adipocyte biology was strong because the Cowart lab specialized
in metabolic disease, and many questions about the roles of sphingolipids in adipocytes
were left to be answered. Adipocytes are one of the lynchpins of metabolic homeostasis,
by acting like a sponge to take up excess circulating lipid. In other words, the membranes
of adipocytes are highly plastic and dynamic, able to quickly take on increases and
decreases in cell surface area and morphology while storing neutral lipids in its large
droplet. This emphasizes the importance of sphingolipids in the adipocyte, for they are
membrane structural molecules themselves, but also peculiar bioactive signaling
molecules that impact cell function from autophagy to inflammation.
The hypothesis that, the adipocyte sphingolipids and the adipocyte circadian clock
interact, grew from the known metabolic facts that fatty acids and lipids in circulation are
not constant and that fatty acids directly affect sphingolipids. Moreover, obesity is highly
characterized by the derangement of adipocytes, and it is well-established that misaligned
circadian clocks (e.g., due to shift-working) elicit deleterious effects upon the human body,
and this has been demonstrated in a variety of laboratory animal models (Chaix, et al.,
2019; Esquirol, et al., 2009; Karlsson, et al., 2009; Ramin, et al., 2015). Obesity is also
known to increase SK1 expression and S1P levels, in rodents and in patients in the clinic
(Anderson, et al., 2020; Kowalski, et al., 2013; Nagahashi, et al., 2018)
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Sphingosine kinase 1, responsible for the phosphorylation of sphingosine to
sphingosine-1-phosphate, is integral to maintaining the balance of sphingolipid
metabolites. Between cells, tissues, and circulating fluids, S1P gradients are tightly
controlled to elicit important responses, such as the gradient of S1P necessary to bring
thymocytes out of the lymphoid organs and into the lymphatic fluid (Druzd, et al., 2017;
Obinata and Hla, 2019). Evolutionarily speaking, segregating the action of S1P to a
particular time of the day is advantageous for the fitness of the organism so that proinflammatory and pro-mitogenic signaling are concerted with other physiological
processes. Since S1P is a bioactive lipid and has strong effects on the liver, it further
corroborates the evolutionary necessity for S1P to be cyclically stimulating a robustly
circadian organ (Geng, et al., 2015). Moreover, fatty acids are known to oscillate in the
circulation, which may contribute then to potential cyclical activation of the sphingolipid
biosynthetic pathway. It remains to be seen the true extent to which the circadian clock
and sphingolipids may cross-regulate one another.
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CHAPTER 6

SOLUTIONS TO BE FOUND
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This project could have benefitted from a commercially available anti-SPHK1
(SPHK1 of mouse origin) antibody that detects native SPHK1 but not the truncated protein
lacking exons 3-6 in the Cowart lab’s model (Allende, et al., 2011). Future endeavors with
SPHK1 might involve in-house generation of a suitable antibody. Moreover, primary
culture of adipocytes is cumbersome due to the 7-day grow-up period and the ~10-day
differentiation period. This makes transfection of these cells difficult since plating occurs
approximately 10 days before the cells are mature, lipid-filled adipocytes for harvest
(Figure 15). Moreover, this severely hampers turnaround time and continuity for
experimental processing and interpretation.
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Figure 15. Matured primary adipocytes in culture. Under bright light, mature
adipocytes are visualized as the golden cells with circular lipid droplets. The slight blue
color pictured beneath the mature rounded adipocytes is barely visible, indicating that the
culture achieved >90% differentiation. However, some preadipogenic precursors and
stromal stem cells remain below, which is typical in a semi-purified primary culture system
as this one. SK1-/- is SPHK1-/-.
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It is believed that the significance of circadian regulation of SPHK1 conveys to
other cellular systems, especially considering the pulsatile Sphk1 message levels in a
circadian mouse lung dataset (Supplemental Figure 5). Therefore, further studies into
Sphk1 and circadian regulatory mechanisms may be explored more deeply and
comprehensively in a simpler cell line model, perhaps of human origin. Some experiments
of particular interest would be to transfect cells with circadian clock components (as
control, overexpression, and/or knockout vectors, with or without fluorescent tags) and
assess several aspects described in this work, but at an -omics level. For example, under
conditions of Bmal1 overexpression and depletion, to answer whether SPHK1 (and
sphingolipids in general) become disrupted, assess by transcriptomics the expression of
sphingolipid genes, analyze by proteomics the same, perform ChIP-Sequencing in
BMAL1- and CLOCK-based immunoprecipitations, and determine by lipidomics/tandem
mass spectrometry the effect on sphingolipid species levels in cells and media. These
experiments could also be doubled-up with side-by-side fumonisin B1 treatments, to inhibit
the de novo biosynthesis pathway and instead probe the circadian nature of the recycling
pathways.
A troublesome aspect for the project was the apparent non-response of the clock
to exogenously added S1P. For example, various experiments were performed to
determine if S1P addition and/or antagonism of the 5 S1P receptors influenced core clock
transcripts and proteins, but nothing notable transpired from such treatments according to
the readouts measured, which was typically BMAL1 protein expression (Anderson, data
not shown). Moreover, antagonists of the S1P receptors were utilized in the absence and
presence of S1P to also determine if an S1P/S1P-receptor-based mechanism was at play;
and similar to before, treatments with S1Pr antagonists and subsequent protein
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expression assessment of core clock proteins revealed no differences among treatments
and control (Anderson, data not shown). This led the logic down the path that SPHK1 is
acting in a manner independent of its enzymatic product or that S1P was acting through
an intracellular mechanism that could not properly be assessed simply by adding
exogenous S1P to the cell culture media.
Another probable and tantalizing reason for the lack of response to exogenous
S1P treatment could be the identity of the experimental carrier/vehicle used in the Cowart
lab model, which is fatty acid-free BSA, since albumin is a known carrier of S1P in the
bloodstream (Kharel, et al., 2020). This is a tantalizing idea because perhaps albuminbound S1P is well-suited to act on hepatocytes, where a clear response to S1P/albumin
is noted in various experiments in the Cowart lab, such as phosphorylation of AKT at
serine 473 (Montefusco and Jamil, unreported). The same experiment in primary
adipocytes does not yield an increase in pAKT (Anderson, data not shown). Insulin
treatment in HEK293 cells stimulated pAKT at serine 473, but S1P treatment side-by-side
did not induce such phosphorylation of AKT (Zaslavsky, et al., 2005). Perhaps the
adipocyte would rather take in S1P from a lipoprotein particle rather than albumin, a
hypothesis worth further testing in the future. Moreover, many other labs studying S1P
utilize the albumin carrier to conduct S1P signaling analyses. It was always important that
the albumin was especially prepared without fatty acids in order to reduce the confounding
effects of other signaling lipids as well as to facilitate efficient S1P complexing to albumin.
The other known prominent S1P carrier in the circulation is high density lipoprotein (HDL),
specifically the ApoM moieties (Blaho, et al., 2015; Kurano, et al., 2020). It was also shown
recently that S1P can be transported by ApoA4 (Obinata, et al., 2019). Perhaps
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experiments in the future may utilize HDL-like carriers for S1P exogenous treatments in
cell culture, as long as HDL carriers are readily available as reagents.
Secretory extracellular vesicles from hepatocytes were shown to carry S1P in a
SK1- and SK2-dependent fashion, in which S1P promoted a deleterious pro-inflammatory
phenotype in neighboring immune cells which responded to the vesicles of S1P (Liao, et
al., 2018). Moreover, it is well-known that S1P undergoes “inside-out” autocrine signaling,
meaning that it is readily export out of the cell once it’s generated by intracellular kinase
action (Nagahashi, et al., 2018; Takabe, et al., 2008). This would highly suggest that any
cell type other than lipoprotein-excreting-capable cells (i.e., hepatocytes) must be
secreting S1P in a fashion independent of these known HDL-associated apolipoproteins.
Thus, it is hypothesized that S1P leaving the adipocyte and re-entering the adipocyte is
either free, albumin-bound, or unidentified other carrier-bound. These notions are worth
further investigation in the future. It was stated in a biophysical study of S1P that “two
important differences between S1P and ceramide are that S1P stabilizes the lipid bilayer
structure, and physiologically relevant concentrations of S1P can exist dispersed in the
cytosol” (García-Pacios, et al., 2009).
S1P was also discovered to travel throughout the circulation on HDL through
apolipoprotein M, and it was found that the identity of the carrier for S1P generally had
effects on its signaling and degradation kinetics (Christoffersen, et al., 2011; Kurano, et
al., 2013; Mishima, et al., 2018). S1P and ApoM were shown to ameliorate insulin
resistance by enhanced phospho-AKT signaling in livers of mice overexpressing ApoM
(Kurano, et al., 2020). Moreover, ApoM-bound S1P (but not albumin-bound) led to
decreases in lymphopoiesis, thereby maintaining physiological levels of circulating
immune cells and gating against autoreactive autoimmune responses (Blaho, et al., 2015).
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In mice lacking both ApoM and albumin, S1P was still detectable and identified on another
HDL carrier, ApoA4 (Obinata, et al., 2019). In humans, it was found that single nucleotide
polymorphisms in ApoA4 and other triacylglycerol-modulating genes were correlated with
worse atherosclerosis-based clinical outcomes in a population samples from China (Fu,
et al., 2015). Additionally, Yu and coworkers found that liposomal-S1P versus nonliposomal S1P had differential migratory effects on various cell lines in culture (Yu, et al.,
2009). In another study utilizing liposomes (consisting of egg phosphatidylcholine and
cholesterol) as a drug delivery vehicle, N,N,N-trimethylsphingosine (TMS) was efficiently
delivered to cancer cells while having lower toxicity to healthy tissue (especially blood)
compared to delivery of free TMS (Park, et al., 1994). Liposomes are widely used in the
cancer field and medicine to better deliver drugs, with liposomes conferring such
properties as better efficacy, targeted release, longer half-life, and better tolerability.
These studies seriously suggest that the cargo, carrier, chaperone, or other vehicle
for S1P is crucial to its downstream signaling and physiological effects. Thus, future
studies should aim to clearly associate findings not just with S1P itself but the carrier to
which S1P was complexed for any experiments. This further suggests that cell types are
specialized to receive S1P in a specific context and not just on any carrier in order to elicit
effects.
Studies from this project utilized S1P on fatty-acid-free bovine serum albumin,
which is typical for much of the current literature. It is well-accepted that S1P binds albumin
as well as HDL, owing to the amphipathic/zwitterionic properties of the phosphorylated
long chain amino alcohol (Camerer, et al., 2009; Sposito, et al., 2019). However, findings
from others and anecdotal evidence from this project would suggest that adipocytes may
not respond readily to albumin-bound S1P. Thus, further studies in the future may aim to
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characterize the role of S1P in physiology by testing treatments that specify albumin,
exosome/extracellular vesicle/liposome, ApoM, ApoA4, or simply HDL.
Similar to work of others, we observed that SPHK1-/- adipocytes accumulated the
substrate for SPHK1, sphingosine (data not shown). Wilkerson et al. demonstrated that
the retinas of SPHK1-/- mice also accumulated approximately double the amount of
sphingosine compared to WT (Wilkerson, et al., 2019). Moreover, we observed in the
SPHK1-/- animals no overt phenotypic consequences of genetic depletion, just as others
did (Lima, et al., 2017; Wilkerson, et al., 2019). Besides the mostly unchanged gross
phenotypic examination, important processes became disrupted with SPHK1 depletion,
such as endocytosis and the adhesion among retinal cells (Lima, et al., 2017; Wilkerson,
et al., 2019). In agreement with the overall findings by Wilkerson et al, Terao and
colleagues found that light stimulus can induce the release of S1P from retinal cells,
implicating a light-responsive property of SK1 (Terao, et al., 2019). These data indicate
that further exploration of SK1 regulation is critical.
In the studies carried out in the Cowart lab, it was found in SPHK1-/- primary
adipocytes that histone acetylation and circadian timing were defective due to depletion
of SPHK1-/-. Hinting that the sphingosine kinases are not as straightforward as might be
expected, Ravichandran et al. assessed metabolic parameters in SPHK2-/- mice, such as
circulating insulin, glucose, and triglycerides (insulin and TAGs were lower, in contrast to
the Cowart SK1fatKO model), and they also showed that adipose of these mutant mice were
not as heavy as control adipose tissue; however, they did not assess anywhere in the
study the concentration of S1P in the blood or tissues (Ravichandran, et al., 2019). It is
worth noting that it is well accepted in the sphingolipid field that SPHK2-/- mice have higher
circulating S1P, which still has yet to fully be explained, although now is thought to rely on
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the lipid phosphate phosphatase 3 transporter (Kharel, et al., 2012, 2020). In another
model, Qin and colleagues showed that SPHK1 depletion in human fibroblasts resulted in
an increase in the substrate sphingosine compared to control, and they reported an
increase in S1P in the SPHK1-/- condition, but did not offer a dedicated discussion for this
particular finding (Qin, et al., 2018). These somewhat perplexing findings illustrate that the
regulation of SPHKs is complex.
The deconvolution of the actions of Sphk1, Sphk2, and S1P (as well as the S1Pdegrading and -transporting enzymes) is critical for a lucid comprehensive understanding
of these special lipid kinases and their bioactive lipid product. Genetic ablation of either of
the isoenzymes has reliably produced conflicting results with supposedly specific
pharmacological inhibitors of the SK isoenzymes (Pyne, et al., 2017). Similar to our
findings that serum S1P and adipose S1P did not decrease in SK1fatKO mice, it was found
that circulating levels of S1P were increased in global Sphk2-/- mice (Anderson, et al.,
2020; Nagahashi, et al., 2016). Moreover, treatment with the SPHK2 inhibitor SRL080811
also paradoxically increased serum levels of S1P (Kharel, et al., 2011). Seemingly
contradictory findings such as these prompt the speculation that SPHK1 and SPHK2
actions are quite complicated and modification of the enzymes alone does not necessarily
predict a logical product outcome for S1P. Therefore, one other possibility or explanation
worth further investigation in the future is that genetic downregulation of Sphk1 with
concomitant unchanged S1P might suggest a dearth of export of intracellular S1P, as a
mechanism to hold on to what is needed inside the cell and perhaps mitigate the outward
transport for other (lower-priority) processes. That is, the intracellular actions of S1P in the
adipocyte are more precious than the expendable extracellular actions in the face of
Sphk1 depletion, therefore, total S1P levels as measured by sphingolipidomics do not
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yield a net change. Intuitively, however, evidence does indeed point to the substrate long
chain base sphingosine building up in SK1-/- adipocytes in vitro (data not shown).
In closing, the circadian clock is a complex system requiring special cell culture
conditions to properly study. As described previously, the regulation of SKs also is not
clean-cut. Here, it was shown that adipocyte SK1 impacts adipocyte cell morphology and
functional processes, such as lipolysis and circadian rhythm. Surprisingly, adipocyte SK1
deficiency also had measurable effects upon the liver, as demonstrated by histological
accumulation of lipid (steatosis) as well as deranged secretion of cholesterol and
triacylglycerol over time. More studies are needed to delineate the effects on the liver,
such as a circadian study of the tissue for transcriptional and histone status readouts.
These effects were observed despite not showing decreases in S1P. This could suggest
that specific pools of S1P generated by either kinase may act within the cell in a specific
manner depending on its source kinase. Again, these questions remain to be answered,
and could potentially direct the development of therapeutics in the future, especially
whether sphingolipid-based therapeutics are more effective when administered at a
particular time of the day.
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CHAPTER 7

MATERIALS AND METHODS
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Generation of Adipocyte-Specific Sphk1 Knockout (“SK1fatKO”) Mouse
Adipocyte-specific Sphk1 knockout mice (SK1fatKO) were generated by crossing B6; FVBTg(Adipoq-cre)1Evdr/J (Jackson Laboratory strain 010803) and B6N.129S6-Sphk1tm2Cgh/J
(Jackson Laboratory strain 019095) (Pappu, et al., 2007). Heterozygous mice were
crossed to generate homozygous flox/flox or +/+ breeding pairs. Genotype was confirmed
using primers for the floxed Sphk1 and Adipoq-Cre. Cre-mediated homologous
recombination removes exons 3-6 from the Sphk1 gene (Supplemental Figure 1A). WT
mice were all Cre carriers. Primers used for genotyping were as follows:
Cre1

5’ ACGGACAGAAGCATTTTCCA 3’

Cre2

5’ GGAGTGCCATGTGAGTCTG 3’

Cre3

5’ CTAGGCCACAGAATTGAAAGATCT 3’

Cre4

5’ GTAGGTGGAAATTCTAGCATCATCC 3’

Flox F

5’ GGAACCTGGCTATGGAACC 3’

Flox R1

5’ ATGTTTCTTTCGAGTGACCC 3’

Flox R2

5’ AATGCCTACTGCTTACAATACC 3’.

Gene depletion was confirmed by PCR amplification of a shortened fragment of the Sphk1
gene in adipocyte genomic DNA from flox/flox:CRE/CRE mice, further described and
shown in Supplemental Figure 1.

Animal Model
All animal experiments conformed to the Guide for the Care and Use of Laboratory
Animals and were in accordance with Public Health Service/National Institutes of Health
guidelines for laboratory animal usage. For Chapter 3, the experimental groups consisted
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of male and female WT and SK1fatKO C57BL/6 mice. Mice were housed in the animal facility
at the Medical University of South Carolina (in vivo studies), and Virginia Commonwealth
University (ex vivo studies). Food and water were provided ad libitum, except when fasting
was required (e.g., glucose tolerance testing). Animals were maintained on a 12h:12h
light:dark cycle and ambient temperature was steadily 21° C. For Chapter 3, animals were
randomized to a high saturated fat diet (HFD) (Envigo, TD.09766) (60% kcal provided by
milkfat) or an isocaloric low fat diet (CD) (Envigo, TD.120455) (17% kcal provided by lard)
at 6 weeks of age, and diets were administered for 18 weeks (n = 8-10 per group). On the
day of sacrifice, mice were fasted for 6 hours, and mice were euthanized humanely by
isoflurane (Hospira, Inc., Lake Forest, IL) followed by cardiac puncture. Cardiac blood was
prepared for non-hemolyzed serum, aliquoted, and stored at -80° C until further analysis.
Tissues were collected accordingly as fresh fixed in 10% neutral buffered formalin or fresh
snap frozen in liquid nitrogen and stored at -80° C until further processing. For Chapter 4,
the experimental groups consisted of male WT and SK1fatKO C57BL/6 mice. Mice were
housed in the animal facility at the Medical University of South Carolina. Standard chow
and water were provided ad libitum, except when fasting was required (e.g., glucose
tolerance testing). Animals were maintained on a 12h:12h light:dark cycle and ambient
temperature was steadily 21° C. For diurnal experiments, unfasted WT and SK1fatKO mice
were sacrificed at ZT0, 3, 6, 9, 12, 15, 18, and 21, which corresponds to 6 a.m., 9 a.m.,
12 p.m., 3 p.m., 6 p.m., 9 p.m., 12 a.m., and 3 a.m. At the time of sacrifice, mice were
humanely euthanized by isoflurane (Hospira, Inc., Lake Forest, IL) followed by cardiac
puncture. Cardiac blood was prepared for non-hemolyzed serum, aliquoted, and stored at
-80° C until further analysis. Tissues were collected accordingly as fresh snap frozen in
liquid nitrogen and stored at -80° C until further processing. All experiments were
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performed under clean conditions, were approved by the Medical University of South
Carolina Institutional Animal Care and Use Committee, the Virginia Commonwealth
University Institutional Animal Care and Use Committee, the Ralph H. Johnson Veterans
Affairs Medical Center, and the Hunter Holmes McGuire Veterans Affairs Medical Center.

Noninvasive Comprehensive Lab Animal Monitoring System (CLAMS)
For Chapter 4, male WT and SK1fatKO C57BL/6 mice, 12-16-weeks old, were housed at
the Center for Comparative Medicine at the University of Alabama at Birmingham under
controlled conditions (28 ± 1°C and 12-h:12-h LD cycle enforced by environmental
chambers) within a Comprehensive Laboratory Animal Monitoring System (CLAMS;
Columbus Instruments Inc., Columbus, OH). These studies were approved by the Medical
University of South Carolina Institutional Animal Care and Use Committee, the University
of Alabama at Birmingham Institutional Animal Care and Use Committee, and the Ralph
H. Johnson Veterans Affairs Medical Center. All mice were housed singly (n=6 per
genotype), and allowed to acclimatize to the CLAMS for 7 days prior to initiation of the
experimental protocol; during acclimatization, mice received standard rodent chow ad
libitum. Throughout all studies, water was provided in an ad libitum fashion. The chow
provided in all studies was Harlan NIH-31 Irradiated Open formula Mouse/Rat Diet (4.7%
fat). Continuous 24-hour monitoring of behavioral and physiological parameters was
performed using the CLAMS. Twenty-four-hour patterns of energy expenditure (indirect
calorimetry), physical activity (beam breaks), and food intake were measured.
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Glucose Tolerance Test
Intraperitoneal glucose tolerance tests were performed on mice after 8 weeks of diet
feeding (i.e., 14 weeks of age). Mice were fasted for 6 hours, before conducting a glucose
tolerance test, generally 0830 hr to 1430 hr. Blood was collected through a nick in the tail
and analyzed neat using a One Touch UltraSmart Blood Glucose Monitoring System at
fasting for baseline blood glucose concentration. Mice received a sterile 2 mg/kg Dglucose injection. Blood glucose was then assessed 15, 30, 60, and 120 minutes after
glucose injection.

Bioplex
Serum cytokines (insulin, leptin) were measured using a multiplex adipokine assay
service, akin to an ELISA method (Eve Biotechnologies).

Triglyceride Assay
Liver tissue homogenates were prepared according to the manufacturer’s instructions with
modifications (StanBio, 2200-225). Approximately 50 mg of liver tissue was homogenized
in 300 μL of solution of 2:1 100% EtOH and 30% KOH, respectively. This was vortexed
and allowed to incubate in a 60° C water bath for 5 hours until the solution turned a
translucent yellow with a visible pellet at the bottom. Then, 1.08 volumes of 1 M MgCl2
was added to the tube and vortexed to reach a milky consistency and left on ice for 10
minutes. Following this, tubes were vortexed and centrifuged for thirty minutes at 18,500
× g at ambient temperature. The supernatant was collected, diluted 1:10 with 1x PBS, and
subjected to the triglyceride assay according to the manufacturer’s instructions. In order
to normalize to protein concentration by BCA, an aliquot was taken from the homogenate
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prior to water bath incubation, dried down, and resuspended in 1x PBS. 10 μL of sample
and standards were assayed with 250 μL of the triglyceride reagent. Water was used as
a blank. Absorbances were read after 5 minutes’ incubation at 37° C at 500 nm.

qPCR
For Chapter 3, total RNA was isolated from gonadal adipose tissue and liver tissue
homogenized in Trizol (Invitrogen, 15596026) followed by RNeasy mini kit (Qiagen,
74106) extraction and column purification. RNA integrity in tissue was assessed using the
Agilent 2100 Bioanalyzer by the MUSC Proteogenomics Facility. All RNA samples had
RIN > 7. cDNA was synthesized from 1 μg of total RNA using iScript Advanced cDNA
Synthesis Kit (Bio-Rad, 1708890). Real time PCR was performed using a CFX96 RealTime System (Bio-Rad) and SSoAdvanced Sybr (Bio-Rad, 172-5272). The following
primers were used: Tbp (Qiagen, PPM03560F), Ppia (Qiagen, PPM03717B), Tnfα
(Qiagen, PPM03113G-200). Mean normalized expression was calculated by normalizing
to the geometric mean of reference genes Ppia and Tbp in gonadal adipose tissue (i.e.,
root2[Cq gene 1 ⨯ Cq gene 2]) using the 2-ΔΔCt method. Mean normalized expression was
calculated by normalizing to the expression of Hmbs1 in liver tissue. Other primers are
listed next:
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Gene

Forward (5' to 3')
AAGGGAGAATCATGGACCAG
GAGCTGTTTGCAGACAAAGTTC
ATGAGGGTGATTCGAGTGGG
TGTTCCTCTTAATCCTGCCCA
TGGCTTGCGAGACGTAGAC

Tbp
Ppia
Hmbs1
Adipoq
Arg1
Dgat2
GAGGGGTCTGGGCGATGGGGCAC
Fasn
GACTCGGCTACTGACACGAC
F4/80
TCATGGCATACCTGTTCACC
Il-6
TAGTCCTTCCTACCCCAATTTCC
iNOS
TTCCATGCTAATGCGAAAGG
Mcp1
TTAAAAACCTGGATCGGAACCAA
Sphk1
GAGTGCTGGTGCTGCTGAA
Sphk2
CACGGCGAGTTTGGTTCCTA
Tgf-β1
TGGCGTTACCTTGGTAACC
Primers used for qPCR analysis.

Reverse (5' to 3')
CCGTAAGGCATCATTGGACT
CCCTGGCACATGAATCCTGG
TTGTCTCCCGTGGTGGACATA
CCAACCTGCACAAGTTCCCTT
GCTCAGGTGAATCGGCCTTTT
CGACGGTGGTGATGGGCTTGGAGT

CGAGTTGAGCTGGGTTAGGG
GAATGGGAGCTAAGGTCAGTC
TTGGTCCTTAGCCACTCCTTC
GCTCCTCTTCCAAGGTGCTT
GCATTAGCTTCAGATTTACGGGT

AGGTTATCTCTGCCTCCTCCA
CTTCTGGCTTTGGGCGTAGT
GGTGTTGAGCCCTTTCCAG

For Chapter 4, total RNA was isolated from cultured primary adipocytes or gonadal
adipose tissue homogenized in Trizol (Invitrogen, 15596026) followed by RNeasy mini kit
(Qiagen, 74106) extraction and column purification. cDNA was synthesized from 1 μg of
total RNA using iScript Advanced cDNA Synthesis Kit (Bio-Rad, 1708890). Real time PCR
was performed using a CFX96 Real-Time System (Bio-Rad) and SSoAdvanced Sybr (BioRad, 172-5272). The primers used for cDNA qPCR and DNA CHIP-qPCR are shown in
the following table. Mean normalized expression was calculated by normalizing to the
geometric mean of reference genes Ppia and Tbp in gonadal adipose tissue (i.e., root2[Cq
gene 1 ⨯ Cq gene 2]) using the 2-ΔΔCt method. ChIP normalization was carried out with a
10% input control.
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Method
ChIP
ChIP
ChIP
ChIP
ChIP
ChIP
ChIP
ChIP
ChIP
ChIP
ChIP
qPCR
qPCR
qPCR
qPCR
qPCR
qPCR
qPCR
qPCR
qPCR

Gene
Cbxypa1
Atgl
Dbp
Lipe
Nr1d1 (Reverbα)
Per2
Per3
Pgc1α
Pparγ
Sphk1 -1800
Sphk1 -300
Ppia
Tbp
Bmal1 (Arntl)
Dbp
Nr1d1 (Reverbα)
Per2
Per3
Rorγ
Sphk1

Forward (5' to 3')

Reverse (5' to 3')

CATGGTCAAGGGTGAAAG
CGGCGGAGGCGGAGACGCT
AATGACCTTTGAACCTGATCCCGCT
GCTGCCCTGGGAGGATTAAGCC
ACGACCCTGGACTCCAATAA
CAACACAGACGACAGCATCA
CTGCTCCAACTCAGCTTCCTTT
GCAATTCAATTCGGGTCCATCTCACC
CTGTACAGTTCACGCCCCTC
TACACCGGGGCACGTGTGCATT
ACTTTGTCCCACGTGCATGGA
GAGCTGTTTGCAGACAAAGTTC
AAGGGAGAATCATGGACCAG
TGACCCTCATGGAAGGTTAGAA
CGTGGAGGTGCTTAATGACCTTT
TACATTGGCTCTAGTGGCTCC
CCATCCACAAGAAGATCCTAC

CTGAGGTCTGAGGCCTTTTT
TCCCTGCTTGATCCAGTTGGAT
GCTCCAGTACTTCTCATCCTTCTGT
CAAAAGCCTGAGAGGTTTCTCCGAG
CCATTGGAGCTGTCACTGTAGA
TCCTGGTCCTCCTTCAACAC
TTAGACAGCAAGGCTCTGGTTCT
GGACTTCAGCGTGTTTGCATTCAGTAC
TCACACTGGTGTTTTGTCTATG
TCTTTCCCCCCAGGGAACACTA
TCCCGCTGACAAGGGGCCA
CCCTGGCACATGAATCCTGG
CCGTAAGGCATCATTGGACT
GGACATTGCATTGCATGTTGG
CATGGCCTGGAATGCTTGA
CAGTAGGTGATGGTGGGAAGTA
GCTCCACGGGTTGATGAAGC

CCCTACGGTTGCTATCTTCAG
GACTGGAGGACCTTCTACG
GAGTGCTGGTGCTGCTGAA

CTTTCGTTTGTGCTTCTGCC
TCCCACATTGACTTCCTCTG
AGGTTATCTCTGCCTCCTCCA

Primers used for ChIP/qPCR and qPCR analysis.

Chromatin Immunoprecipitation
Primary WT and SPHK1-/- matured, synchronized adipocytes were plated on 15-cm plates
per 2 ChIPs. Briefly, cells were washed twice with room temperature 1x PBS and the
dishes were then placed on an orbital rocker (Sigma, Z768502) in a measured volume of
freshly-made PBS solution containing 2 mM disuccinimidyl glutarate (DSG) (ProteoChem,
c1104) for 10 minutes. After 10 minutes, fresh 37% formaldehyde (Fisher, BP531-500)
was added directly to the solution to a final concentration of 1% and continued swirling
gently for another 12 minutes. Finally, the crosslinking reactions were quenched with
glycine at a final concentration of 125 mM for 5 additional minutes. Following, the solution
was discarded as hazardous waste and the cells were washed twice with cold 1x PBS.
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The PBS was aspirated, and the cells were scraped into 1.8 mLs adipocyte hypotonic lysis
buffer (5mM PIPES pH 7.8, 10 mM KCl, 1% Igepal, plus protease/phosphatase inhibitors
and PMSF immediately before use) per 15-cm plate. The cells were collected in a Dounce
homogenizer and were sheared with 10 strokes of the Dounce until visibly dissociated.
The cells were also passed through a 22G needle to ensure disruption of the monolayer
but preservation of the nuclei. The resulting slurry was vortexed and kept on ice for 10
minutes. Next, the tubes were centrifuged at 8,500 ˟ g at 4° C for 8 minutes to remove a
significant fat cake at the top as well as the cytoplasmic infranatant and to leave the
nuclear pellet intact and undisturbed. The pellets were resuspended in the same lysis
buffer to wash excess adipocyte lipid from the nuclear pellet and vortexed. They were re
spun, and the pellets were saved. Next, the pellets were suspended in 600 µL sonication
lysis buffer (50 mM Tris-HCl, pH 8.0, 10 mM EDTA, 1% SDS, and protease/phosphatase
inhibitors and PMSF fresh) per 15-cm plate. The 600 µL was split into two 1.5-mL
Eppendorf tubes of 300 µL, and then were sonicated (Branson 150, Branson Ultrasonics,
Danbury, CT) for 8 rounds of 30 seconds on, 30 seconds off in a 4° C water bath. The
resulting sonicate was then subjected to centrifugation at 18,000 ˟ g at 4° C to clarify the
chromatin. The chromatin supernatant was collected and split to two chromatin
immunoprecipitations as well as the 10% input control. Thus, approximately 500 µL of
recovered sonicate was split to 200 µL per ChIP plus a 20-µL 10% input. The ChIP
samples were diluted 1:10 with Dilution/Low Salt buffer (20 mM Tris-HCl pH 8.0, 150 mM
NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% SDS), pre-cleared with ChIP-grade Protein
A/G magnetic beads (Thermo Fisher Scientific, 26162)

for one hour, and

immunoprecipitated with 1 µg of antibody overnight at 4° C while rocking. The following
day, pre-equilibrated magnetic ChIP-grade Protein A/G beads were added to the samples
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for 2 hours. They were then subjected to extensive washing on the magnetic rack,
performing two washes in Low Salt Buffer, 2 subsequent washes in high salt buffer (20
mM Tris-HCl pH 8.0, 500 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% SDS), 2
subsequent washes in LiCl Buffer (10 mM Tris-HCl pH 8.0, 500 mM NaCl, 1 mM EDTA,
1% deoxycholate, 1% NP-40, 0.25 M LiCl), and finally 2 washes in TE buffer (10 mM TrisHCl pH 8.0, 1 mM EDTA). After these 8 washes, 100 µL of ChIP elution buffer (0.1 M
NaHCO3, 1% SDS) was added to the beads, in addition to the reverse crosslinking
reagent, 4 µL of 5 M NaCl, and these were incubated overnight at 65° C. The next morning,
the samples were treated with RNase A (Thermo Fisher Scientific, EN0531) for 1 hour at
37° C, and after that, treated with Proteinase K (Thermo Fisher Scientific, EO0491) for 1
hour at 60° C. After this, the samples were subjected to DNA isolation and purification with
a column-based washing approach (Zymo Research, D5205). The samples were eluted
from the column in 120 µL and 2 µL per well, assayed in triplicate, were used for real time
qPCR of the DNA. Primers used for ChIP are shown in the previous section qPCR.
Antibodies used for ChIP are as follows:
Application

Target Antibody

Host

Supplier Catalog #

ChIP
ChIP
ChIP
W.B. and ChIP
W.B. and ChIP

Mouse H3K9ac
Mouse H3K27ac
Normal IgG
Mouse BMAL1
Mouse CLOCK

Rabbit
Rabbit
Rabbit
Rabbit
Rabbit

Thermo
Thermo
Bethyl
Bethyl
Bethyl

Antibodies used for ChIP analysis.
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Concentration or Dilution

710293
1 µg per IP
MA5-24671 1 µg per IP
P120-101 1 µg per IP
A302-616A 1 µg per IP
A302-618A 1 µg per IP

Basal Lipolysis Assay for Non-esterified Fatty Acids
Sera from mice and cell culture media containing only fatty acid-free bovine serum albumin
were prepared for non-esterified fatty acid assay according to the manufacturer’s
instructions (Wako Diagnostics, 999-34691, 995-34791, 991-34891, 993-35191, 27676491). Briefly, 5 μL of sample (neat or diluted 1:10), calibrators, and blank were added
in duplicate to a 96-well plate. 200 μL of Color Reagent A solution was added and
incubated at 37° C for 5 minutes. Absorbance at 550 nm was acquired. Next, 100 μL of
Color Reagent B solution was added and incubated at 37° C for 5 minutes. Absorbance
was read once more at 550 nm. After subtracting the blanks, the first reading was
subtracted from the second reading to obtain the final absorbance, and concentrations
were determined by standard curve normalization.

Glycerol Assay
Protocol was adapted from Sigma. 25 µL cell culture media was assayed in duplicate in a
96-well plate. 100 µL of free glycerol reagent (Sigma, F6428) was added per well and
incubated for 5 minutes at 37° C. Absorbance at 540 nM was measured on a
spectrophotometer. Relative concentrations of glycerol were determined by normalization
to a standard curve. Tissue explants glycerol release was normalized to tissue weight.

Lipolysis in Adipose Tissue Explants (ex vivo)
Gonadal adipose tissue was harvested from WT and SK1fatKO mice at 4-6 weeks of age.
Tissue was cut into ~12 mg pieces. Two pieces were added to each well of a 12-well plate
in 1 mL of DMEM/F12 (Corning, 10-090-CV) + 1% FAF BSA (Thermo Fisher Scientific,
9704100) and 1% penicillin streptomycin antimycotic solution (Sigma, A5955-100ML).
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Explants "rested" in the incubator overnight at 37° C and 10% CO2. The next day, explants
were transferred using clean forceps to new 12-well plates containing fresh media. Media
was collected after 24 hours for glycerol measurement.

Histology and Immunohistochemistry
Fresh liver tissue was snap frozen in liquid nitrogen. 10-µm frozen sections were prepared
for measurement of hepatic neutral lipid accumulation by Oil Red O staining. Sections
were counterstained with hematoxylin. Paraffin sections were prepared with adipose and
liver tissue fixed in 10% neutral buffered formalin (1 hour). Adipose sections were stained
with hematoxylin and eosin (H&E) for adipocyte size analysis. Slides were imaged on a
light microscope (Leica DMI1 microscope, Leica MC170 HD camera), and only for the
adipose H&E was a fluorescence microscope utilized for better contrast with a 555 laser.
For immunofluorescence histology, sections were subjected to antigen retrieval overnight
at 60° C in 10 mM sodium citrate, 0.05% Tween 20 pH 6.0 buffer. Slides were blocked
using 5% donkey serum (host secondary antibody species). Slides were imaged on a
Zeiss FV10i fluorescent microscope for myeloperoxidase (R&D Systems, AF3667, goat
anti-mouse MPO, 15 µg/mL), a marker of infiltrating inflammatory immune cells.
Secondary detection antibodies were from Life Technologies: Alexa 488 (Invitrogen, A11055, donkey anti-goat, 1:2000) and ToPro3 to stain nuclei (Thermo Fisher Scientific,
T3605, 1:2000). Ten representative images per slide were analyzed by fluorescence
intensity of puncta using ImageJ software.
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Serum Cholesterol and Triacylglycerol Measurements
Non-hemolyzed serum was tested for levels of total cholesterol (total free and total
cholesterol esters) and total triacylglycerol with commercially available kits (Cayman
Chemical, 10007640, 10010303). For the cholesterol assay, sera were diluted 1:300 using
a kit-provided buffer, and for the triacylglycerol assay, the sera were tested
undiluted/”neat.”

Cell Culture, Isolation of Stromal Vascular Fraction (SVF) and Differentiation to
Mature Adipocytes
Primary adipose-derived stem cells (ADSCs) were isolated from inguinal adipose tissue
of 3-8-week-old WT, SPHK1-/-, or SK1fatKO mice. Subcutaneous adipose tissue was
digested using 0.1% collagenase (Sigma, C6885) in digestion buffer (100 mM HEPES,
120 mM NaCl, 50 mM KCl, 5 mM glucose, 1 mM CaCl , 1.5% BSA) in a 37⁰ C shaking
2

incubator (New Brunswick Scientific) (150 rpm) for 40 minutes. The digest was filtered
through a 100-µM cell strainer and centrifuged at 500 ˟ g for 5 minutes. The SVF pellet
was re-suspended in media, filtered through a 40-µM cell strainer and plated. Media was
changed after two hours to remove non-adherent cells. Cells were grown to confluency in
proliferation media (DMEM/12 50:50 (Corning, 10-090-CV), 10% fetal bovine serum (FBS)
(Atlanta Biologicals), 1% penicillin streptomycin antimycotic cocktail (MilliporeSigma,
A5955). 48 hours post-confluency, differentiation was induced using 10 µg/mL insulin
(Santa Cruz Biotechnology, sc-360248), 1 µM dexamethasone (MilliporeSigma, D4902),
0.5 mM IBMX (Enzo Life Sciences, BMLPD1401000), and 1 µM rosiglitazone (Cayman
Chemical, 71740) for two days. Differentiation was maintained with insulin for days 3-4
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and proliferation media days 5-8. Mature adipocytes were visualized under a brightfield
microscope to assess lipid droplet formation, and plates with large lipid droplets and >90%
differentiation were used for experiments (Figure 15).

in vitro Circadian Rhythm
Unless otherwise noted, the in vitro circadian experiments are all performed in the same
manner, in which primary WT and SPHK1-/- ADSCs were brought to maturity, and on the
day of the experiment, the cells were synchronized with 50% horse serum (Gibco, 26050070) and 50% DMEM/F12 for 2 hours. Following the horse serum shock, the cell
monolayer was gently rinsed once with warm 1x PBS and 2% fatty-acid-free BSA in
DMEM/F12 was kept on the cells for the duration of the experiment, which generally lasted
48 hours in toto.

S1P Treatment
WT primary matured, synchronized adipocytes were allowed to cycle for 24 hours, after
which, cells were treated with a final concentration 150 nM S1P (Avanti Polar Lipids,
860492) complexed to 4 mg/mL FAF BSA or 4 mg/mL FAF BSA without S1P and assayed
by ChIP for acetylated histone H3 signal at various adipocyte and circadian gene loci.

17

C-Sphingosine Treatment

WT primary matured, synchronized adipocytes were allowed to cycle for 24 hours, after
which, cells were treated with a final concentration 5 µM

17

C-sphingosine (Avanti Polar

Lipids, 860640) (dissolved in 100% ethanol) for exactly 30 minutes, collected immediately
with addition of phosphatase inhibitors, for an exact volume of media in a 5-mL borosilicate
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glass tube and for a cell pellet in minimal PBS in a separate 5-mL borosilicate glass tube,
capped, and stored at -80° C until analysis by tandem liquid chromatography and mass
spectrometry lipidomics. This 30-minute procedure was repeated every 4 hours over a 24hour period to assay in situ the enzymatic turnover of

17

C-sphingosine to

17

C-S1P

(Spassieva, et al., 2007).

Lipid Measurements
For Chapters 3 and 4, sphingolipids were measured using liquid chromatography/tandem
mass spectrometry at the Virginia Commonwealth University Lipidomics and
Metabolomics Core and performed using previously published methods (Haynes, et al.,
2009; Shaner, et al., 2009). For Chapter 4, sphingolipids were also measured at the
Medical University of South Carolina Shared Lipidomics Resource according to previously
published methods (Bielawski, et al., 2010; Spassieva, et al., 2007).

Cellular Fractionation for Nuclear and Cytoplasmic Enrichment
The Thermo NE-PER Kit (Thermo Fisher Scientific, 78835) was utilized to separate
cytoplasmic (post-nuclear) and nuclear fractions from matured primary white adipocytes,
with modifications. In a 10-cm dish, adherent mature adipocytes were gently rinsed twice
with 1x PBS on the dish, and excess was aspirated with a 200-µL plastic pipet tip from the
tilted dish. Next, ~400 µL of CER I solution was added to the monolayer, and adipocytes
were scraped into the solution. Importantly, the collected cells were then passed through
a 22G syringe 5 times to disperse the cell conglomerate but keep the nuclei intact. These
were vortexed and placed on ice for 10 minutes. Next, per the NE-PER protocol, 22 µL of
CER II solution was added and tube was vortexed vigorously and placed on ice for 2
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minutes. The tube was centrifuged at 500 × g for 5 minutes at 4° C. The fat cake and
infranatant were collected to a separate tube (as the cytoplasmic/post-nuclear and fat cake
components) while not disturbing the pellet at the bottom. The cytoplasmic tube was spun
again in the same manner so that the fat cake and cytoplasmic-enriched infranatant could
be separated. The cytoplasmic/post-nuclear infranatant was collected with a 28.5G insulin
syringe, avoiding as much lipid as possible, at which point this sample was ready for BCA
protein concentration determination. The tube with the pellet was cleaned of excess lipid
on the sides of the tube by wicking carefully with a Kimwipe (Kimberly-Clark Professional,
34120), and the pellet was resuspended in 200 µL of NER, passed 5 times through a 28.5
gauge insulin syringe to break up the pellet, sonicated for 20 seconds in a sonicator bath,
vortexed vigorously for 30 seconds, and placed on ice for 40 minutes. Finally, the nuclear
natant was collected as the nuclear-enriched fraction after a 20-minute spin at 4° C at
18,000 × g. Cytoplasmic and nuclear fractions were assessed by Western blot after
normalization by BCA. Nuclear fractions tended to be at least 5-fold lower in protein
concentration.

Nuclear Extracts for Immunoprecipitation followed by Lipid Measurements
This method was developed in Hait, et al., 2009. WT primary matured, synchronized
adipocytes were allowed to cycle for 24 hours, after which, cells were harvested over a
time course. Cells were washed with cold PBS and re-suspended in buffer containing 10
mM HEPES (pH 7.8), 10 mM KCl, 0.1 mM EDTA, 1 mM Na3VO4, 1 mM DTT, 1:500
protease inhibitors (Sigma) and 0.2 mM PMSF, and incubated on ice for 15 min. NP-40
was added (0.75%) and cells were vortexed for 10 sec. Nuclei and supernatant
(“cytoplasm”) were separated by centrifugation at 1000 × g for 3 min at 4˚ C. Nuclei were
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resuspended in buffer containing 20 mM HEPES (pH 7.8), 0.4 M NaCl, 1 mM EDTA, 1
mM Na3VO4, 1 mM DTT and 1:500 protease inhibitors and incubated on ice for 15 min.
Nuclear extracts were cleared by centrifugation at 14,000 × g for 5 min at 4˚ C. Equal
milligrams protein from each fraction was immunoprecipitated overnight at 4˚ C (rotating)
with 1 µg BMAL1, HDAC1, and HDAC2 antibodies, and the next day immunocomplexes
were captured with Protein A/G magnetic beads (Thermo Fisher Scientific, 88802) for an
additional 2 hours at 4˚ C, then washed extensively. Immunocomplexes were eluted in
100% methanol and tested by LC:MS/MS at the Virginia Commonwealth University
Lipidomics and Metabolomics Core facility for sphingolipids.

Western Blotting
For Chapter 3, gonadal adipose tissue was homogenized in RIPA buffer with protease
and phosphatase inhibitors (Thermo Fisher Scientific, 78446) using a Dounce
homogenizer for at least 30 strokes, or until visibly homogenized. Homogenates were
vortexed well and centrifuged at 10,000 ⨯ g for 10 minutes at 4° C. The resulting
infranatant (below fat cake, and above cell debris pellet) was transferred to a new tube
with an insulin syringe (28.5G). Protein content was quantified using a BCA protein
determination assay (Thermo Fisher Scientific, 23225). 10 µg protein was used for
western blotting. Non-hemolyzed mouse sera was diluted in PBS 1:20, and isovolumetric
amounts of diluted sera plus loading buffer was loaded for western blotting. gWAT proteins
and sera proteins were separated by SDS-PAGE (Bio-Rad Criterion TGX Stain-Free
precast gels), and transferred to nitrocellulose membranes, and sera proteins were
transferred to PVDF membranes. The membranes were blocked for 1 hour in 5% BSA.
Proteins were detected using (gWAT) HRP-linked anti rabbit secondary (1:5000; Cell
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Signaling Technology, 7074) or (sera) StarBright-700-linked anti rabbit secondary
(1:2,500; Bio-Rad, 12004161), Clarity ECL Western Blotting Substrate (Bio-Rad,
1705061) for HRP, and a ChemiDoc Imaging System (Bio-Rad, 17001401, 17001402).
Blots were assessed for protein expression of adiponectin (1:2000; Cell Signaling
Technology, 2789), adipose triglyceride lipase (ATGL) (1:2000, Cell Signaling
Technology, 2439), ABHD5 (CGI-58) (1:1000, Novus Biologicals, NB100-5-7850), and
FABP4 (1:2000, Cell Signaling Technology, 2120). Vinculin (1:2,000; Cell Signaling
Technology, 4650) and stain-free total protein were used to determine even loading. Band
intensity was quantified using ImageJ. For Chapter 4, gonadal adipose tissue was
homogenized in RIPA buffer with protease and phosphatase inhibitors (Thermo Fisher
Scientific, 78446) using a Dounce homogenizer for at least 30 pulses, or until visibly
homogenized. Homogenates were vortexed well and centrifuged at 10,000 ⨯ g for 10
minutes at 4° C. The resulting infranatant (below fat cake, and above cell debris pellet)
was transferred to a new tube with an insulin syringe (28.5G). Cultured adipocyte wholecell homogenates were homogenized in RIPA buffer with 1 mM PMSF, and protease and
phosphatase inhibitors (Thermo Fisher Scientific, 78446). Cultured adipocyte cell fractions
were collected as described in Cellular Fractionation for Nuclear and Cytoplasmic
Enrichment. Protein content was quantified using a BCA protein determination assay
(Thermo Fisher Scientific, 23225). 5-10 µg protein was used for western blotting. gWAT
whole-cell homogenates, cultured adipocyte whole-cell homogenates, and fractionated
adipocyte proteins were separated by SDS-PAGE, and transferred to PVDF membranes.
The membranes were blocked for 1 hour in 5% BSA. Proteins were detected using HRPlinked anti rabbit secondary (1:5000; Cell Signaling Technology, 7074), Clarity ECL
Western Blotting Substrate (Bio-Rad, 1705061) for HRP, and a ChemiDoc Imaging
194

System (Bio-Rad, 17001401, 17001402). Blots were assessed for protein expression of
proteins shown in the table below. Vinculin (1:2,000; Cell Signaling Technology, 4650),
Ponceau S, and stain-free total protein were used to determine even loading. Band
intensity was quantified using ImageJ.

Application Target

Antibody

Host

Supplier

Western
blot
Mouse HDAC1
Rabbit Bethyl
Western
blot
Mouse HDAC2
Rabbit Bethyl
Western
blot
Mouse HDAC3
Rabbit Bethyl
Western
Histone
Cell Signaling
blot
Mouse H3
Rabbit Technology
Western
Cell Signaling
blot
Mouse Lamin B1
Rabbit Technology
Western
Cell Signaling
blot
Mouse Vinculin
Rabbit Technology
Western
HRP-antiCell Signaling
blot
Rabbit Rabbit IgG Goat
Technology
W.B. and
ChIP
Mouse BMAL1
Rabbit Bethyl
W.B. and
ChIP
Mouse CLOCK
Rabbit Bethyl
Antibodies used for Western blotting analysis.

Catalog
#
A300713A
A300705A
A300464A

Concentration
or Dilution

1:2,000
1:2,000
1:5,000

4499

1:2,000

13435

1:1,000

4650

1:1,000

7074
A302616A
A302618A

1:5,000
1 µg per IP
1 µg per IP

Cosinor Statistical Analysis
A single component cosinor nonlinear regression goodness of fit analysis was performed
in Graphpad Prism 8 according to definitions from accepted literature (Cornelissen, 2014;
Halberg, 1969; Halberg & Johnson, 1967; Morelli, et al., 2019; Refinetti, et al., 2007). The
equation used for this analysis was : f(t) = MESOR + A * Cos[(2 πt/T)+ Acrophase].
MESOR is the “midline estimating statistic of rhythm” and this value corresponds with the
rhythm adjusted mean of the dataset or “baseline” value. Amplitude (A) is calculated as
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half the difference between the minimum and maximum, as defined by the cosinor fitted
curve. The acrophase is the measure of the time at which overall high values recur in each
cycle. R2 corresponds to how well the dataset fit the standard cosinor curve, with 1 being
a perfect fit. In other words, R2 is the resulting statistic that measures the percent variance
accounted for by the 24 h approximating waveform (Bray, et al., 2013). Time (t) is
presented in hours, where .5 hour is equivalent to 30 minutes. The constants in this
equation are 2 × π × 1/T, where T is assumed to be a period of 24 hours. Thus, 1/12 π =
0.2618.

Statistical Analysis
All values are presented as mean ± SEM. For single pairwise comparisons of normally
distributed data sets, a Student’s t-test was performed. For multiple comparisons of
means, a one-way ANOVA with Tukey-Kramer post hoc test was performed. p<0.05 was
considered statistically significant. All hypothesis tests were conducted using Graphpad
Prism 8 software.
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